Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download here - EULAR
Document related concepts
Transcript
http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... EULAR 2016 Congress London - Preliminary Scientific Programme - PLEASE OBSERVE THE EMBARGO Please note that this is a Preliminary Version of the Scientific Programme for the EULAR Congress 2016 in London. The programme is subject to change at any time. THE EULAR ABSTRACT EMBARGO IS IN PLACE UNTIL 8 JUNE 2016 00:01 CET. See the EULAR Congress Website Details on Oral Abstract Presentations and Poster Tours will be published approximately one month prior to the congress. Until then, you will see the lecture slot, but without presenter name and without abstract title. To select single time slots, please use the drop down selection option (Standard: Overview all days and sessions). To print, please use the 'File - Print' option of your browser. Best results are achieved using landscape and scaling down to 75 percent in the printer preferences. Wednesday 08.06.2016 13:30 - 14:30 Health Professionals Session - Capital Suite 07 Health Professional Welcome Session Chair Backhouse Michael (United Kingdom) Chair Cornell Patricia (United Kingdom) Speaker Opava Christina H. (Sweden) Update on HP scientific and educational subcommittees work Speaker Redmond Anthony (United Kingdom) Update on HP standing committee Speaker Adams Jo (United Kingdom) HP mentoring and networking activities Speaker Faculty (-) Interaction with the faculty Wednesday 08.06.2016 15:00 - 16:30 What is New (WIN) - ICC Auditorium WIN Session 1 Speaker 1 of 111 Kallenberg Cees G.M. (Netherlands) SP0001 Vasculitis 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Varga John (United States) SP0002 Systemic Sclerosis Challenges in Clinical Practice Session - Hall B Catastrophizing pain in RA Chair Hetland Merete (Denmark) Chair Bliddal Henning (Denmark) Presenter Mathiessen Alexander (Norway) SP0003 Case 1 presentation: "an RA patient with catastrophizing pain" Discussant Hammer Hilde Berner (Norway) SP0004 Case 1 discussion: The impact of catastrophizing in obtaining remission in RA Presenter Rifbjerg-Madsen Signe (Denmark) Discussant Amris Stine (Denmark) Case 2 presentation: "An RA patient in remission with persistent pain" SP0005 Case 2 discussion: The PDQ used as a clinical tool Clinical Science Session - Hall D Axial spondyloarthritis and psoriatic arthritis: Emerging pathways Chair van der Heijde Désirée (Netherlands) Chair Poddubnyy Denis (Germany) Speaker Baeten Dominique (Netherlands) SP0006 The IL17-pathway Speaker Elewaut Dirk (Belgium) The IL 22/23-pathway Speaker Lories Rik (Belgium) The role of mechanostress Abstract Braun Juergen (Germany) OP0001 EFFECT OF SECUKINUMAB, AN INTERLEUKIN-17A INHIBITOR, ON SPINAL RADIOGRAPHIC CHANGES THROUGH 2 YEARS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF THE PHASE 3 STUDY, MEASURE 1 Abstract van der Heijde Désirée (Netherlands) OP0002 TOFACITINIB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: A PHASE 2, 16-WEEK, RANDOMISED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY How to Treat / Manage (HOT) - Hall E HOT Session 1 2 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Richette Pascal (France) Speaker Ostergaard Mikkel (Denmark) Gout and CPPD SP0007 Imaging in diagnosis Clinical Science Session - Hall C Balancing benefits and risk of glucocorticoids; a challenge for implementation Chair van der Goes Marlies (Netherlands) Chair da Silva José Antonio P. (Portugal) Speaker Buttgereit Frank (Germany) SP0008 Under what conditions may long-term glucocorticoids have a good benefit-risk ratio Speaker Caeyers Nele (Belgium) SP0009 Patients view on the EULAR recommendations Speaker de Wit Maarten (Netherlands) SP0010 Can we change perceptions? Speaker Jacobs Johannes W.G. (Netherlands) SP0011 Long-term glucocorticoid use and the skin Abstract Stone John H. (United States) OP0003 DEVELOPMENT OF A GLUCOCORTICOID TOXICITY INDEX USING MULTI-CRITERIA DECISION ANALYSIS Outcome Science Session - Hall A What CVD outcomes to use in clinical rheumatological practice? 3 of 111 Chair Finckh Axel (Switzerland) Chair Clarson Lorna (United Kingdom) Speaker de Pablo Paola (United Kingdom) Which CV outcomes are increased in immune mediated diseases and to what extend? Speaker Sattar Naveed (United Kingdom) SP0012 How to assess the CVD risk in the individual patient ? Speaker Nurmohamed Michael (Netherlands) SP0013 Is it enough just to treat inflammation? Abstract Gossec Laure (France) OP0004 COLLECTION AND MANAGEMENT OF SELECTED COMORBIDITIES AND THEIR RISK FACTORS IN CHRONIC INFLAMMATORY RHEUMATIC DISEASES IN DAILY PRACTICE IN FRANCE 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Ikdahl Eirik (Norway) OP0005 HOW TO IMPLEMENT CARDIOVASCULAR DISEASE RISK ASSESSMENT FOR PATIENTS WITH INFLAMMATORY JOINT DISEASES IN DAILY RHEUMATOLOGY PRACTICE: AN OVERWIEW OF THE NATIONWIDE NOCAR PROJECT Health Professionals Session - Capital Suite 07 Different perspectives on pain in osteoarthritis Chair van der Esch Martin (Netherlands) Chair Ferreira Ricardo (Portugal) Speaker Arendt-Nielsen Lars (Denmark) Speaker Peat George M. (United Kingdom) SP0015 Pain trajectory groups in persons with osteoarthritis Speaker van der Leeden Marike (Netherlands) SP0016 Pain and inflammation in osteoarthritis: pharmacological and physical management Speaker Arokoski Jari P. (Finland) SP0017 The effect of non-pharmacological interventions for hand OA Abstract Bieler Theresa (Denmark) OP0006-HPR EVEN IN THE LONG RUN NORDIC WALKING IS SUPERIOR TO STRENGTH TRAINING AND HOME BASED EXERCISE FOR IMPROVING PHYSICAL FUNCTION IN OLDER PEOPLE WITH HIP OSTEOARTHRITIS - AN RCT. SP0014 Peripheral and central pain sensitivity in osteoarthritis Basic and Translational Science Session - Capital Suite 11 Epigenetics solving the OA puzzle 4 of 111 Chair Malfait Anne-Marie (United States) Chair Ospelt Caroline (Switzerland) Speaker Reynard Louise (United Kingdom) SP0018 DNA Methylation and osteoarthritis Speaker Monteagudo Silvia (Belgium) SP0019 Histone modification and osteoarthritis Speaker Clark Ian (United Kingdom) SP0020 Long and short RNA in osteoarthritis Abstract Frank-Bertoncelj Mojca (Switzerland) OP0007 DEEP RNA SEQUENCING REVEALS ARTHRITIS-SPECIFIC LNCRNA TRANSCRIPTOMES OF SYNOVIAL FIBROBLASTS AT DIFFERENT ANATOMIC LOCATIONS Abstract Meier Florian (United Kingdom) OP0008 SYNOVIAL FIBROBLAST PROLIFERATION IS ENHANCED BY MICRORNA-223 DELIVERY THROUGH MONOCYTE-DERIVED MICROPARTICLES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Basic and Translational Science Session - Capital Suite 14 Muscle Biology & inflammation Chair Lundberg Ingrid (Sweden) Chair de Langhe Ellen (Belgium) Speaker Lanner Johanna (Sweden) SP0021 Free radical signalling behind the muscle weakness associated with rheumatoid arthritis Speaker De Paepe Boel (Belgium) SP0022 Inflammatory mediators in inflammatory myopathies Speaker Sampaolesi Maurilio (Belgium) Abstract Alvarado-Cardenas Marcelo (Spain) OP0009 DISTINCTIVE IMMUNOFLUORESCENCE PATTERN IN STATIN-ASSOCIATED AUTOIMMUNE MYOPATHY WITH ANTI-HMGCR AUTOANTIBODIES Abstract Pinal-Fernandez Iago (United States) OP0010 THIGH MAGNETIC RESONANCE IMAGING REVEALS INCREASED ACTIVE AND CHRONIC MUSCLE DAMAGE IN NECROTIZING MYOSITIS COMPARED TO POLYMYOSITIS AND DERMATOMYOSITIS Muscle stem cells and regeneration PReS Session - Capital Suite 02 Lessons from the children (monogenic causes of autoimmunity) Chair Avcin Tadej (Slovenia) Chair Gattorno Marco (Italy) Speaker Belot Alexandre (France) SP0023 Protein kinase C delta deficiency Speaker Belot Alexandre (France) SP0024 Type I interferonopathies Speaker Trouw Leendert (Netherlands) SP0025 Complement system deficiencies and rheumatic diseases Abstract Saito Megumu (Japan) OP0011 INDUCED PLURIPOTENT STEM CELL-DERIVED MONOCYTIC CELL LINES FROM CONGENITAL IMMUNOLOGICAL DISORDERS SERVE A VERSATILE PLATFORM FOR PHENOTYPE-BASED COMPOUND SCREENING Abstract Schulert Grant (United States) OP0012 MICRORNA ASSOCIATED WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS REGULATE CD163 EXPRESSION IN POLARIZED MACROPHAGES THROUGH TWO DISTINCT MECHANISMS The Young Rheumatologist - Capital Suite 01 5 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... ABC of statistics Chair Aletaha Daniel (Austria) Chair Ramiro Sofia (Netherlands) Speaker Michaud Kaleb (United States) Speaker Norton Sam (United Kingdom) SP0026 The basics of a regression analysis Speaker Carmona Loreto (Spain) SP0027 Confounding - friend or foe? How to handle? Abstract Sergeant Jamie (United Kingdom) OP0013 Statistics in research in rheumatology - how to make the best use of it? PREDICTION OF NON-RESPONSE TO METHOTREXATE THERAPY IN THE RHEUMATOID ARTHRITIS MEDICATION STUDY (RAMS) Practical Skills Session - Capital Suite 06 Crystals I Chair Pascual Eliseo (Spain) Chair Tausche Anne Kathrin (Germany) Tutor Norkuviene Eleonora (Lithuania) Tutor Sivera Francisca (Spain) Tutor Pimentao José (Portugal) Tutor Oliviero Francesca (Italy) Practical Skills Session - Capital Suite 13 Capillaroscopy I 6 of 111 Chair Herrick Ariane L. (United Kingdom) Chair Smith Vanessa (Belgium) Speaker Smith Vanessa (Belgium) SP0028 How to differentiate normal from abnormal capillaroscopic patterns: role of in early diagnosis Speaker Sulli Alberto (Italy) SP0029 Counting and scoring the capillaries: manual versus (semi)automatic systems Speaker Herrick Ariane L. (United Kingdom) SP0030 Capillaroscopic versus laser doppler analysis of the microcirculation Speaker Cutolo Maurizio (Italy) Why capillaroscopy can predict severity and prognosis 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Hermann Walter (Germany) Speaker Faculty (-) SP0031 How to select the most appropriate capillaroscopic device: pros and cons Practical session with patients and case discussion Joint Session PARE / Clinical - Room S19 Optimizing treatment and patient care through precision medicine: A threat or an opportunity for patients and patient organisations? Chair Bosworth Ailsa (United Kingdom) Chair Combe Bernard (France) Speaker Burmester Gerd Rüdiger (Germany) Introduction to precision medicine in the field of rheumatology: Is there a new role for patients? Speaker Kirkham Bruce (United Kingdom) The patient perspective on treat-to-target: Is remission an achievable goal for all patients? Speaker Glintborg Bente (Denmark) SP0032 Collaboration between research and patient organisations: Improving patient care through the Danish Rheumatological Biobank Speaker van Eijk-Hustings Yvonne (Netherlands) SP0033 Improving the screening and management of comorbidities in rheumatic diseases Abstract Van Rompay Jef (Belgium) OP0014-PARE UPDATING THE PATIENT PARTNER EDUCATIONAL PROGRAM FOR RHEUMATOID ARTHRITIS IN BELGIUM: A SYSTEMATIC, SCIENTIFIC-BASED APPROACH LED BY PATIENT EXPERTS EULAR Projects in Musculoskeletal Imaging - Room S20 EULAR Projects in Musculoskeletal Imaging 7 of 111 Chair Naredo Esperanza (Spain) Chair Terslev Lene (Denmark) Speaker Iagnocco Annamaria (Italy) Speaker d'Agostino Maria-Antonietta (France) Speaker Möller Ingrid (Spain) Speaker Gandjbakhch Frédérique (France) SP0034 Development of the EULAR Recommendations for the Use of Imaging in Osteoarthritis Clinical Practice Development of EULAR Recommendations/Criteria for the Appropriate Use of Musculoskelatal Ultrasound in Rheumatology Clinical Practice SP0035 Development of EULAR Standardised Procedures for Rheumatology Ultrasound Imaging Definition of Rheumatoid Arthritis bone erosion 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Kelly Stephen (United Kingdom) Speaker Siddle Heidi (United Kingdom) Speaker Faculty (-) Development of a standardized training model for ultrasound-guided synovial biopsy’s in small and large joints SP0036 The role and training needs of non-medical health professionals using musculoskeletal ultrasound for the management of patients with rheumatic and musculoskeletal diseases Q&A and discussion Wednesday 08.06.2016 17:00 - 18:30 Challenges in Clinical Practice Session - Hall B Difficult osteoporosis Chair Poor Gyula (Hungary) Chair Bultink Irene E.M. (Netherlands) Presenter Blavnsfeldt Anne-Birgitte (Denmark) Discussant Langdahl Bente (Denmark) Presenter Vignot Emmanuelle (France) Case 2 presentation: Still fragile after long treatment: a clinical case from the clinical pratice Discussant Ferrari Serge (Switzerland) Case 2 What to do after 5 years treatment? Stopping? Drug Holiday? Continuing treatment? Treat to Target? Case 1 presentation: Fragility fracture after prolonged treatment with oral bisphosphonates SP0037 Case 1 discussion: What to do when a fracture occurs after 3 years treatment with an oral biphosphonate Clinical Science Session - Hall D Clinical relevance of immunogenicity and therapeutic drug monitoring 8 of 111 Chair Pimentel dos Santos Fernando (Portugal) Chair Jani Meghna (United Kingdom) Speaker Wolbink Gert-Jan (Netherlands) Value of immunogenicity and therapeutic drug monitoring in rheumatology Speaker Kvien Tore K. (Norway) Biosimilars: observational real-life data Speaker van Vollenhoven Ronald (Netherlands) SP0038 How can the proliferation of biosimilars' manufacturers impact on R&D and quality? 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Nagore Daniel (Spain) OP0015 ANTIBODIES TO INFLIXIMAB IN REMICADE-TREATED RHEUMATIC PATIENTS SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILAR CT-P13 Abstract López-Rodríguez R (Spain) OP0016 INCREASED FREQUENCY OF ANTI-DRUG ANTIBODIES IN PATIENTS CARRYING COMPATIBLE IGG1 ALLOTYPES AND TREATED WITH ANTI-TNF ANTIBODIES How to Treat / Manage (HOT) - Hall E HOT Session 3 Speaker Huizinga Tom (Netherlands) Undifferentiated inflammatory & early rheumatoid arthritis Speaker Emery Paul (United Kingdom) Modern management principles of RA Clinical Science Session - Hall C Hepatitis C and rheumatology: The impact of new therapies Chair Vassilopoulos Dimitrios (Greece) Chair Quartuccio Luca (Italy) Speaker Pol Stanislas (France) SP0039 New strategies for the treatment of hepatitis C Speaker Cacoub Patrice (France) SP0040 Implications of recent advances in HCV therapy on management of rheumatic diseases Speaker Faculty (-) Discussion and Q&A Outcome Science Session - Hall A Outcome measures in clinical practice in gout and CPPD. The use of the new EULAR guidelines 9 of 111 Chair Petersson Ingemar (Sweden) Chair Verstappen Suzanne (United Kingdom) Speaker Jacobsson Lennart (Sweden) Speaker Pascual Eliseo (Spain) Speaker Doherty Michael (United Kingdom) SP0042 The role of imaging in the management of gout Speaker Uhlig Till (Norway) SP0043 Clinical outcomes for gout patients in rheumatological care SP0041 Gout-the coming epidemic. The impact on the health care system and the society The role of crystal analysis in the management of gout 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Scheepers L. (Netherlands) OP0017 MEDICATION TAKING BEHAVIOUR OF ALLOPURINOL TREATMENT AMONG PATIENTS WITH GOUT: A RETROSPECTIVE COHORT STUDY IN THE CLINICAL PRACTICE RESEARCH DATALINK (CPRD) Abstract Raymond Warren (Australia) OP0018 HYPERURICEMIA INCREASES MORTALITY ONLY IN PATIENTS WITH GOUT AND EXISTING CARDIOVASCULAR DISEASE. A PROSPECTIVE ANALYSIS FROM THE BUSSELTON HEALTH STUDY Health Professionals Session - Capital Suite 07 Hand Osteoarthritis: State of the art and future perspectives Chair Moe Rikke Helene (Norway) Chair Adams Jo (United Kingdom) Speaker Berenbaum Francis (France) How do we understand hand osteoarthritis? Speaker Dziedzic Krysia (United Kingdom) SP0044 Functional consequences of hand osteoarthritis Speaker van den Ende Els (Netherlands) Assessing hand OA in clinical care and research Speaker Kjeken Ingvild (Norway) Abstract Nery Michele (Brazil) SP0045 The effect of non-pharmacological interventions for hand OA OP0019-HPR EFFECTIVENESS OF A PROGRESSIVE RESISTANCE STRENGTH PROGRAM ON HAND OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL Basic and Translational Science Session - Capital Suite 11 Chronobiology of the immune response 10 of 111 Chair Cutolo Maurizio (Italy) Chair Straub Rainer H. (Germany) Speaker Lange Tanja (Germany) Speaker Straub Rainer H. (Germany) Speaker Gibbs Julie (United Kingdom) SP0047 Circadian clocks and inflammation: the clock as a pharmacological target for inflammatory disease Abstract Kåss Anita (Norway) OP0020 THE ASSOCIATION OF GONADOTROPIN-RELEASING HORMONE AND CYTOKINES IN RHEUMATOID ARTHRITIS SP0046 Sleep as a modulator and adjuvant in immunity The neuroendocrine circadian modulators of the immune response 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Santos-Moreno Pedro (Colombia) OP0021-HPR SLEEP DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RELATIONSHIP WITH DISEASE ACTIVITY Basic and Translational Science Session - Capital Suite 14 Nanomedicine in rheumatology Chair Tas Sander W. (Netherlands) Chair Bijlsma Johannes W.J. (Netherlands) Speaker Shah Ankoor (United States) SP0048 What are nanoparticles: physics for medical doctors Speaker Strehl Cindy (Germany) SP0049 Nanoparticles and the immune system Speaker Sarmento Bruno (Portugal) SP0050 Nanoparticles: a breakthrough in the treatment of arthritis? Abstract Codullo Veronica (Italy) OP0022 TARGETING FIBROBLASTOID-LIKE CELLS BY DRUG LOADED ENGINEERED GOLD NANOPARTICLES AS A NOVEL APPROACH FOR ILD-SSC TREATMENT Abstract Colombo Federico (Italy) OP0023 TARGETED POLYMERIC NANOPARTICLES AS DIAGNOSTIC AND THERAPEUTIC TOOL FOR RHEUMATOID ARTHRITIS How to Treat / Manage (HOT) - Capital Suite 02 HOT Session 2 Speaker Choy Ernest (United Kingdom) SP0051 Pain Management Speaker Williams David (United States) SP0052 Fibromyalgia The Young Rheumatologist - Capital Suite 01 Beyond EMEUNET: development of a European-wide network of young clinicians from different specialties focusing on inflammatory diseases 11 of 111 Chair Gossec Laure (France) Chair Richez Christophe (France) Speaker Moltó Anna (France) SP0053 Experiences from young rheumatologists into EMEUNET Speaker Hindryckx Pieter (Canada) SP0054 Experiences from young gastroenterologists into Y-ECCO 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Smith Eve (United Kingdom) SP0055 Experiences from young representative of Paediatric Rheumatology European Society Speaker da Costa Ferreira Ana Carina (Portugal) SP0056 Experiences from the Young Nephrologists’ Platform Practical Skills Session - Capital Suite 06 Data visualisation: tables and graphs for publication and presentation I Speaker Boers Maarten (Netherlands) SP0057 Data visualisation: tables and graphs for publication and presentation Practical Skills Session - Capital Suite 13 Ultrasound Basic I Chair Hammer Hilde Berner (Norway) Chair Hanova Petra (Czech Republic) Speaker d'Agostino Maria-Antonietta (France) Speaker Möller Ingrid (Spain) SP0058 Scoring OA + demo Speaker Diamantopoulos Andreas (Norway) SP0059 Scoring Large Vessel vasculitis Speaker Tamborrini Giorgio (Switzerland) SP0060 Tutor Oernbjerg Lykke (Denmark) Composite scoring system for RA synovitis + demo Impact on scoring - machine and experience PARE Session - Room S19 Patient organisations in action 12 of 111 Chair Ekroth Maria (Finland) Chair Zabalan Codruta (Romania) Speaker Pappa Athanasia (Greece) How a change to a user-led concept of a patient organisation is leading to success? Speaker Agapidaki Eirini (Greece) Involving patients in shaping health policy: research findings Speaker Facey Karen (United Kingdom) SP0061 Abstract Richards Dawn (Canada) OP0024-PARE DEVELOPMENT AND USE OF A CANADIAN ARTHRITIS PATIENT CHARTER The role of patient organisations in health technology assessment 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Vázquez Lojo Ana Isabel (Spain) OP0025-PARE INFORMATIVE AND PREVENTIVE CAMPAIGNS AT THE CITY COUNCILS IN THE GALICIAN REGION. EULAR Projects in Paediatric Rheumatology - Room S20 Hot topics in pediatric rheumatology Chair Martini Alberto (Italy) Chair Hofer Michael (Switzerland) Speaker Vastert Sebastian (Netherlands) Speaker Beresford Michael (United Kingdom) SP0062 SHARE recommendations on connective tissue diseases Speaker Ruperto Nicola (Italy) SP0063 Clinical trial design in pediatric rheumatology SHARE recommendations on JIA Thursday 09.06.2016 08:15 - 09:45 Basic and Translational Science Session - Capital Suite 11 Plasma cells as key players and therapeutic target in rheumatic diseases Chair Pisetsky David S. (United States) Chair Hoyer Bimba F. (Germany) Speaker Radbruch Andreas (Germany) Speaker Toes Rene (Netherlands) Speaker Fillatreau Simon (Germany) SP0065 Plasmablasts regulate inflammation Abstract Scherer Hans (Netherlands) OP0026 SYNOVIAL FLUID MONONUCLEAR CELLS PROVIDE AN ENVIRONMENT FOR LONG-TERM SURVIVAL OF ANTIBODY SECRETING CELLS AND PROMOTE THE SPONTANEOUS PRODUCTION OF ANTI-CITRULLINATED PROTEIN ANTIBODIES Abstract Torigoe Masataka (Japan) OP0027 ABNORMAL B CELL ACTIVATION THROUGH CELLULAR METABOLIC REPROGRAMMING AND ITS RELEVANCE TO THE PATHOGENESIS OF SLE SP0064 Plasmacells in rheumatic diseases Antibody glycosylation modulating inflammation/disease Basic and Translational Science Session - Capital Suite 14 13 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Global Year against Joint Pain Chair Pincus Theodore (United States) Chair Vincent Tonia (United Kingdom) Speaker Sikandar Shafaq (United Kingdom) SP0066 Pain Speaker Neogi Tuhina (United States) SP0067 Sensitisation and pain in OA Speaker Walsh David (United Kingdom) SP0068 Angiogenesis and joint pain Abstract Blom Arjen (Netherlands) OP0028 ASSOCIATION OF DIFFERENTIAL SYNOVIAL EXPRESSION PATTERNS IN EARLY OSTEOARTHRITIS WITH PAIN AND PROGRESSION OF JOINT DAMAGE Abstract O'Leary Helen (Ireland) OP0029 PAIN SENSITIZATION AND RESPONSE TO PHYSIOTHERAPY TREATMENT IN PEOPLE WITH MODERATE TO SEVERE OSTEOARTHRITIS OF THE KNEE Thursday 09.06.2016 10:15 - 11:45 What is New (WIN) - ICC Auditorium WIN Session 2 Speaker Smolen Josef S. (Austria) RA therapy Speaker So Alexander (Switzerland) Gout and crystal diseases Abstract Session - Hall B Abstract Session: Prognosis and outcome in RA 14 of 111 Chair Petersson Ingemar (Sweden) Chair van Vollenhoven Ronald (Netherlands) Abstract Bouman Chantal (Netherlands) OP0175 RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS TAPERING TNF INHIBITORS IS PRIMARILY DRIVEN BY MEAN DISEASE ACTIVITY OVER TIME, NOT SO MUCH BY FLARING OR LOWER TNF INHIBITOR EXPOSITION Abstract Akdemir Gulsah (Netherlands) OP0176 FIVE YEAR OUTCOMES OF REMISSION STEERED TREATMENT INCLUDING DRUG TAPERING STRATEGIES IN EARLY ARTHRITIS PATIENTS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Haavardsholm Espen (Norway) OP0177 ULTRASOUND IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS: RESULTS FROM THE RANDOMIZED CONTROLLED ARCTIC TRIAL Abstract Harrold L R (United States) OP0178 IMPACT OF ANTI-CYCLIC CITRULLINATED PEPTIDE AND RHEUMATOID FACTOR STATUS ON RESPONSE TO ABATACEPT THERAPY: FINDINGS FROM A US OBSERVATIONAL COHORT Abstract Gottheil Stephanie (Canada) OP0179 COMPARING INITIAL TREATMENT STRATEGIES WITH METHOTREXATE ON FIRST USE OF BIOLOGIC THERAPY: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT Abstract Forslind Kristina (Sweden) OP0180 OCCURRENCE OF REPAIR OF EROSIONS DURING EIGHT YEARS IN A LARGE INCEPTION COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS – A BARFOT-STUDY Abstract Lamers-Karnebeek Femke (Netherlands) OP0181 PREDICTION OF FLARE AFTER STOPPING TNF-INHIBITOR BY BASELINE ULTRASONOGRAPHY AND PATIENT CHARACTERISTICS IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY : 12-MONTH RESULTS. Abstract Gerlag Daniëlle (Netherlands) OP0182 PREVENTION OF RHEUMATOID ARTHRITIS BY B CELL DIRECTED THERAPY IN THE EARLIEST PHASE OF THE DISEASE: THE PRAIRI STUDY Abstract Session - Hall D Abstract Session: Advances in SLE Therapeutics 15 of 111 Chair Isenberg David (United Kingdom) Chair Seror Raphaele (France) Abstract Stott-Miller Marni (United Kingdom) Abstract Johnston Geoff (United Kingdom) OP0040 PERIPHERAL BLOOD TRANSCRIPTIONAL CHANGES ELICITED BY TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS WITH DAPIROLIZUMAB PEGOL (A PEGYLATED ANTI-CD40L FAB’) Abstract Monaghan Katherine (Australia) OP0041 JNJ-473 POTENTLY AND SPECIFICALLY DEPLETES PDCS IN SLE PATIENT BLOOD IN VITRO AND ABLATES TLR9-INDUCED INTERFERON ALPHA RESPONSES Abstract Md Yusof Md Yuzaiful (United Kingdom) OP0042 HUMANISED ANTI-CD20 ANTIBODIES IMPROVE DEPLETION AND RESPONSE IN SLE PATIENTS WITH RESISTANCE TO RITUXIMAB: RESULTS FROM THE FIRST 100 PATIENTS AT A SINGLE CENTRE Abstract Little Jayne (United Kingdom) OP0043 CORTICOSTEROID USE OVER TIME IN THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) INCEPTION COHORT - A DESCRIPTIVE ANALYSIS OP0039 IMPACT OF BELIMUMAB USE ON FLARES AMONG PATIENTS DIAGNOSED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A US COMMERCIALLY INSURED DATABASE: 2010-2014 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Furie Richard (United States) OP0044 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RESPONDER INDEX [SRI(4)] RESPONSE IS ASSOCIATED WITH GLOBAL BENEFIT IN PATIENTS WITH MODERATE TO SEVERE SLE Abstract Doria Andrea (Italy) LB0001 EFFICACY AND SAFETY OF SUBCUTANEOUS BELIMUMAB PLUS STANDARD CARE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) WITH LOW COMPLEMENT AND POSITIVE ANTI-DSDNA How to Treat / Manage (HOT) - Hall E HOT Session 4 Speaker Ruperto Nicola (Italy) SP0069 JIA and other paediatric rheumatic diseases Speaker Stone John H. (United States) SP0070 IgG4 associated diseases Abstract Session - Hall C Abstract Session; Diagnosis and management of SSc 16 of 111 Chair Distler Jörg (Germany) Chair Ponte Cristina (Portugal) Abstract Elhai Muriel (France) OP0030 ASSOCIATED FACTORS WITH MORTALITY AND DERIVATION OF A SIMPLE 5-FACTORS TO PREDICT MORTALITY IN SSC-PATIENTS IN THE EUSTAR COHORT Abstract Lazzaroni Maria Grazia (Italy) OP0031 RISK FACTORS FOR MALIGNANCIES SYNCHRONOUS TO THE ONSET OF SYSTEMIC SCLEROSIS IN PATIENTS POSITIVE FOR ANTI- RNA POLYMERASE III ANTIBODIES: A EUSTAR MULTICENTRE STUDY Abstract Luchetti Michele Maria (Italy) OP0032 GASTROINTESTINAL DISEASE AND MICROBIAL TRANSLOCATION IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN OBSERVATIONAL STUDY ON THE EFFECT OF NUTRITIONAL INTERVENTION AND IMPLICATIONS FOR THE ROLE OF THE MICROBIOMA IN THE PATHOGENESIS OF THE DISEASE. Abstract Nevskaya Tatiana (Canada) OP0033 EUROPEAN SCLERODERMA STUDY GROUP ACTIVITY INDEX CAPTURES VARIATIONS IN DISEASE ACTIVITY OVER TIME AND PREDICTS ORGAN DAMAGE IN EARLY SYSTEMIC SCLEROSIS: DATA FROM THE CANADIAN SCLERODERMA RESEARCH GROUP Abstract Distler Oliver (Switzerland) OP0034 THE SEROTONIN RECEPTOR 2 INHIBITOR TERGURIDE HAS BENEFICIAL EFFECTS ON SKIN FIBROSIS: RESULTS FROM A PHASE 2 PROOF OF CONCEPT STUDY 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Berti Alvise (Italy) OP0035 CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY Abstract Young Amber (United States) OP0036 SCREENING FOR PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS: COMPARISON OF THE PREDICTIVE ACCURACY OF VARIOUS ALGORITHMS Abstract Bissell Lesley-Anne (United Kingdom) OP0037 FIRST PILOT STUDY OF AN IMPLANTABLE LOOP RECORDER (ILR) IN SYSTEMIC SCLEROSIS DETECTS SIGNIFICANT CARDIAC ARRHYTHMIAS WITH CMR ABNORMALITIES Abstract Li Lingyi (Canada) OP0038 IMPROVED SURVIVAL IN DERMATOMYOSITIS AND POLYMYOSITIS: A GENERAL POPULATION-BASE STUDY Abstract Session - Hall A Abstract Session: Vasculitis 17 of 111 Chair Gonzalez-Gay Miguel Angel (Spain) Chair Ciccia Francesco (Italy) Abstract Yates Max (United Kingdom) OP0053 EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS. Abstract Grayson Peter (United States) OP0054 NEUROIMMUNOMODULATION OF NEUTROPHILS AS A NOVEL MECHANISM OF LEVAMISOLE-INDUCED VASCULITIS Abstract Floris Alberto (Italy) OP0055 USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AS A SCREENING TOOL IN PATIENTS WITH SUSPECTED VASCULITIS Abstract Nakajima Toshiki (Japan) OP0056 ASSOCIATION OF IL-12P40 AND IL-12P70 WITH PATHOPHYSIOLOGY OF TAKAYASU ARTERITIS Abstract Bulanov Nikolay (Russian Federation) OP0057 URINARY AND SERUM KIM-1, MCP-1 AND TYPE IV COLLAGEN LEVELS IN THE ASSESSMENT OF ANCA-ASSOCIATED NEPHRITIS ACTIVITY Abstract Cornec Divi (United States) OP0058 USING MASS SPECTROMETRY TO QUANTIFY RITUXIMAB AND PERFORM INDIVIDUALIZED IMMUNOGLOBULIN PHENOTYPING IN ANCA-ASSOCIATED VASCULITIS Abstract Lee Sang Jin (Korea, Republic Of) OP0059 SERUM CXCL10 LEVELS ARE ASSOCIATED WITH CLINICAL MANIFESTATIONS AND DISEASE ACTIVITY IN BEHCET’S DISEASE 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract PUÉCHAL Xavier (France) LB0002 DOES ADDING AZATHIOPRINE TO GLUCOCORTICOID INDUCTION INCREASE THE REMISSION RATE AND PREVENT RELAPSES IN PATIENTS WITH SYSTEMIC NECROTIZING VASCULITIDES WITHOUT POOR-PROGNOSIS FACTORS? A MULTICENTER, DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL Abstract Session - Capital Suite 07 HPR Abstract Session: Developing evidence-based non-pharmacological care Chair Stamm Tanja (Austria) Chair Alliot Francoise (France) Abstract Ndosi Mwidimi (United Kingdom) OP0060-HPR CROSS-CULTURAL VALIDATION OF THE SYSTEMIC SCLEROSIS QUALITY OF LIFE QUESTIONNAIRE IN SIX EUROPEAN COUNTRIES: A TOOL VALIDATION STUDY Abstract Hendricks Candice (South Africa) OP0061-HPR THE EFFECT OF A CONTEXTUALLY RELEVANT NON-PHARMACOLOGICAL INTERVENTION ON THE FUNCTIONING OF SOUTH AFRICAN WOMEN WITH OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL Abstract De Rooij Mariëtte (Netherlands) OP0062-HPR EFFICACY OF TAILORED EXERCISE THERAPY IN PATIENTS WITH KNEE OSTEOARTHRITIS AND COMORBIDITY: A RANDOMIZED CONTROLLED TRIAL Abstract Van Der Esch Martin (Netherlands) OP0063-HPR HIGH PROPORTION OF NON-CONTRACTILE TISSUE IN THE VASTUS MEDIALIS MUSCLE IS ASSOCIATED WITH MUSCLE WEAKNESS IN PATIENTS WITH KNEE OSTEOARTHRITIS; RESULTS FROM THE AMS-OA COHORT Abstract Alcacer-Pitarch Begonya Alcacer- OP0064-HPR A MODEL INCLUDING FOOT-RELATED FACTORS IMPACTING ON QUALITY OF LIFE Pitarch (United Kingdom) (QOL) IN SYSTEMIC SCLEROSIS. Abstract Estévez-López Fernando (Spain) OP0066-HPR PERFORMANCE-BASED MEMORY IS NOT IMPAIRED IN FIBROMYALGIA. A STUDY IN A LARGE SAMPLE ALSO TESTING GENDER DIFFERENCES. THE AL-ÁNDALUS PROJECT Abstract Grønhaug Gudmund (Norway) OP0067-HPR EXCERSISE AS MEDICINE? - DESCRIPTION OF OA TREATMENT IN DISCHARGE REPORTS Abstract Session - Capital Suite 11 Abstract Session: SpA and PsA clinical 18 of 111 Chair Rudwaleit Martin (Germany) Chair Moltó Anna (France) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Kiltz Uta (Germany) OP0084 VALIDATION OF THE ASAS HEALTH INDEX: RESULTS OF A MULTICENTER INTERNATIONAL STUDY IN 23 COUNTRIES Abstract Ez-Zaitouni Zineb (Netherlands) OP0085 DOES THE PRESENCE OF MULTIPLE SPA-FEATURES IN PATIENTS WITH CHRONIC BACK PAIN ALWAYS LEAD TO DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS? Abstract Baraliakos Xenofon (Germany) OP0086 WHICH CELLS CORRESPOND TO THE TYPICAL SIGNALS FOR FATTY AND INFLAMMATORY LESIONS SEEN IN MAGNETIC RESONANCE IMAGING IN ANKYLOSING SPONDYLITIS ? – A PROSPECTIVE STUDY USING BIOPSY MATERIAL OBTAINED DURING SPINAL SURGERY - Abstract Varkas Gaelle (Belgium) OP0087 THE ASSOCIATION OF EXTRA-ARTICULAR MANIFESTATIONS WITH DISEASE DURATION IN AXIAL SPA: RESULTS FROM THE (BE-) GIANT COHORT AND THE ASPECT STUDY. Abstract Navarro-Compán Victoria (Netherlands) OP0088 INFLAMMATION ON MRI OF THE SPINE IS LONGITUDINALLY RELATED TO DISEASE ACTIVITY IN SMOKERS BUT NOT IN NON-SMOKERS IN AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE DESIR COHORT Abstract Putrik Polina (Netherlands) OP0089 ARE INDIVIDUAL OR COUNTRY LEVEL SOCIO-ECONOMIC DETERMINANTS RELATED TO DISEASE ACTIVITY AND SELF-REPORTED PHYSICAL FUNCTION IN PATIENTS WITH SPONDYLOARTHRITIS? RESULTS FROM MULTI-NATIONAL CROSS-SECTIONAL STUDY ASAS-COMOSPA Abstract de Hooge Manouk (Netherlands) OP0090 MRI LESIONS ORIGINATING FROM EITHER AXSPA OR DEGENERATION ARE RELATED TO SITE OF PAIN IN PATIENTS WITH CHRONIC BACK PAIN INCLUDED IN THE SPACECOHORT Abstract El Miedany Yasser (United Kingdom) PSORIATIC ARTHRITIS COMORBIDITY INDEX: DEVELOPMENT AND VALIDATION OF A NEW SPECIFIC TOOL FOR CLASSIFYING PROGNOSTIC COMORBIDITY IN PSORIATIC ARTHRITIS PATIENTS OP0091 Abstract Session - Capital Suite 14 Abstract Session: New horizons in osteoarthiritis 19 of 111 Chair dell'Accio Francesco (United Kingdom) Chair Bijsterbosch Jessica (Netherlands) Abstract Bihlet Asger (Denmark) OP0092 IDENTIFICATION OF PAIN SUBTYPES ASSOCIATED WITH PLACEBO-RESPONSE: DATA FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS IN SYMPTOMATIC KNEE 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... OSTEOARTHRITIS Abstract Pan Feng (Australia) OP0093 DOES “PAIN ELSEWHERE” INFLUENCE THE ASSOCIATION BETWEEN KNEE STRUCTURAL PATHOLOGY AND KNEE PAIN? Abstract Castrejon Isabel (United States) OP0094 PHYSICIAN AND PATIENT ESTIMATES OF GLOBAL STATUS ARE MORE LIKELY TO BE DISCORDANT IN OSTEOARTHRITIS THAN IN RHEUMATOID ARTHRITIS Abstract Kloppenburg Margreet (Netherlands) OP0095 RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE CLINICAL EFFICACY AND STRUCTURE MODIFYING PROPERTIES OF SUBCUTANEOUS ETANERCEPT (ETN) IN PATIENTS WITH EROSIVE INFLAMMATORY HAND OSTEOARTHRITIS (OA) Abstract Martel-Pelletier Johanne (Canada) OP0096 MENISCAL EXTRUSION AND BONE MARROW LESIONS ARE INDEPENDENTLY ASSOCIATED WITH INCIDENT AND PROGRESSIVE KNEE OSTEOARTHRITIS Abstract Wittoek Ruth (Belgium) OP0097 IMMUNOSCINTIGRAPHIC DETECTION OF TNF BY RADIOLABELED CERTOLIZUMAB PEGOL IN PATIENTS WITH EROSIVE HAND OSTEOARTHRITIS IN RELATION TO DISEASE ACTIVITY AND STRUCTURAL PROGRESSION: A PROOF OF CONCEPT STUDY Abstract Kroon Féline (Netherlands) OP0098 EFFECT OF ETANERCEPT ON SYNOVITIS AND BONE MARROW LESIONS IN EROSIVE HAND OSTEOARTHRITIS Abstract Burkov Ilya (United Kingdom) OP0099 3D CORTICAL BONE MAPPING OF THE PROXIMAL FEMUR IN A LARGE PROSPECTIVE POPULATION-BASED STUDY SUPPORTS THE GANZ HYPOTHESIS OF HIP OSTEOARTHRITIS CAUSATION: THE AGES-REYKJAVIK STUDY Abstract Session - Capital Suite 02 Abstract Session: Clinical Osteoporosis: new insights 20 of 111 Chair Haugeberg Glenn (Norway) Chair Raterman Hennie G. (Netherlands) Abstract Langdahl B (Denmark) OP0100 SUPERIOR GAINS IN BONE MINERAL DENSITY AND ESTIMATED STRENGTH AT THE HIP FOR ROMOSOZUMAB COMPARED WITH TERIPARATIDE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TRANSITIONING FROM BISPHOSPHONATE THERAPY: RESULTS OF THE PHASE 3 OPEN-LABEL STRUCTURE STUDY Abstract Sokal Aurelien (France) OP0101 BISPHOSPHONATES DURING PREGNANCY : A PROSPECTIVE STUDY. Abstract Inderjeeth Charles (Australia) OP0103 FRACTURE LIAISON SERVICE IMPLEMENTED IN A METROPOLITAN TERTIARY CENTRE IN WESTERN AUSTRALIA IMPROVED TREATMENT AND RECURRENT FRACTURE RATES BY 12 MONTHS. 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Ruaro Barbara (Italy) OP0104 BONE QUALITY, AS MEASURED BY TRABECULAR BONE SCORE, IN FEMALE POSTMENOPAUSAL PATIENTS WITH SYSTEMIC SCLEROSIS AND RHEUMATOID ARTHRITIS Abstract Hirano Yuji (Japan) OP0105 THE PREDICTORS FOR 12 MONTHS EFFICACY OF DENOSUMAB, AN ANTI-RANKL ANTIBODY, ON OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM MULTICENTER STUDY (TBCR-BONE). Abstract Rasch Linda (Netherlands) OP0106 CHANGE IN BONE MINERAL DENSITY WITH HIGH-DOSE PREDNISONE IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Fassio Angelo (Italy) OP0107 TERIPARATIDE AND DENOSUMAB COMBINATION THERAPY AND SKELETAL METABOLISM Abstract Pan Feng (Australia) OP0102 GENETIC EFFECTS ON TRABECULAR AND CORTICAL VOLUMETRIC BONE MINERAL DENSITIES AND BONE MICROSTRUCTURE MEASURED BY HRPQCT Abstract Session - Capital Suite 01 Abstract Session: SpA and PsA basic and translational research 21 of 111 Chair Wordsworth Paul (United Kingdom) Chair Poddubnyy Denis (Germany) Abstract Schweikhard Eva (Germany) OP0076 AUTOANTIBODIES AGAINST CD74 – A NEW DIAGNOSTIC MARKER FOR SPONDYLOARTHRITIS (SPA) Abstract Kragstrup Tue (Denmark) OP0077 IL-20 AND IL-24 LINK INNATE IMMUNE ACTIVATION AND NEW BONE FORMATION IN SPONDYLOARTHRITIS Abstract Heftdal Line (Denmark) OP0078 SYNOVIAL MYOFIBROBLASTS FROM SPONDYLOARTHRITIS PATIENTS PRODUCE IL-26 SPONTANEOUSLY AND THE PRODUCTION IS ENHANCED UPON IL-1, TNF-Α AND LPS STIMULATION Abstract Toussirot Eric (France) OP0079 INCREASED FREQUENCIES OF IL-23R POSITIVE T CELLS AND IL-22 AND IL-17 PRODUCING MAIT CELLS IN THE PERIPHERAL BLOOD OF PATIENTS WITH ANKYLOSING SPONDYLITIS: PRELIMINARY RESULTS. Abstract Poddubnyy Denis (Germany) OP0080 HIGHER SERUM LEVEL OF LEPTIN MIGHT BE RESPONSIBLE FOR LESS STRUCTURAL DAMAGE IN THE SPINE IN FEMALE PATIENTS WITH ANKYLOSING SPONDYLITIS Abstract Ciccia Francesco (Italy) OP0081 TISSUE DEFICIENCY OF THE ATYPICAL CHEMOKINE RECEPTOR D6 IS ASSOCIATED WITH THE SELECTIVE INCREASE OF GUT-DERIVED PRO-INFLAMMATORY 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... CXCR1HIGHLY6HIGHTL1A+IL-23+CCR7+ CELLS IN THE PERIPHERAL BLOOD, SYNOVIAL FLUIDS AND BONE MARROW OF AS PATIENTS Abstract Lindström Ulf (Sweden) OP0082 INFECTIONS OF THE GUT, UROGENITAL AND RESPIRATORY TRACT AND APPENDICITIS DURING CHILDHOOD, AND THE RISK OF DEVELOPING ANKYLOSING SPONDYLITIS. Abstract Wade Sarah (Ireland) OP0083 MIR-125A DECREASED IN PSA SYNOVIUM AND PERIPHERAL BLOOD CD14+ MONOCYTES AND CORRELATES TO JOINT ANGIOGENESIS. Abstract Session - Capital Suite 06 Abstract Session: Cartilage, Bone, Synovium 22 of 111 Chair Vincent Tonia (United Kingdom) Chair Kostine Marie (France) Abstract van den Bosch M (Netherlands) OP0068 WISP1 INDUCES PATHOLOGY IN EXPERIMENTAL OSTEOARTHRITIS AND PREDICTS DISEASE PROGRESSION IN EARLY OSTEOARTHRITIS PATIENTS. Abstract Hood John (United States) OP0069 DISCOVERY OF A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY (SM04690) AS A POTENTIAL DISEASE MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS Abstract Greisen Stinne (Denmark) OP0070 PD-L2 – A NEW LINK BETWEEN INFLAMMATION AND BONE MODULATION IN RHEUMATOID ARTHRITIS Abstract Tsiklauri Lali (Germany) OP0071 ADIPOKINE EFFECTS ON DIFFERENTIATION OF OSTEOPOROSIS AND OSTEOARTHRITIS SPONGIOSA-DERIVED MESENCHYMAL STROMAL CELLS Abstract Lin Neng Yu (Germany) OP0072 INHIBITION OF NOTCH1 PROMOTES HEDGEHOG SIGNALING IN A HES1-DEPENDENT MANNER AND EXACERBATES EXPERIMENTAL OSTEOARTHRITIS Abstract Schoenfeld Christiane (Germany) OP0073 RNA-SEQ BASED IDENTIFICATION OF FACTORS INVOLVED IN KNEE JOINT REGENERATION AFTER INDUCED OSTEOARTHRITIS IN NOTOPHTHALMUS VIRIDESCENS Abstract Lee Chang-Hoon (Korea, Republic Of) OP0074 EBSELEN IS A POTENTIAL ANTI-OSTEOPOROSIS AGENT BY SUPPRESSING RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND-INDUCED OSTEOCLAST DIFFERENTIATION IN VITRO AND LIPOPOLYSACCHARIDE-INDUCED INFLAMMATORY BONE DESTRUCTION IN VIVO Abstract Roeleveld Debbie (Netherlands) OP0075 SENSITIVE SPECT/CT IMAGING OF SYNOVIAL FAP EXPRESSION AFTER ANTI-IL-22 TREATMENT IN EXPERIMENTAL ARTHRITIS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Session - Capital Suite 13 Abstract Session: New pathways to treatment Chair Pisetsky David S. (United States) Chair Voll Reinhard E. (Germany) Abstract Reddy Venkat (United Kingdom) OP0159 IMPROVING B-CELL DEPLETION IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS: RESISTANCE TO RITUXIMAB AND THE POTENTIAL OF OBINUTUZUMAB Abstract Idborg Helena (Sweden) OP0160 CHARACTERIZATION OF SYSTEMIC LUPUS ERYTHEMATOSUS SUBGROUPS WITH FEATURES OF ANTIPHOSPHOLIPID OR SJÖGRENS´S SYNDROME UTILIZING AFFINITY PROTEOMICS Abstract Young Nicholas (United States) OP0161 CARDIAC MAGNETIC RESONANCE IMAGING OF LUPUS NEPHRITIS-INDUCED CARDIOVASCULAR DISEASE CORRELATES WITH MYOCARDITIS, FIBROSIS, AND ENHANCED PRO-INFLAMMATORY CYTOKINE EXPRESSION IN A MOUSE MODEL Abstract Sakata Kei (Japan) OP0162 TOLL-LIKE RECEPTOR 7-, BUT NOT TOLL-LIKE RECEPTOR 9-, MEDIATED INTERFERON-Α PRODUCTION FROM PLASMACYTOID DENDRITIC CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Zhang Zhuoya (China) OP0163 MESENCHYMAL STEM CELLS PREVENT PODOCYTE INJURY IN LUPUS PRONE MICE VIA EDUCATING MACROPHAGE INTO AN ANTI-INFLAMMATORY PHENOTYPE Abstract Chalmers Samantha (United States) OP0164 BLOCKADE OF IMMUNE COMPLEX-MEDIATED GLOMERULONEPHRITIS BY HIGHLY SELECTIVE INHIBITION OF BRUTON’S TYROSINE KINASE Abstract Guo Xiang (United States) OP0165 BENEFICIAL EFFECTS OF AN ANTI-IFNAR1 MONOCLONAL ANTIBODY ON IMMUNE CELL DYSREGULATION AND COMPLEMENT SYSTEM ABNORMALITIES OF SYSTEMIC LUPUS ERYTHEMATOSUS: AN EXPLORATORY ANALYSIS OF PHASE IIB CLINICAL TRIAL OF ANIFROLUMAB Abstract Qi Jingjing (China) OP0166 IL-27 PARTICIPATES IN SJOGREN'S SYNDROME BY REGULATING LYMPHOCYTE SUBSETS PARE Session - Room S19 Designing solutions to support young people to address the challenges of living with a rheumatic or musculoskeletal disease Chair 23 of 111 van Nieuwkoop Linda (Netherlands) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Chair Ramiro Sofia (Netherlands) Speaker Balazova Petra (Slovakia) SP0071 The role of Young PARE in getting organised: the Virtual Knowledge Centre Speaker Alunno Alessia (Italy) SP0072 The role of health professionals in improving shared decision making with young people with RMDs Speaker Murphy Irene (Ireland) SP0073 Empowering young people with RMD to find their voice and claim their space Abstract Olsder Wendy (Netherlands) OP0116-PARE DEVELOPMENT OF THE GUIDE FOR NATIONAL ONLINE YOUTH PLATFORMS INCLUDING IMPLEMENTATION IN THREE COUNTRIES Abstract Ekroth Maria (Finland) OP0117-PARE ILOA ELÄMÄÄN – PEER SUPPORT AND NETWORKING EVENT FOR CHILDREN, YOUTH AND FAMILIES WITH MSD DISEASE Abstract Session - Room S20 Abstract Session: New insights into imaging 24 of 111 Chair Juhl Pedersen Susanne (Denmark) Chair Janta Iustina (Romania) Abstract Sakellariou Garifallia (Italy) OP0118 DEVELOPMENT OF THE EULAR RECOMMENDATIONS FOR THE USE OF IMAGING IN THE CLINICAL MANAGEMENT OF OSTEOARTHRITIS Abstract Sundlisater Nina (Norway) OP0119 PREDICTORS OF RADIOGRAPHIC PROGRESSION IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED BY AN AGGRESSIVE TIGHT CONTROL REGIME Abstract Leineman Iana (Russian Federation) OP0120 POST-PROCESSING TECHNIQUES FOR ENHANCED VISUALIZATION OF PULMONARY VASCULITIS AND PULMONARY THROMBOSIS BY MULTISLICE SPIRAL COMPUTED TOMOGRAPHY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME Abstract Meric de Bellefon Laurent (Belgium) OP0121 SAFETY, TOLERABILITY AND FEASIBILITY OF MINIMALLY INVASIVE ULTRASOUNDGUIDED SYNOVIAL BIOPSY OF WRIST AND METACARPOPHALANGEAL JOINTS - AN ULTRASOUND FOLLOW-UP STUDY Abstract Filippou Georgios (Italy) OP0122 INTER-READER AND INTRA-READER RELIABILITY OF THE NEW OMERACT ULTRASONOGRAPHIC CRITERIA FOR THE DIAGNOSIS OF CPPD Abstract Burgers Leonie (Netherlands) OP0123 MRI-DETECTED INFLAMMATION IS ASSOCIATED WITH FUNCTIONAL DISABILITY IN EARLY ARTHRITIS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Glimm Anne-Marie (Germany) OP0124 IMAGING REMISSION BY MUSCULOSKELETAL ULTRASOUND LEADS TO A BETTER FUNCTIONAL OUTCOME – RESULTS OF THE US IMPERA STUDY - US 7-SCORE IMPLEMENTATION STUDY IN EARLY RHEUMATOID ARTHRITIS Abstract Ammitzbøll-Danielsen Mads (Denmark) OP0125 A RANDOMISED, DOUBLE-BLIND, CONTROLLED STUDY OF INTRAMUSCULAR VERSUS ULTRASOUND GUIDED PERITENDINOUS BETAMETHASONE INJECTION FOR TENOSYNOVITIS IN RHEUMATOID ARTHRITIS PATIENTS Thursday 09.06.2016 11:45 - 13:30 Poster Tour - Poster Area PARE - Poster Tour I Chair Skingle Diana (United Kingdom) Chair de Wit Maarten (Netherlands) Abstract Beermann Madeleine (Sweden) PARE0001 THE “SWEDISH YOUNG RHEUMATICS” PARTNERED UP WITH ANOTHER YOUNG IMID ASSOCIATION AND ABBVIE TO PRODUCE AN INFORMATIVE AND HOPE GIVING BOOK ON “STARTING A FAMILY”. THE COLLABORATION RESULTED A HIGHLY INFORMATIVE BOOK THAT PROVIDES A WEALTH OF INFORMATION ON FAMILY PLANNING. Abstract Ziegler Benedikt (Germany) PARE0002 A PHOTO-PROJECT ABOUT YOUNG PEOPLE SUFFERING FROM JUVENILE ARTHRITIS Abstract Bellerby Toby (United Kingdom) PARE0003 WHAT DO I WANT TO TALK ABOUT? Abstract van den Brink Rianne (Netherlands) PARE0004 TOOLS FOR A CUSTOMIZED HEALTHCARE PLAN FOR DUTCH PEOPLE WITH RHEUMATIC DISEASES Abstract Egert Yona (Israel) PARE0005 BRIEF OVERVIEW OF ENCA (EUROPEAN NETWORK FOR CHILDREN WITH ARTHRITIS) Abstract Gobbo Milena (Spain) PARE0006 IDENTIFICATION AND PRIORITIZATION OF RESOURCES FOR RHEUMATIC PATIENTS (REUMAPPA) Abstract Phoka Charalambous Androulla (Cyprus) PARE0007 A SUCCESFULL CAPS RECYCLING PROGECT "NOT SATIATE CAPS" Abstract Ostuzzi Silvia (Italy) PARE0008 SETTING UP A YOUTH GROUP: A CHALLENGE WORTH TACKLING ANMAR’S STEP ZERO PROJECT Poster Tour: Axial SpA - Clinical aspects Chair 25 of 111 Landewé Robert B.M. 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... (Netherlands) Chair Navarro-Compán Victoria (Spain) Abstract Klingberg Eva (Sweden) THU0374 A LONGITUDINAL STUDY OF GUT INFLAMMATION AND THE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE IN ANKYLOSING SPONDYLITIS Abstract Wendling Daniel (France) THU0375 ASDAS-BASED REMISSION WAS LESS FREQUENT THAN BASDAI-BASED REMISSION, AND BOTH WERE RELATED TO CRP AND SMOKING IN EARLY AXIAL SPONDYLOARTHRITIS. THE DESIR COHORT. Abstract De Winter Janneke (Netherlands) THU0376 PREVALENCE OF PERIPHERAL AND EXTRA-ARTICULAR DISEASE IN ANKYLOSING SPONDYLITIS VERSUS NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A META-ANALYSIS Abstract Mease Philip (United States) THU0377 ARE PATIENTS WITH ANKYLOSING SPONDYLITIS REALLY DIFFERENT FROM NON-RADIOGRAPHIC AXIAL SPA: RESULTS FROM CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY Abstract Jacquemin Charlotte (France) THU0378 HOW FREQUENT WERE PATIENT REPORTED FLARES IN ANKYLOSING SPONDYLITIS PATIENTS BEFORE THE WIDE USE OF ANTITNF AND WHAT IS THE VALIDITY OF PATIENT REPORTED FLARES? A CROSS-SECTIONAL ANALYSIS OF 234 PATIENTS Abstract Poddubnyy Denis (Germany) THU0379 CLINICAL DISEASE ACTIVITY MEASURES ARE ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS Abstract Landewé Robert (Netherlands) THU0380 A SINGLE DETERMINATION OF C-REACTIVE PROTEIN DOES NOT SUFFICE TO DECLARE A PATIENT WITH A DIAGNOSIS OF AXIAL SPA ‘CRP-NEGATIVE’ Abstract Lim Doo-Ho (Korea, Republic Of) THU0381 THE INCIDENCE OF HERPES ZOSTER INFECTION IN PATIENTS WITH ANKYLOSING SPONDYLITIS: ANALYSIS FROM KOREAN NATIONAL HEALTH INSURANCE SERVICE– COHORT SAMPLE DATABASE. Abstract Ez-Zaitouni Zineb (Netherlands) THU0382 DEVELOPMENT OF SPA-FEATURES IN PATIENTS WITH CHRONIC BACK PAIN OVER A ONE-YEAR COURSE: DATA FROM THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE)-COHORT. Abstract Van Lunteren Miranda (Netherlands) THU0383 DOES CHANGE IN DISEASE ACTIVITY OVER ONE YEAR RESULT IN CHANGE IN HEALTH-RELATED QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS PATIENTS? Poster Tour: Cartilage, Bone, Synovium 26 of 111 Chair Malfait Anne-Marie (United States) Chair Blüml Stephan (Austria) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Arad Uri (Israel) THU0016 HEPARANASE IS ACTIVE IN HUMAN OSTEOARTHRITIC CARTILAGE AND DRIVES CATABOLIC RESPONSES IN PRIMARY HUMAN CHONDROCYTES. Abstract Tchetina Elena (Russian Federation) THU0017 DEFEROXAMINE SUPPRESSES COLLAGEN CLEAVAGE IN CULTURED HUMAN OSTEOARTHRITIC ARTICULAR CARTILAGE VIA A PROCESS INVOLVING DOWNREGULATION OF PROTEASE ACTIVITY, PROINFLAMMATORY CYTOKINES AND TYPE X COLLAGEN EXPRESSION AND UPREGULATION OF AMPK AND CITRIC ACID CYCLE GENES. Abstract Lee Chang Min (Korea, Republic THU0018 Of) REGULATION OF XYLOSYLTRANSFERASE-1 EXPRESSION BY FIBRONECTIN FRAGMENT IN HUMAN ARTICULAR CHONDROCYTES Abstract Nielsen Andreas (Denmark) THU0019 AGE-RELATED HISTOLOGICAL CHANGES IN CALCIFIED CARTILAGE AND SUBCHONDRAL BONE PLATE IN COMPLETE HUMAN FEMORAL HEADS Abstract Krishnamurthy Akilan (Sweden) THU0020 IMMATURE DENDRITIC CELL ARE POTENT OSTEOCLASTS PRECURSORS IN RA AND ARE TARGETED BY RA-SPECIFIC ANTIBODIES Abstract Liphardt Anna-Maria (Germany) THU0021 IMPACT OF IMMOBILIZATION ON SERUM LEVELS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN AND IMPLICATIONS FOR CLINICAL PRACTICE IN MUSCULOSKELETAL DISORDERS Abstract Zhang Weidong (Canada) THU0022 HYPERGLYCEMIA-RELATED ADVANCED GLYCATION END-PRODUCTS IS ASSOCIATED WITH THE ALTERED PHOSPHYTIDYLCHOLINE METABOLISM IN OSTEOARTHRITIS PATIENTS Abstract Crotti Tania (Australia) THU0023 EXPRESSION OF OSCAR IN THE SYNOVIUM OF EARLY RA PATIENTS Poster Tour: Clinical aspects of fibromyalgia 27 of 111 Chair Bergman Stefan (Sweden) Chair Perrot Serge (France) Abstract Bondesson Elisabeth (Sweden) Abstract Estévez-López Fernando (Spain) THU0542 PAIN CATASTROPHIZING AND SELF-EFFICACY AS DETERMINANTS OF SUBJECTIVE AND OBJECTIVE PHYSICAL FUNCTION IN WOMEN WITH FIBROMYALGIA: THE AL-ÁNDALUS PROJECT Abstract Dubost Jean-Jacques (France) THU0543 EVALUATION OF THE FIBROMYALGIA RAPID SCREENING TOOL (FIRST) QUESTIONNAIRE TO SCREEN FIBROMYALGIA ASSOCIATED WITH INFLAMMATORY RHEUMATIC DISEASE Abstract Atzeni Fabiola (Italy) THU0544 IMPAIRED PULMONARY DIFFUSING CAPACITY IN PATIENTS WITH FIBROMYALGIA THU0541 PAIN FROM STRUCTURAL PATHOLOGY IS A RISK FACTOR FOR LATER GENERALIZED PAIN: A POPULATION BASED COHORT STUDY 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Lee Young Ho (Korea, Republic Of) THU0545 COMPARATIVE EFFICACY AND TOLERABILITY OF DULOXETINE, PREGABALIN, AND MILNACIPRAN FOR THE TREATMENT OF FIBROMYALGIA: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Abstract Lichtenstein Adi (Israel) THU0546 CROSS-SECTIONAL ANALYSIS OF THE ASSOCIATIONS BETWEEN FIBROMYALGIA AND OTHER CHRONIC CO MORBIDITIES Abstract Parker Rosalind (New Zealand) THU0547 IS PAIN CATASTROPHISING ASSOCIATED WITH IMPAIRED CONDITIONED PAIN MODULATION IN PEOPLE WITH CHRONIC WIDESPREAD PAIN? Abstract Yeung Wai (United Kingdom) THU0548 SLEEP ARCHITECTURE AND CLINICAL PARAMETERS IN FIBROMYALGIA AND OSTEOARTHRITIS Abstract Guzzo Maria Paola (Italy) THU0549 FATIGUE AND THE ROLE OF SLEEP IN FIBROMYALGIA: OBJECTIVE AND SUBJECTIVE MEASURES Abstract Cochrane Andy (Ireland) THU0550 EARLY MULTIDISCIPLINARY INTERVENTIONS TO PROMOTE WORK PARTICIPATION IN PEOPLE WITH REGIONAL MUSCULOSKELETAL PAIN: A SYSTEMATIC REVIEW Poster Tour: Comorbidities update 2016, part I 28 of 111 Chair Bijlsma Johannes W.J. (Netherlands) Chair Konijn Nicole (Netherlands) Abstract Fleischmann Roy (United States) THU0073 DAS28-CRP AND DAS28-ESR CUTOFFS FOR HIGH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS ARE NOT INTERCHANGEABLE Abstract Fleischmann Roy (United States) THU0074 IMPACT OF THE DISCORDANCE BETWEEN C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION RATE ON CLINICAL RESPONSE TO COMBINATION ETANERCEPTMETHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS Abstract Jacobsen Christina (Germany) THU0075 EFFICIENT SCREENING SYSTEM FOR EARLY ARTHRITIS – A PROJECT OF THE T2T INITIATIVE IN GERMANY Abstract Helliwell Henrietta (United Kingdom) THU0076 ASSOCIATION BETWEEN BODY MASS INDEX AND QUALITY OF LIFE AT ONE AND THREE YEARS POST DIAGNOSIS OF RHEUMATOID ARTHRITIS: RESULTS FROM AN INCEPTION COHORT Abstract Meissner Yvette (Germany) THU0077 INSUFFICIENT CARDIOVASCULAR TREATMENT IS A MAJOR RISK FACTOR FOR STROKE IN RA PATIENTS: A MATCHED CASE CONTROL STUDY FROM THE GERMAN BIOLOGICS REGISTER RABBIT Abstract Humphreys Jennifer (United Kingdom) THU0078 MODERATE ALCOHOL CONSUMPTION IS NOT ASSOCIATED WITH SERUM LIVER ABNORMALITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS TAKING 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... METHOTREXATE: DATA FROM THE CLINICAL PRACTICE RESEARCH DATABASE (CPRD) Abstract Rodríguez-Carrio Javier (Spain) THU0079 HDL, IGG ANTI-HDL ANTIBODIES AND PON1 AXIS IN RHEUMATOID ARTHRITIS PATIENTS: A NEW TARGET FOR CV DISEASE Abstract Navarro-Millan Iris (United States) THU0080 LIPID TESTING AND MANAGEMENT AMONG RHEUMATOID ARTHRITIS PATIENTS COMPARED TO PATIENTS WITH DIABETES AND THE GENERAL POPULATION Abstract Tejera Segura Beatriz (Spain) THU0081 ROLE OF THE SOLUBLE FORM OF DIPEPTYDIL PEPTIDASE-4(DPP4) IN THE INSULIN RESISTANCE OF PATIENTS WITH RHEUMATOID ARTHRITIS. Abstract Michaud Kaleb (United States) THU0082 MEDICATION IMPACT ON THE RISK OF INCIDENT DIABETES MELLITUS IN PATIENTS WITH RHEUMATOID ARTHRITIS: HYDROXYCHLOROQUINE AND ABATACEPT PROTECT WHILE GLUCOCORTICOIDS AND STATINS WORSEN Poster Tour: Crystal and metabolic bone diseases; bone diseases other than osteoporosis 29 of 111 Chair Pascual Eliseo (Spain) Chair Ea Hang-Korng (France) Abstract Conijn Nienke (Netherlands) THU0490 ASYMPTOMATIC GOUT IN CHRONIC KIDNEY DISEASE: PREVALENCE STUDY USING DUAL ENERGY CT AND ULTRASOUND Abstract Hyndman David (United States) THU0491 A NOVEL METHOD OF ESTIMATING EXTRA-RENAL CLEARANCE OF URIC ACID Abstract Liu Sha (United States) THU0492 URIC ACID TRANSPORT KINETICS IN THE KIDNEY: DETECTION OF RENAL SECRETION AND THE MECHANISM OF LOW FEUA Abstract Lu Na (United States) THU0493 RACIAL DISPARITIES IN THE RISK OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS AS URATE-LOWERING DRUG ADVERSE EVENTS IN THE US Abstract Quilis Neus (Spain) THU0494 SKIN EVENTS WITH FEBUXOSTAT IN GOUT PATIENTS WITH PREVIOUS SKIN REACTIONS TO ALLOPURINOL. A RETROSPECTIVE REVIEW. Abstract Saag Kenneth (United States) THU0495 EXAMINATION OF SERUM URIC ACID (SUA) LOWERING AND SAFETY WITH EXTENDED TREATMENT WITH LESINURAD AND ALLOPURINOL IN SUBJECTS WITH GOUT Abstract Scheepers L. (Netherlands) THU0496 ASSOCIATIONS OF PLASMA URIC ACID AND PURINE METABOLITES WITH BLOOD PRESSURE IN CHILDREN: THE KOALA BIRTH COHORT STUDY Abstract Norkuviene Eleonora (Lithuania) THU0497 ULTRASOUND IN GOUT: WHICH JOINTS SHOULD BE EVALUATED CONCERNING DIFFERENCES BETWEEN THE EARLY AND LATE GOUT? Abstract Fransen Jaap (Netherlands) GENDER DIFFERENCES IN THE PHENOTYPE OF GOUT AND ITS EFFECT ON CLASSIFICATION USING THE ACR-EULAR CRITERIA. THU0498 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Bardelli Marco (Italy) THU0499 NEUTROPHIL EXTRACELLULAR TRAPS (NETS): A SHARED FEATURE OF ACUTE MICROCRYSTALLINE ARTHRITIS Poster Tour: How to treat osteoporosis in patients with elevated disease Chair Lems Willem F. (Netherlands) Chair Raterman Hennie G. (Netherlands) Abstract Taskina Elena (Russian Federation) THU0456 MAJOR RISK FACTORS OF FEMORAL NECK OSTEOPOROSIS IN RHEUMATOID ARTHRITIS PATIENTS Abstract Dai Lie (China) THU0457 COMPREHENSIVE DISEASE CONTROL WITH LESS RELAPSE AND RADIOGRAPHIC PROGRESSION AT ONE YEAR BY INTENSIVE THERAPY WITH ADDITIONAL SHORTCOURSE OF TOCILIZUMAB: A REAL-WORLD, PROSPECTIVE COHORT STUDY IN CHINESE PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Kanayama Yasuhide (Japan) THU0458 INFLUENCE OF ORAL PREDNISOLONE ON EFFECT OF DENOSUMAB ON OSTEOPOROSIS IN PATIENTS WITH JAPANESE RHEUMATOID ARTHRITIS; 12 MONTHS OF FOLLOW-UP ~A MULTICENTER REGISTRY STUDY~ Abstract Furuya Takefumi (Japan) THU0459 COMPARISON BETWEEN THE AMERICAN RECOMMENDATIONS AND THE JAPANESE GUIDELINES FOR GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Mraihi Hamza (Switzerland) THU0460 WHAT IS THE BEST LUMBAR SPINE VERTEBRAE COMBINATION TO PREDICT MAJOR OSTEOPOROTIC FRACTURE? THE OSTEOLAUS COHORT STUDY Abstract Aubry Rozier Bérengère (Switzerland) THU0461 REBOUND-ASSOCIATED VERTEBRAL FRACTURES AFTER DENOSUMAB DISCONTINUATION: A SERIES OF 8 WOMEN WITH 35 SPONTANEOUS VERTEBRAL FRACTURES. Abstract Bukhari Marwan (United Kingdom) THU0462 THE PREDICTORS OF FRACTURE IN PATIENTS WITH COELIAC DISEASE: AN OBSERVATIONAL STUDY Abstract Mathieu Sylvain (France) THU0463 VIEWPOINTS OF DENTAL SURGEONS ON THE USE OF BISPHOSPHONATES IN RHEUMATOLOGY PATIENTS Abstract Yoshimura Noriko (Japan) THU0464 OSTEOPOROSIS, NOT OSTEOARTHRITIS, COULD PREDICT THE OCCURRENCE OF SARCOPENIA IN THE NEAR FUTURE: A 4-YEAR FOLLOW-UP OF THE ROAD STUDY. Abstract Inderjeeth Charles (Australia) THU0465 FRACTURE LIAISON SERVICE REDUCES RE-FRACTURE RATE, COST-EFFECTIVE AND COST SAVING IN WESTERN AUSTRALIA. Poster Tour: Immunity in rheumatic diseases 30 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Chair Taams Leonie (United Kingdom) Chair Trouw Leendert (Netherlands) Abstract Sacre Karim (France) THU0001 TERTIARY LYMPHOID ORGANS IN TAKAYASU ARTERITIS: ARE LOCALLY MATURED B CELLS INVOLVED IN THE PATHOGENESIS? Abstract Arumugakani Gururaj (United Kingdom) THU0002 PREVALENCE OF MONOCLONAL B-CELL DISORDERS IN PATIENTS WITH AUTOIMMUNITY IN THE UK Abstract Kim Alfred (United States) THU0003 MOUSE B CELL CYTOKINE PRODUCTION REQUIRES OXIDATIVE PHOSPHORYLATION MEDIATED BY GLYCOLYSIS AND FATTY ACID OXIDATION Abstract Eloranta Maija-Leena (Sweden) THU0004 ACTIVATED PLASMACYTOID DENDRITIC CELLS (PDCS) ALTER THE COMPOSITION OF THE BLOOD B CELL SUBSETS Abstract Matsumoto Kazuko (Germany) THU0005 DRUG RE-PURPOSING WITH A COMMERCIALLY AVAILABLE CHEMICAL LIBRARY IDENTIFIES NOVEL B-CELL INHIBITORY COMPOUNDS. Abstract Barrett Christine (United Kingdom) THU0006 NOVEL CHANGES IN B AND T-CELL PHENOTYPES WITH BELIMUMAB IN AN AUTOANTIBODY MEDIATED DISEASE Abstract Akiyama Mitsuhiro (Japan) THU0007 ENHANCED IGG4 PRODUCTION BY FOLLICULAR HELPER TYPE 2 T CELLS IN IGG4-RELATED DISEASE Abstract Urushima Hayato (Japan) THU0008 LEUCINE-RICH ALPHA 2 GLYCOPROTEIN PROMOTES THE DIFFERENTIATION OF TH17 AND DETERIORATES COLLAGEN INDUCED ARTHRITIS THROUGH ENHANCEMENT OF TGF BETA SIGNALING Abstract Zhang Miaojia (China) THU0009 ADIPONECTIN-ADIPOR1-STAT3 DEPENDENT PATHWAY IS A CRITICAL REGULATOR OF TH17 CELL DIFFERENTIATION IN COLLAGEN-INDUCED ARTHRITIS Abstract Bradford Claire (United Kingdom) THU0010 LACK OF CRP RESPONSE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS - WHAT ARE THE IMMUNOLOGICAL CAUSES, AND HOW CAN WE HARNESS THIS DATA TO IMPROVE DISEASE OUTCOMES Poster Tour: Outcome measures of RMDs 31 of 111 Chair Boonen Annelies (Netherlands) Chair Courvoisier Delphine (Switzerland) Abstract Hewlett Sarah (United Kingdom) THU0593 VALIDITY OF THE BRISTOL RA FATIGUE MULTI-DIMENSIONAL QUESTIONNAIRE (BRAF-MDQ) AND RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) SCALE ACROSS 6 EUROPEAN COUNTRIES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Radner Helga (Switzerland) THU0594 TOWARDS DEVELOPMENT OF A MINIMUM CORE DATASET AND STANDARDS OF DATA COLLECTION FOR OBSERVATIONAL RHEUMATOID ARTHRITIS RESEARCH- A EULAR INITIATIVE Abstract Drenkard Cristina (United States) THU0595 IMPACT OF PHYSICIAN-PATIENT INTERACTIONS ON DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Eugenio Gisela (Portugal) THU0596 PHYSICIAN’S GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS, REFLECTS SOLELY OBJECTIVE MEASURES AND DISREGARDS PATIENT REPORTED OUTCOMES Abstract Sordet Christelle (France) THU0597 COMPARAISON OF SELF ASSESSMENT OF DISEASE ACTIVITY TO DAS28 IN RHEUMATOID ARTHRITIS : DATA FROM THE RANDOMIZED "ROC" TRIAL Abstract Putrik Polina (Netherlands) THU0598 VARIATIONS IN POLICIES AND SOCIAL SECURITY REGULATIONS FOR PATIENTS WITH RHEUMATOID ARTHRITIS THAT EXPERIENCE RESTRICTIONS IN WORK PARTICIPATION: RESULTS FROM A SURVEY ACROSS 44 COUNTRIES OF THE EUROPEAN REGION Abstract Kachroo Sumesh (United States) THU0599 KEY DRIVERS IN BIOSIMILAR PRESCRIPTION IN INFLAMMATORY AUTOIMMUNE DISEASES INDICATIONS IN GERMANY Abstract Magro Rosalie (Malta) THU0600 PATIENTS' PERCEPTION AND SATISFACTION OF WAITING TIME AT MEDICAL OUTPATIENTS Abstract Lillegraven Siri (Norway) THU0601 WORK PARTICIPATION AFTER TWO YEARS IS EXCELLENT IN EARLY RA PATIENTS TREATED ACCORDING TO A TIGHT CONTROL STRATEGY, AND IMPROVED COMPARED TO PREVIOUS CLINICAL PRACTICE Abstract Ferreira Ricardo (Portugal) THU0602 PATIENT GLOBAL ASSESSMENT IN RHEUMATOID ARTHRITIS CONVEYS A VARIABLE BLEND OF DISEASE ACTIVITY AND DISEASE IMPACT: A CROSS-SECTIONAL STUDY WITH 311 PATIENTS Poster Tour: Prognosis and outcome in RA 32 of 111 Chair Petersson Ingemar (Sweden) Chair de Pablo Paola (United Kingdom) Abstract Smolen J (Austria) Abstract van der Ven Myrthe (Netherlands) THU0030 THU0029 PREDICTING DAS28-CRP <2.6 AND LOW DISEASE ACTIVITY STATUS AT 6 MONTHS BASED ON EARLY CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS ULTRASOUND INFLAMMATION IN ARTHRALGIA PATIENTS PREDICTS THE DEVELOPMENT OF ARTHRITIS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Tanaka Yoshiya (Japan) THU0031 BASELINE CHARACTERISTICS AND TREATMENT OUTCOMES OF PATIENTS WHO ACHIEVE DEEP REMISSION IN RHEUMATOID ARTHRITIS Abstract Nieuwenhuis Wouter (Netherlands) THU0032 DIAGNOSTIC ACCURACY OF HAND AND FOOT MRI FOR EARLY RHEUMATOID ARTHRITIS Abstract Cheng Tsz Ho (Hong Kong) THU0033 EFFECTS OF EARLY REMISSION ON WORK ABILITY AND ABSENTEEISM IN EARLY RHEUMATOID ARTHRITIS Abstract Raynauld Jean-Pierre (Canada) THU0034 USE OF RITUXIMAB COMPARED TO ANTI-TNF AGENTS AS SECOND AND THIRD-LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. A 6-YEAR FOLLOW-UP REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY. Abstract Bessette Louis (Canada) THU0035 SIX YEARS TOCILIZUMAB USE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH ONE PREVIOUS ANTI-TNF AGENT EXPOSURE: COMPARISON WITH ADALIMUMAB AND ETANERCEPT FROM THE PROVINCIAL ELECTRONIC DATABASE AND REGISTRY RHUMADATA® Abstract Dolhain Radboud (Netherlands) THU0036 IDENTIFYING CLINICAL FACTORS ASSOCIATED WITH LOWER DISEASE ACTIVITY DURING PREGNANCY IN PATIENTS WITH RHEUMATOID ARTHRITIS TO SELECT THOSE PATIENTS IN WHOM MEDICATION CAN BE SAFELY TAPERED. Poster Tour: Psoriatic arthritis 33 of 111 Chair Lories Rik (Belgium) Chair Sousa Elsa (Portugal) Abstract Højgaard Pil (Denmark) THU0418 OBESITY IMPAIRS THE RESPONSE TO TUMOUR NECROSIS FACTOR-ALPHA INHIBITORS IN PSORIATIC ARTHRITIS: RESULTS FROM THE DANBIO AND ICEBIO REGISTRIES. Abstract Coates Laura (United Kingdom) THU0419 RAPID3 PERFORMS WELL IDENTIFYING TREATMENT EFFECT IN THE TIGHT CONTROL OF PSORIATIC ARTHRITIS STUDY Abstract Mease Philip (United States) THU0420 APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (52-WEEK) IMPROVEMENTS IN BASDAI IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS Abstract Chandran Vinod (Canada) THU0421 SERUM-BASED SOLUBLE MARKERS MAY DIFFERENTIATE PSORIATIC ARTHRITIS FROM OSTEOARTHRITIS Abstract Wells Alvin (United States) THU0422 APREMILAST MONOTHERAPY AS THE FIRST SYSTEMIC TREATMENT IN DMARD-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 3-YEAR TREATMENT RESULTS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Harrold Leslie (United States) THU0423 TIME TO REBOUND IN JOINT SYMPTOMS FOLLOWING DISCONTINUATION OF TNFI THERAPY AFTER ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PSORIATIC ARTHRITIS PATIENTS ENROLLED IN THE US CORRONA REGISTRY Abstract Eder Lihi (Canada) THU0424 TREATMENT WITH TNF ALPHA BLOCKERS IS ASSOCIATED WITH REDUCED PROGRESSION OF ATHEROSCLEROTIC PLAQUES IN PATIENTS WITH PSORIATIC DISEASE – A PROSPECTIVE STUDY Abstract Becker-Capeller Detlef (Germany) THU0425 THE EARLY DIAGNOSIS OF PSORIATIC ARTHRITIS: STANDARDIZED EVALUATION OF SPECIFIC ENTHESES, TENDONS AND CAPILLARIES IN PATIENTS WITH FRESH DIAGNOSED PSORIASIS Abstract Michelsen Brigitte (Norway) THU0426 ACHILLES ENTHESITIS DEFINED BY ULTRASOUND IS NOT ASSOCIATED TO CLINICAL ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS Abstract Queiro Ruben (Spain) THU0427 STUDY OF PREVALENCE AND PREDICTORS OF MINIMAL DISEASE ACTIVITY (MDA) STATE IN A SPANISH POPULATION WITH PSORIATIC ARTHRITIS. MAAPS STUDY Poster Tour: RA treatments - non biological, small molecules 34 of 111 Chair Takeuchi Tsutomu (Japan) Chair Taylor Peter C. (United Kingdom) Abstract Strand Vibeke (United States) THU0165 LONG-TERM RADIOGRAPHIC AND PATIENT-REPORTED OUTCOMES BASED ON CLINICAL DISEASE ACTIVITY INDEX RESPONSES WITH TOFACITINIB AT 6 MONTHS Abstract Smolen Josef (Austria) THU0166 SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS Abstract Genovese Mark (United States) THU0167 THE EFFECT OF FILGOTINIB (GLPG0634), AN ORAL JAK1 SELECTIVE INHIBITOR ON PATIENT-REPORTED OUTCOMES: RESULTS FROM TWO 24-WEEK PHASE 2B DOSE RANGING STUDIES Abstract van der Heijde Desiree (Netherlands) THU0168 BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS Abstract Keystone Edward (Canada) THU0169 PERSISTENCE OF TOFACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES UP TO 7 YEARS Abstract Todoerti Monica (Italy) THU0170 ADHERENCE TO PARENTERAL METHOTREXATE IN RHEUMATOID ARTHRITIS IS NOT A MAJOR ISSUE AND DOES NOT INFLUENCE THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Luchikhina Elena (Russian Federation) THU0171 EFFECT OF FAST ESCALATION OF THE DOSE OF SUBCUTANEOUS METHOTREXATE ON THE NEED FOR BIOLOGICAL DMARDS IN PATIENTS WITH VERY EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS Abstract Wilson Jessica (Switzerland) THU0172 RISK FOR SERIOUS ADVERSE EVENTS ASSOCIATED WITH ORAL CORTICOSTEROID THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK POPULATION-BASED STUDY Abstract Kavanaugh Arthur (United States) THU0173 FILGOTINIB (GLPG0634), AN ORAL JAK1 SELECTIVE INHIBITOR IS EFFECTIVE AS MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM A 24-WEEK PHASE 2B DOSE RANGING STUDY Poster Tour: SpA and PsA Basic and Translational research 35 of 111 Chair Breban Maxime (France) Chair Jacques Peggy (Belgium) Abstract Chen Liye (United Kingdom) THU0363 POSITION 97 (P97) OF HLA-B, A RESIDUE IMPLICATED IN ANKYLOSING SPONDYLITIS PATHOGENESIS, PLAYS A KEY ROLE IN CELL SURFACE FREE HEAVY CHAIN EXPRESSION VIA INTERACTIONS WITH Β2-MICROGLOBULIN Abstract Appleton Louise (United Kingdom) THU0364 RARE ERAP1 ALLOTYPE COMBINATIONS DO NOT EXPLAIN THE ERAP1 ASSOCIATION WITH ANKYLOSING SPONDYLITIS Abstract Yang Bin (China) THU0365 LIGHT RS1077667 G>A GENE POLYMORPHISM IS ASSOCIATED WITH SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS IN A CHINESE HAN POPULATION Abstract Roberts Rebecca (New Zealand) THU0366 ASSOCIATION OF CHROMOSOME 1Q32 WITH ANKYLOSING SPONDYLITIS IS INDEPENDENT OF BOWEL SYMPTOMS AND FAECAL CALPROTECTIN Abstract Tost Jorg (France) THU0367 IDENTIFICATION OF DIFFERENTIALLY METHYLATED GENES IN PURIFIED DISEASERELEVANT BLOOD CELL POPULATIONS IN PATIENTS WITH SPONDYLOARTHRITIS Abstract El-Sherbiny Yasser (United Kingdom) THU0368 IL-22 IMPACT ON HUMAN BONE MARROW MESENCHYMAL STEM CELLS FUNCTIONS; A NOVEL PATHWAY THAT MAY CONTRIBUTE TO ABERRANT NEW BONE FORMATION IN HUMAN SPA Abstract Andersen Thomas (Denmark) THU0369 IL-17A+ AND IL-22+ T CELLS INCREASE DURING ANTI-TNFΑ TREATMENT IN SPONDYLOARTHRITIS - A LINK TO RADIOGRAPHIC PROGRESSION? Abstract Fishman Emily (United States) THU0370 DISEASE ACTIVITY, NOT DRUG EXPOSURE, AFFECTS PREGNANCY OUTCOMES IN INFLAMMATORY ARTHRITIS Abstract Bautista-Caro María-Belén (Spain) THU0371 INCREASED FREQUENCY OF REGULATORY CD19+CD24HIGH CD38HIGH B CELLS IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Faustini Francesca (Germany) THU0372 SUBCLINICAL JOINT INFLAMMATION IN PSORIASIS PATIENTS WITHOUT CONCOMITANT PSORIATIC ARTHRITIS- A CROSS-SECTIONAL AND LONGITUDINAL ANALYSIS Poster Tour: Walk through new pathways, biomarkers and potential treatments in SLE and Sjögren's 36 of 111 Chair Voll Reinhard E. (Germany) Chair Venhoff Nils (Germany) Abstract Idborg Helena (Sweden) THU0240 DYSREGULATIONS IN THE SPHINGOLIPID PATHWAY IN SLE PATIENTS Abstract Haacke Erlin (Netherlands) THU0241 PRESENCE OF GERMINAL CENTERS IN DIAGNOSTIC BIOPSIES OF PRIMARY SJÖGREN’S SYNDROME PATIENTS IS NOT A RISK FACTOR FOR THE DEVELOPMENT OF PAROTID MALT LYMPHOMAS Abstract Schulz-Knappe Peter (Germany) THU0242 HIGH-THROUGPUT SCREENING DISCOVERS NOVEL AUTOANTIBODIES IN AUTOIMMUNE DISEASES: THE SEROTAG APPROACH IN SYSTEMIC LUPUS, SYSTEMIC SCLEROSIS AND RHEUMATOID ARTHRITIS Abstract Perez-Sanchez Carlos (Spain) THU0243 INTEGRATED ANALYSIS OF MICRORNA AND MRNA EXPRESSION PROFILES RELATED TO CARDIOVASCULAR DISEASE IN MONOCYTES FROM SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS Abstract Kim Alfred (United States) THU0244 NONINVASIVE ASSESSMENT OF MACROPHAGE ACTIVATION IN EXPERIMENTAL GLOMERULONEPHRITIS USING OPTICAL IMAGING WITH NEAR-INFRARED LIGHT SERVES AS A SURROGATE OF DISEASE ONSET Abstract Haselmayer Philipp (Germany) THU0245 INDIVIDUAL VERSUS COMBINED BLYS OR/AND APRIL NEUTRALIZATION REVEALS DEVELOPMENTAL PLASTICITY FOR PLASMA CELL SURVIVAL FACTOR REQUIREMENTS Abstract Liarski Vladimir (United States) THU0246 ROLE OF IGE IN THE PATHOGENESIS OF TUBULOINTERSTITIAL INFLAMMATION IN HUMAN LUPUS NEPHRITIS. Abstract Eloranta Maija-Leena (Sweden) THU0247 THE EFFECT OF HYDROXYCHLOROQUINE AND IRAK4 INHIBITION ON THE IFN-A AND TNF-A PRODUCTION INDUCED BY SLE RELATED IMMUNE COMPLEXES Abstract Felten Renaud (France) THU0248 THERAPEUTIC INTEREST OF ANTI-CD3 AND ANTI-BAFF MONOCLONAL ANTIBODIES IN THE NOD MODEL OF SJÖGREN’S SYNDROME Abstract Lewis Myles (United Kingdom) THU0249 FUNCTIONAL CLUSTERS OF AUTOANTIBODIES TARGETING TLR AND SMAD PATHWAYS DEFINE NEW SUBGROUPS IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Chiche Laurent (France) THU0250 DYSREGULATION OF AUTOPHAGY IN SYSTEMIC LUPUS ERYTHEMATOSUS IS CORRELATED TO TRANSCRIPTIONAL INTERFERON SIGNATURES AND PROVIDES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... CANDIDATE BIOMARKERS Abstract Del Mastro Andrea (Italy) THU0251 ABSENCE OF CASPASE-ACTIVATED DNASE AFFECTS NETOSIS AND ITS MODULATION OF DENDRITIC CELL ACTIVATION IN A SEX-DEPENDENT MANNER PReS - Poster Tour: Arthritis in childhood Chair Avcin Tadej (Slovenia) Chair Vastert Sebastian (Netherlands) Abstract Ramanan Athimalaipet (United Kingdom) THU0213 ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL Abstract Horneff Gerd (Germany) THU0214 SAFETY OF ADALIMUMAB IN PEDIATRIC PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, ENTHESITIS-RELATED ARTHRITIS, PSORIASIS, AND CROHN’S DISEASE Abstract Ruperto N (Italy) THU0215 LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL Abstract Ruperto N (Italy) THU0216 SAFETY AND EFFECTIVENESS OF ADALIMUMAB±METHOTREXATE FOR THE TREATMENT OF POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA): STRIVE REGISTRY Abstract Fisher Corinne (United Kingdom) THU0217 DKK-1 LEVELS ARE ELEVATED IN PATIENTS WITH ENTHESITIS RELATED ARTHRITIS WITHOUT SACROILIAC JOINT FUSION Abstract Vähäsalo Paula (Finland) THU0218 COW’S MILK ALLERGY IN INFANCY AND LATER DEVELOPMENT OF JUVENILE IDIOPATHIC ARTHRITIS: A REGISTER-BASED CASE-CONTROL STUDY Abstract Quesada-Masachs Estefania (Spain) THU0219 PROSPECTIVE ANALYSIS OF THE IMMUNOGENIC RESPONSE IN JIA PATIENTS (PAEDIATRIC AND ADULT) ON ANTITNF TREATMENT Abstract Sardar Elham (France) THU0220 RETROSPECTIVE STUDY EVALUATING TREATMENT DECISION AND OUTCOME OF NON-JUVENILE IDIOPATHIC ARTHRITIS (JIA)-ASSOCIATED CHILDHOOD UVEITIS Abstract Aktay Ayaz Nuray (Turkey) THU0221 EFFICACY OF BIOLOGICAL AGENTS IN COLCHICINE RESISTANT CHILDREN WITH FMF Abstract Tanous Osama (Israel) THU0222 THE DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER FOLLOWING THE INITIAL PRESENTATION OF MONOARTHRITIS Thursday 09.06.2016 13:30 - 15:00 37 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... What is New (WIN) - ICC Auditorium WIN Session 3 Speaker Raza Karim (United Kingdom) Speaker Gabay Cem (Switzerland) SP0074 Early Arthritis Clinical aspects of RA Challenges in Clinical Practice Session - Hall B Combined cases: Sjögren's and a pediatric case Chair de Vita Salvatore (Italy) Chair Pilkington Clarissa (United Kingdom) Presenter Alexander Tobias (Germany) Case 1 presentation: an unusual case of Sjögren´s syndrome Discussant Bowman Simon (United Kingdom) Case 1 discussion: an unusual case of Sjögren´s syndrome Presenter Smith Eve (United Kingdom) Case 2 presentation: a child with systemic autoimmune disease Discussant Kamphuis Sylvia (Netherlands) Case 2 discussion: a child with systemic autoimmune disease Clinical Science Session - Hall D Advancements in the imaging of PsA 38 of 111 Chair Vlad Violetta (Romania) Chair Dejaco Christian (Austria) Speaker Filippucci Emilio (Italy) Speaker d'Agostino Maria-Antonietta (France) Speaker Ostergaard Mikkel (Denmark) SP0076 Prognostic value of imaging markers in PsA Abstract Fukuda Takeshi (Japan) OP0126 DUAL ENERGY CT WITH IODINE MAP IS PROMISING NEW IMAGING MODALITY IN THE EVALUATION OF HAND PSORIATIC ARTHRITIS Abstract Merashli Mira (United Kingdom) OP0127 LOW FREQUENCY OF US DETERMINED EROSIONS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE LEEDS SPARRO COHORT SP0075 Linking histology and imaging in the pathogenesis of PsA Imaging in monitoring therapy response in PsA: why, what and when? 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... How to Treat / Manage (HOT) - Hall E HOT Session 5 Speaker Houssiau Frederic (Belgium) SLE Speaker Barone Francesca (United Kingdom) Sjögren's Syndrom Clinical Science Session - Hall C When and how to treat Raynaud's phenomenon and related complications Chair Sulli Alberto (Italy) Chair Mouthon Luc (France) Speaker Smith Vanessa (Belgium) SP0077 Differential diagnosis between primary and secondary Raynaud's phenomenon Speaker Cracowski Jean-Luc (France) SP0078 When and how to manage the primary Raynaud's phenomenon Speaker Herrick Ariane L. (United Kingdom) SP0079 When and how to manage the secondary Raynaud's phenomenon and related conditions Abstract Ruaro Barbara (Italy) OP0128 EVALUATION OF PERIPHERAL BLOOD PERFUSION BY LASER SPECKLE CONTRAST ANALYSIS IN SYSTEMIC SCLEROSIS PATIENTS TREATED WITH AMINAPHTONE. Abstract Teixeira Lídia (Portugal) OP0129 NAILFOLD CAPILLAROSCOPY IN RHEUMATOLOGY PRACTICE - A SINGLE CENTER EXPERIENCE. Outcome Science Session - Hall A Role of new imaging techniques as RMD outcomes 39 of 111 Chair Petersson Ingemar (Sweden) Chair Ohrndorf Sarah (Germany) Speaker Finzel Stephanie (Germany) Speaker Conaghan Philip (United Kingdom) Speaker Dalbeth Nicola (New Zealand) SP0080 Imaging in early detection of RA joint damage. What technique and how to use? Imaging in predicting outcomes in OA. What´s new? SP0081 Imaging in the management of gout. Clinical tool or endpoint? 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Eathakkattu Antony Benny Samuel (Australia) OP0130 Abstract Keller Kresten Krarup (Denmark) OP0131 RADIOGRAPHIC AND MAGNETIC RESONANCE IMAGING MARKERS PREDICT CARTILAGE VOLUME LOSS AND KNEE SYMPTOMS OVER 10.7 YEARS IN OLDER ADULTS TRABECULAR THINNING IN METACARPOPHALANGEAL JOINTS OF ANTICITRULLINATED PEPTIDE ANTIBODY POSITIVE PATIENTS WITH ARTHRALGIA Joint Session HPR / PARE - Capital Suite 07 "Fewer words - more action" - tailored care for men with rheumatic diseases? Chair Gobbo Montoya Milena (Spain) Chair Wiek Dieter (Germany) Speaker Björk Mathilda (Sweden) SP0082 Disability in men and women with RA. Does it differ and does it matter? Speaker Demtröder Frank (Germany) SP0083 Balancing work and life: "When is a man a man?" Speaker Appel Esbensen Bente (Denmark) SP0084 “Being physically active is a salvation” – Men’s preferences for physical activity Speaker Flurey Caroline (United Kingdom) SP0085 Abstract Martin Melanie (United Kingdom) OP0132-HPR AXIAL SPONDYLOARTHRITIS KNOW-HOW: WHAT ARE THE BENEFITS OF A BRIEF EXERCISE AND SELF-MANAGEMENT EDUCATION GROUP PROGRAMME? A QUALITATIVE INVESTIGATION Design of a self-management intervention for men with RA Basic and Translational Science Session - Capital Suite 11 Recent advances in our understanding of macrophage biology 40 of 111 Chair Apparailly Florence (France) Chair Shaw Tanya (United Kingdom) Speaker Mowat Allan (United Kingdom) Speaker Udalova Irina (United Kingdom) Regulation of macrophage function Speaker Perlman Harris (United States) Macrophages in experimental and clinical arthritis Abstract Karouzakis Emmanuel (Switzerland) SP0086 OP0133 Macrophages in intestinal homeostasis and inflammation DNA DEMETHYLATION PATHWAY ANALYSIS IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS AND MACROPHAGES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Dorris Emma (Ireland) OP0134 THE RHEUMATOID ARTHRITIS SUSCEPTIBILITY GENE C5ORF30 ACTS AS AN IMMUNOMODULATOR IN MACROPHAGES Basic and Translational Science Session - Capital Suite 14 Lubricants: potential as osteoarthritis treatment? Chair Berenbaum Francis (France) Chair Ioan-Facsinay Andreea (Netherlands) Speaker Klein Jacob (Israel) SP0087 Natural occurring lubricants to maintain joint homeostasis Speaker Bryant Stephanie J. (United States) SP0088 Hydrogels for osteoarthritis treatment Speaker Jüni Peter (Canada) Abstract Eymard Florent (France) Efficacy of hyaluronic acid as lubrification of the osteoarthritis joint OP0135 PREDICTIVE FACTORS OF FAILURE OF VISCOSUPPLEMENTATION IN PATIENTS WITH KNEE OSTEOARTHRITIS. RESULTS OF A POST-HOC ANALYSIS OF A DOUBLE BLIND, CONTROLLED NON INFERIORITY TRIAL. PReS Session - Capital Suite 02 Extra-articular complications of JIA Chair Zulian Francesco (Italy) Chair Wouters Carine (Belgium) Speaker Ravelli Angelo (Italy) Macrophage activation syndrome Speaker Ramanan Athimalaipet (United Kingdom) Management and outcome of chronic uveitis Speaker Cimaz Rolando (Italy) SP0089 Osteoporosis in JIA Abstract Galstian Lelia (Russian Federation) OP0136 ABATACEPT TREATMENT DURING 1 YEAR PERIOD IN JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS WITHOUT PREVIOUS BIOLOGICS THERAPY Abstract Minden Kirsten (Germany) OP0137 DIABETES PREVALENCE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) The Young Rheumatologist - Capital Suite 01 41 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... The elephant in the room: how to avoid biases in research? Chair Boers Maarten (Netherlands) Chair Aydin Sibel Zehra (Turkey) Speaker Aletaha Daniel (Austria) Risk of bias when designing a trial Speaker Landewé Robert B.M. (Netherlands) Risk of bias when conducting a trial Speaker Yazici Hasan (Turkey) Presenter Sepriano Alexandre (Portugal) Abstract Richter Adrian (Germany) SP0090 Risk of bias when reporting a trial Effect of comedication with conventional synthetic DMARDs on TNF inhibitors-retention in patients with spondyloarthritis: a prospective cohort OP0138 SIMPLE POOLING OF DATA FROM DIFFERENT STUDIES IS INCREASINGLY USED BUT NOT IN LINE WITH METHODOLOGICAL RECOMMENDATIONS: A SYSTEMATIC REVIEW OF METHODS APPLIED IN THE FIELD OF RHEUMATOID ARTHRITIS Practical Skills Session - Capital Suite 06 Crystals II Chair Tausche Anne Kathrin (Germany) Chair Pascual Eliseo (Spain) Tutor Norkuviene Eleonora (Lithuania) Tutor Sivera Francisca (Spain) Tutor Pimentao José (Portugal) Tutor Oliviero Francesca (Italy) Practical Skills Session - Capital Suite 13 Laboratory I 42 of 111 Chair Burmester Gerd Rüdiger (Germany) Chair Dörner Thomas (Germany) Speaker Dörner Thomas (Germany) APS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Miossec Pierre (France) Vasculitis, systemic autoimmunity Speaker Feist Eugen (Germany) Inflammatory joint diseases PARE Session - Room S19 Digital applications for the benefit of the patient Chair Lerstroem Kirsten (United Kingdom) Chair Papastavrou Dora (Greece) Speaker Ernestam Sofia (Sweden) SP0091 Can individual patients benefit from registries? Speaker Murray Elizabeth (United Kingdom) SP0092 Digital interventions to improve self-care Speaker Stones Simon (United Kingdom) SP0093 Abstract Grange Laurent (France) OP0139-PARE THE FIRST SERIOUS GAME EDUBIOT: A MODERN THERAPEUTIC EDUCATIONAL TOOL FOR ADULT PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASE, TREATED WITH BIOTHERAPY. Abstract O Leary Grainne (Ireland) OP0140-PARE SELF-MANAGEMENT ONLINE: FROM CONCEPT TO DELIVERY, LIVING WELL WITH ARTHRITIS ONLINE How innovative technologies can support individuals to better self-manage their conditions EULAR Projects in Clinical Affairs - Room S20 EULAR Projects in Clinical Affairs 43 of 111 Chair van Vollenhoven Ronald (Netherlands) Chair Müller-Ladner Ulf (Germany) Speaker Macfarlane Gary J. (United Kingdom) Revised EULAR recommendations for the management of fibromyalgia Speaker Hatemi Gulen (Turkey) Update of the EULAR Recommendations for the Management of Behçet’s Disease Speaker Lems Willem F. (Netherlands) SP0094 EULAR/EFORT recommendations for prevention and management of osteoporotic fractures Speaker Mukhtyar Chetan (United Kingdom) SP0095 EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Thursday 09.06.2016 15:30 - 17:00 What is New (WIN) - ICC Auditorium WIN Session 4 Speaker da Silva José Antonio P. (Portugal) Rheumatic manifestations arising from endocrine/metabolic disorders Speaker Prakken Berent J. (Netherlands) Paediatric rheumatology Challenges in Clinical Practice Session - Hall B Difficult vasculitis (pulmonary/renal & CNS) Chair Salvarani Carlo (Italy) Chair Vassilopoulos Dimitrios (Greece) Presenter Pipitone Nicolo (Italy) Case 1 presentation: A case of temporal arteritis with uninflamed temporal artery Discussant Cavazza Alberto (Italy) Case 1 discussion: The role of the pathologist in the diagnosis of large vessel vasculitis Presenter Calabrese Cassandra (United States) Case 2 presentation: A case mimicking CNS vasculitis Discussant Calabrese Leonard (United States) Case 2 Discussion: How to recognize CNS-vasculitis mimics Clinical Science Session - Hall D Optimization of MTX in RA treatment 44 of 111 Chair Weinblatt Michael (United States) Chair Burmester Gerd Rüdiger (Germany) Speaker Schiff Michael (United States) SP0096 MTX pharmacokinetics - oral vs SQ or genetics Speaker de Jonge Robert (Netherlands) SP0097 MTX polyglutamate and clinical response Speaker Burmester Gerd Rüdiger (Germany) Best dose of MTX in combination with biologics 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Flipo René-Marc (France) OP0141 WHICH STRATEGIES IN RHEUMATOID ARTHRITIS PATIENT WITH INADEQUATE RESPONSE TO METHOTREXATE MONOTHERAPY: THE STRATEGE STUDY Abstract Michaud Kaleb (United States) OP0142 METHOTREXATE USE IN RA: WHAT 17 YEARS AND 22,621 PATIENTS CAN TEACH US How to Treat / Manage (HOT) - Hall E HOT Session 6 Speaker McInnes Iain (United Kingdom) Psoriatic Arthritis Speaker van den Bosch Filip (Belgium) Spondyloarthritis / Ankylosing Spondylitis Clinical Science Session - Hall C Joint replacement in OA: Friend or Foe? Chair Rannou François (France) Chair van Spil W. Erwin (Netherlands) Speaker Victor Jan (Belgium) Speaker Mandl Lisa (United States) Speaker van der Heide Huub J. L. (Netherlands) Abstract Aitken Dawn (Australia) OP0143 THE EFFECT OF PHYSICAL ACTIVITY ON THE RISK OF TOTAL JOINT REPLACEMENT FOR SEVERE KNEE OR HIP OSTEOARTHRITIS: A POPULATION-BASED PROSPECTIVE COHORT STUDY Abstract Eathakkattu Antony Benny Samuel (Australia) OP0144 INFRA PATELLAR FAT PAD SIGNAL INTENSITY ALTERATIONS AND EFFUSIONSYNOVITIS PREDICT KNEE PAIN, CARTILAGE VOLUME LOSS AND TOTAL KNEE REPLACEMENT OVER 10.7 YEARS IN OLDER ADULTS. Joint replacement for end stage osteoarthritis: the holy grail?! SP0098 For which patient a joint replacement is most successful? Joint prosthesis: one size fits all? Outcome Science Session - Hall A How to identify and follow patients with inflammatory back pain? 45 of 111 Chair Bergman Stefan (Sweden) Chair Hider Sam (United Kingdom) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Mallen Christian D. (United Kingdom) Is the concept of inflammatory back pain relevant in primary care? Speaker Petersson Ingemar (Sweden) How to identify the right back pain patients for rheumatological care? Speaker Landewé Robert B.M. (Netherlands) How can modern imaging modalities facilitate the identification of patients with spondyloarthritis? Abstract Moorthy Arumugam (United Kingdom) OP0145 AN EVALUATION OF INFLAMMATORY BACK PAIN IN THE COMMUNITY – A NOVEL WAY OF USING SOCIAL MEDIA (FACEBOOK) Abstract Van Onna Marloes (Netherlands) OP0146 PATTERNS OF CLINICAL ASSESSMENT OF GENERAL PRACTITIONERS WHEN FACING A PATIENT SUSPECTED FOR SPONDYLOARTHRITIS; A STUDY WITH UNANNOUNCED STANDARDIZED PATIENTS IN DAILY PRACTICE Health Professionals Session - Capital Suite 07 Physical activity assessment – what do we know, what do we do, how does it work? Chair Opava Christina H. (Sweden) Chair Kennedy Norelee (Ireland) Speaker Brodin Nina (Sweden) SP0099 Awareness and use of objective and subjective assessments of physical activity among health professionals and barriers for implementation Speaker Appel Esbensen Bente (Denmark) SP0100 Awareness and use among patients with inflammatory rheumatic disease of objective and subjective assessments of physical activity Speaker Swinnen Thijs (Belgium) SP0101 When to use objective and subjective assessment of physical activity – issues of reliability, validity and usability Speaker Kinneavy Claire (Ireland) SP0102 Perspectives from patients with arthritis Abstract Hörnberg Kristina (Sweden) OP0147-HPR AEROBIC CAPACITY OVER 16 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS; RELATIONS TO RISK FACTORS FOR CARDIOVASCULAR DISEASE. Basic and Translational Science Session - Capital Suite 11 How cell death shapes immunity and tolerance 46 of 111 Chair Kalden Joachim R. (Germany) Chair Rovere-Querini Patrizia (Italy) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Arandjelovic Sanja (United States) SP0103 Apoptotic cell clearance Speaker Kaplan Mariana (United States) Netosis in SLE Speaker Vandenabeele Peter (Belgium) New insights into necroptosis Speaker Herrmann Martin (Germany) SP0104 NETosis in the control of inflammation Abstract Chirivi Renato (Netherlands) OP0148 FIRST IN CLASS THERAPEUTIC ACPA REDUCES INFLAMMATION BY INHIBITION OF NETOSIS Basic and Translational Science Session - Capital Suite 14 "Smoke a joint to protect the joint". Cannabidoids & neuropeptides in pain and inflammation Chair Malfait Fransiska (Belgium) Chair Perrot Serge (France) Speaker Maccarrone Mauro (Italy) SP0105 Biochemistry and pharmacology of the endocannabinoid system Speaker Alawi Khadija (United Kingdom) SP0106 Neuropeptides, TRPs and inflammation: focus on the joint Speaker Biro Tamas (Hungary) SP0107 Cannabinoids and inflammation: focus on the joint Abstract Capellino Silvia (Germany) OP0149 DOPAMINE PATHWAY AND BONE METABOLISM IN RHEUMATOID ARTHRITIS Abstract Okano Takaichi (Japan) OP0150 3-BROMOPYRUVATE AMELIORATES AUTOIMMUNE ARTHRITIS BY EXERTING A DUAL EFFECT ON BOTH TH17 AND TREG CELL DIFFERENTIATION AND DENDRITIC CELL ACTIVATION. Clinical Science Session - Capital Suite 02 EULAR - EMA Session 47 of 111 Chair Vesely Richard (United Kingdom) Chair Breedveld Ferdinand C. (Netherlands) Speaker Vesely Richard (United Kingdom) How are new drugs approved in Europe by EMA? Speaker Maynard Janet (United Kingdom) The drug approval process in the United States Speaker Sieper Joachim (Germany) SP0108 Different approaches to drug approval by EMA and FDA – the example of non-radiographic axial spondyloarthritis 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Breedveld Ferdinand C. (Netherlands) The approval process of Biosimilars in Europe – what should the rheumatologist know? Speaker Faculty (-) Discussion and Q&A with the Faculty The Young Rheumatologist - Capital Suite 01 Teaching clinical skills Chair Doherty Michael (United Kingdom) Chair Romao Vasco C (Portugal) Speaker Doherty Michael (United Kingdom) Speaker Caporali Roberto (Italy) Speaker Hafler Janet (United States) Presenter Kosevoi Alexandra (Romania) Abstract Sukhdeo Aishwarya (Australia) SP0109 How to perform clinical history and physical examination? How to read a plain joint x-ray? SP0110 The art of teaching rheumatology: tips and tricks Relationship between ultrasound-detected synovitis, quality of life and work productivity in patients with rheumatoid arthritis of working age OP0151 A STUDY ON MEDICAL STUDENTS LEARNING ULTRASOUND IN RHEUMATOID ARTHRITIS (ASMSLURA) Practical Skills Session - Capital Suite 06 Local procedures including aspirations, injections and biopsies I 48 of 111 Chair Machado Pedro (Portugal) Chair Damjanov Nemanja (Serbia) Speaker Damjanov Nemanja (Serbia) SP0111 Sonographic-guided joint and periarticular aspirations and injections Speaker Scirè Carlo Alberto (Italy) SP0112 Minimally invasive ultrasound-guided synovial biopsy Speaker Bouffard Antonio (United States) Speaker Ungari Claudio (Italy) Speaker Faculty (-) Interventional radiology: minimally invasive image-guided procedures to diagnose and treat musculoskeletal diseases SP0113 Minimally invasive biopsy of salivary glands Q&A and discussion 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Practical Skills Session - Capital Suite 13 MRI I Chair Ostergaard Mikkel (Denmark) Chair Hermann Kay-Geert (Germany) Speaker Ostergaard Mikkel (Denmark) SP0114 How to define and assess inflammatory and destructive changes in RA and PsA – including quiz cases Speaker Eshed Iris (Israel) SP0115 MRI of inflammatory diseases of vessels and muscles – How to apply, including case stories Speaker Diekhoff Torsten (Germany) SP0116 How to use MRI to differentiate SpA from its differential diagnoses – including quiz cases Speaker Hermann Kay-Geert (Germany) SP0117 When and how to use MRI in clinical practice – including quiz cases PARE Session - Room S19 What is done for people with rare diseases? Can we do more? Chair Carmona Loreto (Spain) Chair Welling Joep (Netherlands) Speaker Wagner Leona (United Kingdom) Living with alkaptonuria and my activities for the alkaptonuria society Speaker Sotirelis Christos (United Kingdom) Rare disease patients’ perspective on improving access to orphan drugs and opportunities for better collaboration Speaker Robinson Peter N. (Germany) Phenomizer: The ultimate app to diagnose rare diseases Abstract Andersen Jeanette (Denmark) OP0152-PARE STARTING A DISEASE SPECIFIC YOUTH GROUP ON A NATIONAL LEVEL Abstract MARCHAL ANJA (Belgium) OP0153-PARE REUMAMAMA’S EN –PAPA’S: INFO SESSIONS FOR (FUTURE) PARENTS WITH RMDS AND FOR PARENTS WITH CHILDREN WITH JUVENILE ARTHRITIS EULAR Projects in Health Professionals - Room S20 The Health Professionals’ approach to pain management in inflammatory arthritis and osteoarthritis 49 of 111 Chair Oliver Susan (United Kingdom) Chair Kamala Nola (United States) Speaker Asenlöf Pernilla (Sweden) SP0118 The ongoing shift of paradigms within physiotherapy and pain management 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Christensen Robin (Denmark) SP0119 Systematic reviews and meta-analyses for dummies: a tutorial on how, when, and why to get started Speaker Geenen Rinie (Netherlands) SP0120 Recommendations for prompt pain management in inflammatory arthritis and osteoarthritis Speaker Overman Cécile (Netherlands) SP0121 The benefits of prompt pain management in inflammatory arthritis and osteoarthritis. A systematic literature review and meta-analysis Abstract Fongen Camilla (Norway) OP0154-HPR SPINAL MOBILITY IS IMPAIRED IN PATIENTS WITH CHRONIC BACK PAIN OF SHORT DURATION, BUT DOES NOT DISCRIMINATE BETWEEN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND OTHER FORMS OF CBP Friday 10.06.2016 08:15 - 09:45 Basic and Translational Science Session - Capital Suite 11 News from kinase inhibitors Chair Pap Thomas (Germany) Chair Firestein Gary S (United States) Speaker Firestein Gary S (United States) Speaker McInnes Iain (United Kingdom) Inflammation - new findings in basic science Speaker Meier Florian (Germany) Protective effects on matrix distruction in cartilage and bone Abstract Telliez Jean-Baptiste (United States) OP0155 DEVELOPMENT OF A JAK3 SPECIFIC INHIBITOR CLINICAL CANDIDATE: FUNCTIONAL DIFFERENTIATION OF JAK3 SELECTIVE INHIBITION OVER PAN-JAK OR JAK1 SELECTIVE INHIBITION Abstract Hammitzsch Ariane (United Kingdom) OP0156 DECIPHERING THE IN VITRO THERAPEUTIC POTENTIAL OF JAK INHIBITORS IN ANKYLOSING SPONDYLITIS SP0122 Kinase inhibitors: clinical aspects Basic and Translational Science Session - Capital Suite 14 Crystal arthritis 50 of 111 Chair Lioté Frederic (France) Chair Gibson Terence (United Kingdom) Speaker Terkeltaub Robert (United States) SP0123 Gout: a variable inflammatory disease 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Abhishek Abhishek (United Kingdom) SP0124 Systemic predisposition to CPPD and interaction with osteoarthritis Speaker Anders Hans Joachim (Germany) SP0125 Renal handling of urate and gout Abstract Kobak Senol (Turkey) OP0157 PREVALENCE AND SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH GOUTY ARTHRITIS Abstract Merriman Tony (New Zealand) OP0158 MITOCHONDRIAL GENETIC VARIATION AND SUSCEPTIBILITY TO GOUT IN POLYNESIANS Educational Session - Room S20 The Lancet - Meet the Editor Chair Burmester Gerd Rüdiger (Germany) Chair Kvien Tore K. (Norway) Chair Combe Bernard (France) Speaker Burmester Gerd Rüdiger (Germany) Introduction Speaker Sargent Jennifer (United States) The Lancet: a Publishing Overview Speaker Faculty (-) Panel discussion Speaker Faculty (-) Q&A with the audience Friday 10.06.2016 10:15 - 11:45 What is New (WIN) - ICC Auditorium WIN Session 5 Speaker Breban Maxime (France) Axial and Peripheral Spondyloarthritis Speaker Veale Douglas (Ireland) Psoriatic arthritis Abstract Session - Hall B 51 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Session: Expanding therapeutic options in spondyloarthritis Chair Dougados Maxime (France) Chair van de Sande M.G. (Netherlands) Abstract Schreiber Stefan (Germany) Abstract Baeten Dominique (Netherlands) OP0108 BIMEKIZUMAB, A MONOCLONAL ANTIBODY THAT INHIBITS BOTH IL-17A AND IL-17F, PRODUCES A PROFOUND RESPONSE IN BOTH SKIN AND JOINTS: RESULTS OF AN EARLY-PHASE, PROOF-OF-CONCEPT STUDY IN PSORIATIC ARTHRITIS Abstract Mease Philip (United States) OP0109 EFFICACY AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM A PHASE 3 STUDY (SPIRIT-P1) Abstract Rogge Lars (France) OP0111 ANTI-TNF THERAPY IN AXIAL SPONDYLOARTHRITIS: PREDICTION OF THERAPEUTIC RESPONSES USING IMMUNOLOGICAL SIGNATURES Abstract Sepriano Alexandre (Portugal) OP0112 EFFECT OF COMEDICATION WITH CONVENTIONAL SYNTHETIC DMARDS ON TNF INHIBITORS-RETENTION IN PATIENTS WITH SPONDYLOARTHRITIS: A PROSPECTIVE COHORT Abstract Maksymowych Walter (Canada) OP0114 SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON Abstract Joshi Avani (United States) OP0115 RELATIVE EFFICACY OF ADALIMUMAB VERSUS SECUKINUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A MATCHING-ADJUSTED INDIRECT COMPARISON OP0113 NO INCREASED INCIDENCE OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES Abstract Session - Hall D Abstract Session: Developments in the treatment of RA 52 of 111 Chair Taylor Peter C. (United Kingdom) Chair Studenic Paul (Austria) Abstract Genovese Mark (United States) OP0223 SAFETY AND EFFICACY OF ABT-494, A NOVEL SELECTIVE JAK1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Westhovens René (Belgium) OP0224 FILGOTINIB (GLPG0634), AN ORAL JAK1 SELECTIVE INHIBITOR IS EFFECTIVE IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM A 24-WEEK PHASE 2B DOSE RANGING STUDY Abstract Glintborg Bente (Denmark) OP0225 THREE MONTHS’ CLINICAL OUTCOMES FROM A NATIONWIDE NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY ARTHRITIS. RESULTS FROM THE DANBIO REGISTRY Abstract J. O'Dell (United States) OP0226 RANDOMIZED, DOUBLE-BLIND STUDY COMPARING CHS-0214 WITH ETANERCEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) DESPITE METHOTREXATE (MTX) THERAPY Abstract Emery Paul (United Kingdom) OP0227 A RANDOMIZED DOUBLE-BLIND TREATMENT STRATEGY STUDY EVALUATING CONTINUATION OR REDUCED-FREQUENCY DOSING OF CERTOLIZUMAB PEGOL VERSUS WITHDRAWAL TO MAINTAIN LOW DISEASE ACTIVITY IN EARLY RA PATIENTS (C-EARLY PERIOD 2) Abstract Takeuchi Tsutomu (Japan) OP0228 BARICITINIB DOSE STEP-DOWN FOLLOWING DISEASE CONTROL IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Takeuchi Tsutomu (Japan) OP0229 BOTH HIGH TITER OF RF/ACPA AT BASELINE IS CLOSELY LINKED WITH HIGH LEVEL OF BASELINE PLASMA TNF LEVEL WHICH RESULTED IN LOW DRUG LEVEL AND LOW CLINICAL RESPONSE IN INFLIXIMAB TREATMENT IN RA PATIENTS: POST-HOC ANALYSIS OF A DOUBLE-BLIND CLINICAL STUDY (RISING STUDY) Abstract Szekanecz Zoltán (Hungary) OP0230 MULTI DRUG RESISTANCE (MDR) PROTEIN ACTIVITY OF ACTIVATED T LYMPHOCYTES IS A PREDICTOR OF BIOLOGICAL TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS SP0126 Myositis How to Treat / Manage (HOT) - Hall E HOT Session 7 Speaker Lundberg Ingrid (Sweden) Speaker Guillevin Loic (France) Vasculitis Abstract Session - Hall C Abstract Session; Epidemiology of RMDs Chair 53 of 111 Hetland Merete (Denmark) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Chair Courvoisier Delphine (Switzerland) Abstract Pelaez-Ballestas Ingris (Mexico) OP0167 PREVALENCE OF RHEUMATIC DISEASE IN LATIN AMERICAN INDIGENOUS POPULATION: A COMMUNITY BASED STUDY Abstract Strangfeld Anja (Germany) FIRST RESULTS FROM THE PROSPECTIVE GERMAN PREGNANCY REGISTER RHEKISS Abstract Chen Hsin-Hua (Taiwan, Province OP0169 of China) ASSOCIATION BETWEEN USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AND DIABETES IN PATIENTS WITH ANKYLOSING SPONDYLITIS, RHEUMATOID ARTHRITIS, OR PSORIASIS/PSORIATIC ARTHRITIS: NATIONWIDE, POPULATION-BASED COHORT STUDY OF 84,989 PATIENTS Abstract Callhoff Johanna (Germany) OP0170 LOW INCOME IS ASSOCIATED WITH LOWER FUNCTIONAL CAPACITY AND HIGHER DISEASE BURDEN IN RA PATIENTS YOUNGER THAN 65 Abstract Rossides Marios (Sweden) OP0171 PROGNOSIS OF STROKE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A POPULATION-BASED COHORT STUDY Abstract De Cock Diederik (Belgium) OP0172 A COST-EFFECTIVENESS ANALYSIS OF DIFFERENT INTENSIVE COMBINATION THERAPIES FOR EARLY RHEUMATOID ARTHRITIS: 1 YEAR RESULTS OF THE CARERA TRIAL Abstract Bartlett Susan (Canada) OP0173 HOW MUCH OF A BARRIER IS EXCESS WEIGHT AND SMOKING FOR ACHIEVING SUSTAINED REMISSION IN EARLY RA? RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT Abstract Hamann Philip (United Kingdom) OP0174 OP0168 THE DEVELOPMENT OF THE MODIFIED DAS28-CRP TO IMPROVE AGREEMENT WITH DAS28-ESR AND ENSURE APPROPRIATE DISEASE ACTIVITY STRATIFICATION IN RA Abstract Session - Hall A Abstract Session: SLE, Sjögren's and APS: clinical aspects (other than treatment) 54 of 111 Chair Boumpas Dimitrios (Greece) Chair Richez Christophe (France) Abstract Arkema Elizabeth (Sweden) OP0189 RATE OF CERVICAL NEOPLASIA IN SYSTEMIC LUPUS ERYTHEMATOSUS: A NATIONWIDE COHORT-STUDY Abstract Durcan Laura (United States) OP0183 HYPOCOMPLEMENTEMIA ASSOCIATES WITH THROMBOSIS IN SLE PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES. 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Gavand Pierre-Edouard (France) OP0184 CLINICAL SPECTRUM AND THERAPEUTIC MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED MACROPHAGE ACTIVATION SYNDROME. DATA FROM A FRENCH NATIONWIDE STUDY OF 81 EPISODES IN 67 ADULT PATIENTS Abstract Zhang Huayong (China) OP0185 CHARACTERISTICS OF PRIMARY SJÖGREN’S SYNDROME PATIENTS WITH IGG4-POSITIVE PLASMA CELLS IN LABIAL SALIVARY GLANDS Abstract Elkon Keith (United States) OP0186 IMMUNE COMPLEX BOUND U1 AND Y1 RNA CORRELATES WITH INTERFERONSTIMULATED GENE EXPRESSION AND DISEASE ACTIVITY: AN OBSERVATIONAL STUDY OF SYSYTEMIC LUPUS ERYTHEMATOSUS PATIENTS. Abstract Souto Alejandro (Spain) OP0187 ALL-CAUSE AND SPECIFIED CAUSES OF MORTALITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL TRIALS Abstract Houssiau Frédéric (Belgium) OP0188 THE DOSE OF GLUCOCORTICOIDS TAKEN AT ONE YEAR, BUT NOT THE INITIAL DOSE PRESCRIBED, IS AN INDEPENDENT PREDICTOR OF DAMAGE ACCRUAL IN LUPUS NEPHRITIS. Abstract Oke Vilija (Sweden) OP0190 INCREASED SERUM LEVELS OF IFN-Λ CORRELATE WITH TH17 AXIS CYTOKINES AND INDEPENDENTLY TO IFN- Α IDENTIFY PATIENT GROUP WITH HIGHER ORGAN DAMAGE Abstract Session - Capital Suite 07 HPR Abstract Session: Shared decision making 55 of 111 Chair de Thurah Annette (Denmark) Chair Appel Esbensen Bente (Denmark) Abstract Rawat Roopa (India) OP0192-HPR TEACHING METHOTREXATE SELF-INJECTION TECHNIQUE TO THE PATIENTS IN A ROUTINE RHEUMATOLOGY OUT-PATIENT CLINIC: FACTORS FAVOURING OR COUNTERING ACCEPTABILITY. Abstract Moholt Ellen (Norway) OP0193-HPR AIMING FOR REMISSION IN EARLY RA: IMPACT ON PAIN DURING THE FIRST 2 YEARS OF TREATMENT Abstract Piemonte Guya (Italy) OP0194-HPR NURSING TRIAGE IN RHEUMATOLOGY: THREE MONTHS EXPERIENCE IN AN OUTPATIENT CLINIC OF THE UNIVERSITY OF FLORENCE (ITALY) Abstract Fayet Francoise (France) OP0195-HPR COMPARISON OF EDUCATIONAL MODELS FOR MAINTAINING OPTIMAL SAFETY IN THE SELF-MANAGEMENT OF BIOTHERAPY AMONGST RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS. 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Van Rossen Liz (United Kingdom) OP0196-HPR DOSE REDUCTION OF BIOLOGIC DRUGS IN AXIAL SPONDYLOARTHRITIS IN CLINICAL PRACTICE Abstract Hazes J.M.W (Netherlands) OP0197-HPR PSYCHOSOCIAL PREDICTORS OF DMARD ADHERENCE IN THE FIRST THREE MONTHS OF TREATMENT FOR EARLY ARTHRITIS Abstract Gavan Sean (United Kingdom) OP0198-HPR EXPLORING FACTORS WHICH INFLUENCE ANTI-TNF TREATMENT DECISIONS FOR RHEUMATOID ARTHRITIS IN ENGLAND – A QUALITATIVE ANALYSIS. Abstract Session - Capital Suite 11 Abstract Session: Cormobidities 56 of 111 Chair Bijlsma Johannes W.J. (Netherlands) Chair van der Helm Annette (Netherlands) Abstract Konijn NPC (Netherlands) OP0262 SIMILAR CLINICAL AND RADIOLOGICAL OUTCOME IN THE COBRA AND COBRA-LIGHT TREATMENT GROUP 4 YEARS AFTER INITIATION OF THE COBRA-LIGHT TRIAL Abstract El Miedany Yasser (United Kingdom) OP0255 RHEUMATOID ARTHRITIS COMORBIDITY INDEX: DEVELOPMENT AND VALIDATION OF A NEW SPECIFIC TOOL FOR CLASSIFYING PROGNOSTIC COMORBIDITY IN RHEUMATOID ARTHRITIS PATIENTS. Abstract Kokkonen Heidi (Sweden) OP0256 PRESENCE OF RISK FACTORS FOR CARDIOVASCULAR DISEASE PREDATES THE ONSET OF SYMPTOMS OF RHEUMATOID ARTHRITIS. Abstract Crowson Cynthia (United States) OP0257 RHEUMATOID ARTHRITIS-SPECIFIC CARDIOVASCULAR RISK CALCULATORS ARE NOT SUPERIOR TO RISK CALCULATORS ESTABLISHED FOR THE GENERAL POPULATION: A VALIDATION ANALYSIS IN A COHORT OF RA PATIENTS FROM 7 COUNTRIES Abstract El Miedany Yasser (United Kingdom) OP0258 OPTIMIZING THERAPY IN INFLAMMATORY ARTHRITIS: PREDICTION OF RELAPSE AFTER TAPERING OR STOPPING DMARDS/ BIOLOGIC AGENTS BY ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS PATIENTS WHO ACHIEVED CLINICAL REMISSION Abstract Curtis Jeffrey (United States) OP0259 IMPACT OF SUSTAINED REMISSION ON RISK FOR INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN A US REGISTRY Abstract Strangfeld Anja (Germany) OP0260 LOWER INTESTINAL PERFORATIONS ARE MORE FREQUENT AND PRESENT UNTYPICALLY IN PATIENTS TREATED WITH TOCILIZUMAB COMPARED TO OTHER BIOLOGIC OR CONVENTIONAL SYNTHETIC DMARDS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Combe Bernard (France) OP0261 7-YEAR TOLERABILITY PROFILE OF GLUCOCORTICOIDS USE IN EARLY RHEUMATOID ARTHRITIS: DATA FROM THE ESPOIR COHORT Abstract Session - Capital Suite 14 Abstract Session: An inflammatory update! Chair Voll Reinhard E. (Germany) Chair Siebert Stefan (United Kingdom) Abstract Szondy Zsuzsanna (Hungary) OP0207 TRANSMEMBRANE TNF-ALPHA REVERSE SIGNALING LEADING TO TGF-BETA PRODUCTION IS SELECTIVELY ACTIVATED BY ANTI-TNF-ALPHA TARGETING MOLECULES Abstract Yu Shuilian (China) OP0208 EMERGING ROLE OF IL-33/ST2 AXIS IN ENDOTHELIAL CELL INJURY OF LUPUS NEPHRITIS Abstract Gan Yuzhou (China) OP0209 ELEVATED GITRL IS ASSOCIATED WITH MULTI-ORGAN INVOLVEMENT AND INCREASED DISEASE ACTIVITY OF PRIMARTY SJOGREN'S SYNDROME AND PROMOTES PATHOGENIC TH17 DIFFERENTIATION Abstract Ascone Giuliana (Netherlands) OP0210 APOLIPOPROTEIN E AGGRAVATES INFLAMMATION AND JOINT DESTRUCTION IN MURINE ANTIGEN - INDUCED ARTHRITIS Abstract Mcgarry Trudy (Ireland) OP0211 REPROGRAMMING OF METABOLIC PATHWAYS INHIBITS TLR2-INDUCED INFLAMMATION IN RA Abstract Audo Rachel (France) OP0212 PHOSPHOLIPID TRANSFER PROTEIN (PLTP): A LINK BETWEEN INFLAMMATION AND LIPIDS IN RHEUMATOID ARTHRITIS? Abstract Tas Sander (Netherlands) OP0213 CD40-MEDIATED ACTIVATION OF NONCANONICAL NF-ΚB SIGNALLING IN DENDRITIC CELLS INDUCES EXTRATHYMIC AUTOIMMUNE REGULATOR (AIRE) EXPRESSION, WHICH IS IMPAIRED IN PRIMARY SJÖGREN’S SYNDROME Abstract Cremers Niels (Netherlands) OP0214 S100A8/A9 PRODUCED LOCALLY DURING EXPERIMENTAL OSTEOARTHRITIS INDUCES LOCAL AND SYSTEMIC CHANGES IN MONOCYTE POPULATIONS Abstract Session - Capital Suite 02 Abstract Session: Advances in pediatric rheumatology Chair 57 of 111 Cimaz Rolando (Italy) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Chair Foster Helen E. (United Kingdom) Abstract Ruperto N (Italy) OP0215 SUBCUTANEOUS ABATACEPT IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC OR NON-BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: PHARMACOKINETICS, EFFICACY AND SAFETY Abstract Horneff Gerd (Germany) OP0216 SAFETY OF TOCILIZUMAB, INTERLEUKIN-1 INHIBITORS AND ETANERCEPT IN 262 SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS. Abstract Swart Joost (Italy) OP0217 ADJUDICATION OF INFECTIONS IN THE PHARMACOVIGILANCE IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS (PHARMACHILD) TREATED WITH BIOLOGIC AGENTS AND/OR METHOTREXATE Abstract Lythgoe Hanna (United Kingdom) OP0218 EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS Abstract Horneff Gerd (Germany) OP0219 UPDATE ON MALIGNANCIES IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS IN THE GERMAN BIKER REGISTRY Abstract Goulart Maria Fernanda (Brazil) OP0220 PERSONAL EXPOSURE TO AIR POLLUTION INFLUENCED DISEASE ACTIVITY AND EXHALED BREATH BIOMARKERS: A PROSPECTIVE STUDY IN A CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS POPULATION Abstract Campanilho-Marques Raquel (United Kingdom) OP0221 EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR-ΑLFA ANTAGONISTS IN A LARGE COHORT OF JUVENILE DERMATOMYOSITIS PATIENTS Abstract Pontikaki Irene (Italy) OP0222 PREGNANCY OUTCOME IN PATIENTS AFFECTED BY JUVENILE IDIOPATHIC ARTHRITIS (JIA) EXPOSED TO BIOLOGICAL AGENTS: A MONOCENTRIC EXPERIENCE IN A TERTIARY CENTRE OF MILAN. Abstract Session - Capital Suite 01 Abstract Session: Scleroderma, myositis and related conditions 58 of 111 Chair Czirják László (Hungary) Chair Becker Mike O. (Switzerland) Abstract Schniering Janine (Switzerland) OP0045 EARLY DETECTION OF LUNG INVOLVEMENT IN SYSTEMIC SCLEROSIS USING MOLECULAR TARGETED IMAGING Abstract Truchetet Marie-Elise (France) OP0046 DECREASED CIRCULATING ILC2 LEVELS CORRELATE WITH SKIN FIBROSIS IN HUMAN SYSTEMIC SCLEROSIS AND ARE ASSOCIATED WITH A SKEWING OF THE ILC1/ILC2 BALANCE IN THE SKIN 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Tomcik Michal (Czech Republic) OP0047 EXPRESSION OF HEAT SHOCK PROTEIN 90 IN MUSCLE TISSUE AND PLASMA IS INCREASED IN IDIOPATHIC INFLAMMATORY MYOPATHIES AND CORRELATES WITH DISEASE ACTIVITY, SKELETAL MUSCLE, HEART AND LUNG INVOLVEMENT Abstract Stratton Richard (United Kingdom) OP0048 IL-31 IS AN INFLAMMATORY PRO-FIBROTIC FACTOR ELEVATED IN A SUBSET OF SCLERODERMA PATIENTS WITH SEVERE PRURITUS Abstract Stellato Mara (Switzerland) OP0049 MYOCARDIAL FIBROGENESIS IN SYSTEMIC SCLEROSIS: INVOLVEMENT OF A NOVEL STROMAL SUB-POPULATION Abstract Praino Emanuela (Italy) OP0050 SERUM LEVELS OF ADIPOKINES IN THE CATEGORIES OF BODY MASS INDEX (BMI) IN PATIENTS WITH SYSTEMIC SCLEROSIS Abstract Soare Alina (Germany) OP0051 DIPEPTIDYL-PEPTIDASE-4 (DPP4) CHARACTERIZES A SUBPOPULATION OF FIBROSISPROMOTING FIBROBLASTS AND IS A MOLECULAR TARGET FOR THE TREATMENT OF FIBROSIS Abstract Costa Pereira Karla Ribeiro (Brazil) OP0052 AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IMPROVES FUNCTIONAL EVALUATION OF SYSTEMIC SCLEROSIS PATIENTS Abstract Session - Capital Suite 06 Abstract Session: Emerging concepts in genomics & genetics 59 of 111 Chair Eyre Stephen (United Kingdom) Chair Padyukov Leonid (Sweden) Abstract Roberts Amity (United Kingdom) OP0231 DIFFERENTIAL TRANSCRIPTION FACTOR BINDING COULD EXPLAIN THE GENETIC ASSOCIATION OF ANKYLOSING SPONDYLITIS WITH POLYMORPHISMS IN THE IL23RIL12RB2 INTERGENIC REGION Abstract Mauro Daniele (United Kingdom) OP0232 C1QTNF4 MUTATION IDENTIFIED BY EXOME SEQUENCING IS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND DYSREGULATION OF TNF-INDUCED APOPTOSIS Abstract Julià Antonio (Spain) OP0233 GENOME-WIDE PATHWAY ANALYSIS REVEALS THAT VEGF GENETIC PATHWAY IS ASSOCIATED WITH ORAL ULCERS IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Brynedal Boel (Sweden) OP0234 RHEUMATOID ARTHRITIS SUBSETS DEFINED BY SUB-SPECIFICITIES OF ANTI-CITRULLINATED ANTIBODIES (ACPAS) HAVE UNIQUE HLA ASSOCIATIONS Abstract Pratt Arthur (United Kingdom) OP0235 IDENTIFICATION OF NOVEL CD4+ LYMPHOCYTE EXPRESSION QUANTITATIVE TRAIT LOCI IN UNTREATED EARLY ARTHRITIS PATIENTS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Oliver James (United Kingdom) OP0236 WHOLE TRANSCRIPTOME INVESTIGATION OF RESPONSE TO ANTI-TNF TREATMENT IN RHEUMATOID ARTHRITIS Abstract Juge Pierre-Antoine (France) OP0237 POLYMORPHISMS OF GENE IMPLICATED IN TYPE 1 INTERFERON PATHWAY ARE ASSOCIATED WITH THE CLINICAL RESPONSE OF RITUXIMAB AT 24 WEEKS IN RHEUMATOID ARTHRITIS. Abstract Terao Chikashi (Japan) OP0238 FCGR2B AND MULTIPLE HLA LOCI ARE ASSOCIATED WITH SUSCEPTIBILITY TO IGG4-RELATED DISEASE. Abstract Session - Capital Suite 13 Abstract Session: Novel clues solved in RA development 60 of 111 Chair Toes Rene (Netherlands) Chair Pakozdi Angela (United Kingdom) Abstract Prendergast Catriona (United Kingdom) Abstract Humby Frances (United Kingdom) OP0240 SYNOVIAL LYMPHOCYTIC AGGREGATES ASSOCIATE WITH HIGHLY ACTIVE RA AND PREDICT EROSIVE DISEASE PROGRESSION AT 12 MONTHS: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT Abstract Zeng Pingling (Sweden) OP0241 REPETITIVE PROLONGED PHYSICAL WORKLOAD IS ASSOCIATED WITH INCREASED RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE SWEDISH EIRA-STUDY Abstract Croft Adam (United Kingdom) OP0242 SELECTIVE DELETION OF FAP EXPRESSING CELLS ATTENUATES SYNOVIAL INFLAMMATION AND PROTECTS AGAINST INFLAMMATORY BONE CHANGES Abstract Sauvageau Gabrielle (Canada) OP0243 SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) IN THE IL-4 RECEPTOR, IL-4, AND CD40 LOCI AND OUTCOME PREDICTION IN PATIENTS WITH EARLY IMMUNE-MEDIATED INFLAMMATORY POLYARTHRITIS Abstract Guo Xiang (United States) OP0244 SUSTAINED SUPPRESSION OF RHEUMATOID ARTHRITIS DISEASE MARKERS BY MAVRILIMUMAB BUT NOT GOLIMUMAB IN ANTI-TUMOR NECROSIS FACTORINADEQUATE RESPONDERS: AN EXPLORATORY ANALYSIS IN THE PHASE IIB EARTH EXPLORER 2 CLINICAL TRIAL Abstract Di Sante Gabriele (Italy) OP0245 HS1,2A ENHANCER POLYMORPHISM IN RHEUMATOID ARTHRITIS DETERMINES HIGH DISEASE ACTIVITY, HIGH NF-KB ACTIVITY IN B CELLS AND LEADS TO A DIFFERENTIAL RESPONSE TO THERAPY. OP0239 DISSECTING THE MOLECULAR BASIS OF IMMUNE CELL ACCUMULATION IN THE INFLAMED JOINT USING A MURINE MODEL OF RHEUMATOID ARTHRITIS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Mankia Kulveer (United Kingdom) OP0246 INCREASED PREVALENCE OF PERIODONTAL DISEASE IN ANTI-CCP POSITIVE INDIVIDUALS AT RISK OF PROGRESSION TO INFLAMMATORY ARTHRITIS: A TARGET FOR PREVENTION? Abstract Session - Room S19 PARE Abstract Session Chair Betteridge Kate (United Kingdom) Chair Grygielska Jolanta (Poland) Abstract Caeyers Nele (Belgium) OP0247-PARE SURVEY: WHAT DO PATIENTS THINK ABOUT THEIR CARE, CARETAKERS AND THE ROLE OF PATIENT ORGANISATIONS? Abstract Koehn Cheryl (Canada) OP0248-PARE UNDERSTANDING THE IMPORTANCE OF A PATIENT’S ROLE IN THE MANAGEMENT OF RA: RESULTS FROM A PATIENT-BASED SURVEY DEVELOPED BY THE RA NARRATIVE GLOBAL ADVISORY PANEL Abstract Mace Kerry (Australia) OP0249-PARE 25 YEARS OF CAMP FREEDOM - A 6 DAY CAMP FOR CHILDREN 7-17 YEARS OLD WITH ARTHRITIS Abstract Kritza Evangelia (Greece) OP0250-PARE SHARED DECISION MAKING IN RHEUMATOID ARTHRITIS - PATIENTS/DOCTORS WORKSHOP Abstract Paskins Zoe (United Kingdom) OP0251-PARE PATIENT AND PUBLIC INVOLVEMENT IN DESIGN, ANALYSIS AND REPORTING OF A PUBLIC PRIORITY SETTING EXERCISE FOR RESEARCH IN OSTEOPOROSIS Abstract Blidberg Kristin (Sweden) OP0252-PARE INCREASING THE INTEREST IN RESEARCH IN RHEUMATOLOGY Abstract Lopuhaä Nique (Netherlands) OP0253-PARE “SAMEN REUMA”- A CLOSED GROUP ON FACEBOOK FOR PEOPLE WITH RHEUMATIC DISEASES Abstract Nowell William (United States) OP0254-PARE RHEUMATOID ARTHRITIS PATIENT CHARACTERISTICS AND WILLINGNESS TO PARTICIPATE IN RESEARCH AMONG MEMBERS OF THE CREAKYJOINTS ARTHRITIS PATIENT COMMUNITY: RESULTS FROM A PATIENT SURVEY Abstract Session - Room S20 Abstract Session: Novel insights into B and T cell immunity in rheumatic disease 61 of 111 Chair Trouw Leendert (Netherlands) Chair Mauri Claudia (United Kingdom) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Pianta Annalisa (United States) OP0199 IMMUNE RESPONSES TO PREVOTELLA COPRI IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Scherer Hans (Netherlands) OP0200 CIRCULATING, AUTO-REACTIVE B CELLS SPECIFIC FOR CITRULLINATED ANTIGENS IN PATIENTS WITH RHEUMATOID ARTHRITIS DISPLAY AN ACTIVATED, PROLIFERATIVE PHENOTYPE Abstract Pandya Naimish (United States) OP0201 SAFETY, TOLERABILITY, AND FUNCTIONAL ACTIVITY OF MGD010, A DART® MOLECULE TARGETING CD32B AND CD79B, FOLLOWING A SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS Abstract Arumugakani Gururaj (United Kingdom) OP0202 LONG-LIVED CD19-NEGATIVE HUMAN PLASMA CELLS ARE GENERATED AT THE PLASMABLAST TO PLASMA CELL TRANSITION Abstract Musters Anne (Netherlands) OP0203 IN RHEUMATOID ARTHRITIS SYNOVITIS IS NOT DOMINATED BY POLYMORPHIC LOCAL, BUT RATHER BY UNIFORM SYSTEMIC T CELL RESPONSES Abstract Della Torre Emanuel (Italy) OP0204 CLONAL EXPANSION OF CD4+ CYTOTOXIC T LYMPHOCYTES IN IGG4-RELATED DISEASE Abstract Kinney G.G. (United States) OP0205 CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASES Abstract Renoux Florian (Switzerland) OP0206 FRA2 IS PLAYING A KEY ROLE IN THE CONTROL OF TREG DEVELOPMENT AND AUTOIMMUNITY Friday 10.06.2016 11:45 - 13:30 Poster Tour - Poster Area HPR - Poster Tour: Focus on rehabilitation 62 of 111 Chair Redmond Anthony (United Kingdom) Chair Moe Rikke Helene (Norway) Abstract Dures Emma (United Kingdom) FRI0643-HPR A MULTICENTRE FOCUS GROUP STUDY ON IMPORTANT OUTCOMES FOR PATIENTS WITH PSORIATIC ARTHRITIS Abstract Sammut Luke (United Kingdom) FRI0644-HPR PERCEIVED PHYSICAL ACTIVITY BENEFITS AND BARRIERS IN RHEUMATOID ARTHRITIS PATIENTS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Claassen Aniek (Netherlands) FRI0645-HPR FREQUENTLY ASKED QUESTIONS OF PATIENTS WITH OSTEOARTHRITIS: A CONSENSUS EXERCISE Abstract Parker Rosalind (New Zealand) FRI0646-HPR DOES PAINFUL HAND ARTHRITIS INFLUENCE MOTOR CORTEX EXCITABILITY AND MOTOR SKILL LEARNING? Abstract Brodin Nina (Sweden) FRI0647-HPR PHYSICAL ACTIVITY AND AEROBIC CAPACITY ASSESSMENT - A SURVEY AMONG PATIENTS WITH RHEUMATIC DISEASE IN SWEDEN, IRELAND, AND DENMARK Abstract Sand-Svartrud Anne-Lene (Norway) FRI0648-HPR GOAL SETTING IN REHABILITATION; A SYSTEMATIC SYNTHESIS OF CLINICAL PRACTICE DESCRIBED IN RANDOMIZED CONTROLLED TRIALS Abstract Fongen Camilla (Norway) FRI0649-HPR INNOVATION IN HEALTH CARE – LABORATORY VALIDITY AND RELIABILITY OF A NEW SENSOR DEVELOPED TO MEASURE CERVICAL ROTATION Abstract Silva Fabiana (Brazil) FRI0650-HPR COMPARISON OF THE EFFECTIVENESS OF FUNCTIONAL AND NIGHT SPLINT FOR RHIZARTHROSIS: A CONTROLLED, RANDOMIZED, BLINDED CLINICAL TRIAL Abstract Iversen Maura (United States) FRI0651-HPR THREE YEAR TRENDS IN PHYSICAL ACTIVITY IN ADULTS WITH RHEUMATOID ARTHRITIS Abstract Sundström Björn (Sweden) FRI0652-HPR SPINAL MOBILITY IN LONG STANDING ANKYLOSING SPONDYLITIS. APPLICATION OF NEWLY DEVELOPED REFERENCE INTERVALS ON CLINICAL DATA PARE - Poster Tour II 63 of 111 Chair Wiek Dieter (Germany) Chair Balazova Petra (Slovakia) Abstract Kullamaa Lembe (Estonia) PARE0009 ESTONIAN YOUTH AWARENESS OF INVISIBLE CHRONIC DISEASES Abstract Viora Ugo (Italy) PARE0010 INFLUENCE OF RMDS ON SEXUALITY AND COUPLE’S RELATIONSHIP: AN HARD PROBLEM FOR PATIENTS WHICH REMAINS UNSPOKEN Abstract Romero Pazos Victoria (Spain) PARE0011 LIGAFLASH, BEYOND AN IMAGE. A PHOTOGRAPHIC EXHIBITION. Abstract Smucrova Hana (Czech Republic) PARE0012 REVMA CHALLENGE 2015 – GIVE A HELPING GLOVE AND SUPPORT A PATIENT WITH RHEUMATOID ARTHRITIS Abstract Stones Simon (United Kingdom) PARE0013 JUVENILE IDIOPATHIC ARTHRITIS: IT’S NOT JUST AN OLD PERSON’S DISEASE Abstract Korevaar Gertie (Netherlands) PATIENT ADVOCACY FOR BETTER INFORMATION ON BIOSIMILARS AND SWITCHING Abstract de Souza Savia (United Kingdom) PARE0015 PATIENT INVOLVEMENT IN THE DESIGN OF TECHNOLOGICALLY-ENHANCED CLOTHING TO HELP MANAGE MUSCULOSKELETAL CONDITIONS Abstract Sobrino Grande Cristina (Spain) FAMILY PLANNING IN WOMEN WITH INFLAMMATORY ARTHRITIS: THE PATIENT'S PERSPECTIVE PARE0014 PARE0016 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Andersen Jeanette (Denmark) PARE0017 EULAR YOUNG PARE: THE VOICE OF YOUNG PEOPLE WITH RHEUMATIC DISEASES ACROSS EUROPE FRI0042 ALTERED PROFILES OF HISTONE LYSINE METHYLATION AFFECT MMP GENE TRANSCRIPTION IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS Poster Tour: Biology of RA I Chair Szekanecz Zoltán (Hungary) Chair Szentpetery Agnes (Ireland) Abstract Araki Yasuto (Japan) Abstract Rivellese Felice (United Kingdom) FRI0043 SYNOVIAL MAST CELLS CORRELATE WITH LOCAL AND SYSTEMIC INFLAMMATION AND ARE FUNCTIONALLY ASSOCIATED WITH ECTOPIC LYMPHOID STRUCTURES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS Abstract Bokarewa Maria (Sweden) FRI0044 SMOKING INDUCES IRREVERSIBLE DEREGULATION OF MICRORNA EXPRESSION IN RHEUMATOID ARTHRITIS Abstract Davies Ruth (United Kingdom) FRI0045 THERAPEUTIC BLOCKADE OF INTERLEUKIN-6 TRANS-SIGNALLING RESTORES VASCULAR FUNCTION IN MURINE COLLAGEN INDUCED ARTHRITIS Abstract Ruiz-Limon Patricia (Spain) FRI0046 TCZ ATTENUATES ATHEROTHROMBOSIS THROUGH THE SPECIFIC INHIBITION OF NETOSIS AND MONOCYTE-MEDIATED PROINFLAMMATORY ACTIVITY Abstract Kim Hae-Rim (Korea, Republic Of) FRI0047 HISTAMINE AND HISTAMINE H4 RECEPTOR PROMOTES OSTEOCLASTOGENESIS IN RHEUMATOID ARTHRITIS Abstract Rantapää-Dahlqvist Solbritt (Sweden) FRI0048 CONCENTRATIONS OF ANTIBODIES AGAINST PORPHYROMONAS GINGIVALIS ARE INCREASED BEFORE THE ONSET OF SYMPTOMS OF RHEUMATOID ARTHRITIS Abstract Di Paolo Julie (United States) FRI0049 PRECLINICAL CHARACTERIZATION OF GS-9876, A NOVEL, ORAL SYK INHIBITOR THAT SHOWS EFFICACY IN MULTIPLE ESTABLISHED RAT MODELS OF COLLAGEN-INDUCED ARTHRITIS Abstract Remuzgo-Martínez Sara (Spain) FRI0050 DIFFERENTIAL EXPRESSION OF OPG/RANKL/TRAIL SYSTEM IN RHEUMATOID ARTHRITIS Abstract Benson Robert (United Kingdom) FRI0051 IN VIVO IMAGING TO CHARACTERISE THE SPECIFICITY, FUNCTION AND BEHAVIOR OF THE CD4+ T CELLS INITIATING ARTICULAR INFLAMMATION Poster Tour: Comorbidities update 2016, part II 64 of 111 Chair Bijlsma Johannes W.J. (Netherlands) Chair Kuchuk Natalia (Netherlands) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Tournadre Anne (France) FRI0106 THE ASSOCIATION OF FATIGUE, COMORBIDITIES AND ANTI RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COMEDRA STUDY. Abstract Chadwick Laura (United Kingdom) FRI0107 NO INCREASED RISK OF HIGH GRADE CERVICAL DYSPLASIA IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract Tiosano Shmuel (Israel) FRI0108 RHEUMATOID ARTHRITIS IS ASSOCIATED WITH INCREASED RATE OF MALIGNANCY: A CROSS-SECTIONAL ANALYSIS OF 69755 PATIENTS Abstract Caprioli Marta (Italy) FRI0109 INFLUENCE OF AROMATASE INHIBITORS THERAPY ON THE OCCURRENCE OF RHEUMATOID ARTHRITIS IN WOMEN WITH BREAST CANCER. RESULTS FROM A LARGE POPULATION BASED STUDY OF THE ITALIAN SOCIETY FOR RHEUMATOLOGY Abstract Winthrop Kevin (United States) FRI0110 ASSESSMENT OF IMMUNOGENICITY OF LIVE ZOSTER VACCINATION IN RHEUMATOID ARTHRITIS PATIENTS ON BACKGROUND METHOTREXATE BEFORE AND AFTER INITIATING TOFACITINIB OR PLACEBO Abstract Fuggle Nicholas (United Kingdom) FRI0111 DENTAL ASSOCIATION OR INCIDENTAL FINDING? A META-ANALYSIS AND SYSTEMATIC REVIEW OF THE RELATIONSHIP BETWEEN RHEUMATOID ARTHRITIS AND PERIODONTITIS Abstract Rodríguez-Lozano Beatriz (Spain) FRI0112 PERIODONTITIS AND RHEUMATOID ARTHIRTIS: CHARACTERISTICS OF CHRONIC PERIODONTITIS AND ITS ASSOCIATION WITH RHEUMATOID ARTHRITIS Abstract Ito Hiromu (Japan) FRI0113 POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS USING A BIOLOGICAL AGENT – A SYSTEMATIC REVIEW AND META-ANALYSIS – Abstract El Miedany Yasser (United Kingdom) FRI0114 DEVELOPMENT OF THE PATIENT MOTIVATION QUESTIONNAIRE: CONCEPTUALIZING AND MEASURING MOTIVATION IN PATIENTS WITH INFLAMMATORY ARTHRITIS Poster Tour: Education 65 of 111 Chair Iagnocco Annamaria (Italy) Chair Mandl Peter (Austria) Abstract Camerlain Monique (Canada) FRI0599 CLINICIAN TRAINING IN MOTIVATIONAL COMMUNICATION SKILLS: THE IMPACT OF THE LANGUAGE OF CHANGE PROGRAM AMONG RHEUMATOLOGISTS FROM ACROSS CANADA Abstract Palominos Penélope (Brazil) FRI0600 FEARS AND BELIEFS OF PEOPLE LIVING WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW Abstract Majeed Shuja (United Kingdom) FRI0601 ROLE OF GROUP LEARNING TO IMPROVE REPRODUCIBILTY OF DAS-28 AMONGST HEALTHCARE PROFESSIONALS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Marras Fernandez-Cid Carlos (Spain) FRI0602 BELIEFS ABOUT SUBCUTANEOUS BIOLOGICAL AND ORAL MEDICATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS. ARCO STUDY Abstract Nowell William (United States) FRI0603 PATIENTS’ PRIORITIZATION OF PATIENT-CENTERED EDUCATION AND RESEARCH TOPICS IN RHEUMATIC DISEASE Abstract Mora Alfonso Sergio Alexander (Colombia) FRI0604 THE EFFECT OF AN EDUCATIONAL INTERVENTION BASED ON CLINICAL SIMULATION IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS DIAGNOSIS BY GENERAL PRACTITIONERS: A RANDOMIZED CLINICAL TRIAL Abstract Mora Alfonso Sergio Alexander (Colombia) FRI0605 EFFECT OF AN EDUCATIONAL INTERVENTION BASED ON CLINICAL SIMULATION IN THE DIAGNOSIS OF SPONDYLOARTHRITIS (SPA) FROM GENERAL PRACTITIONERS, A STUDY BEFORE AND AFTER Abstract Pascual Ramos Virginia (Mexico) FRI0606 THE METHOD USED TO SET PASS MARKS IN AN OBJECTIVE STRUCTURED CLINICAL EXAMINATION (OSCE) DETERMINES THE OVERALL PERFORMANCE OF CANDIDATES DURING AN ACCREDITATION PROCESS. Abstract Das Parthajit (United Kingdom) FRI0607 RHEUMATOLOGY TRAINING IN INDIA – A REFLECTION AND COMPARISON WITH UNITED KINGDOM Abstract Shabbir Shabnam (United Kingdom) FRI0608 SIMULATION FOR JOINT INJECTION AND ASPIRATION. COLLABORATING OUR EXPERIENCES, WHAT HAVE WE LEARNT? Poster Tour: Epidemiology of RMDs 66 of 111 Chair Finckh Axel (Switzerland) Chair Symmons Deborah (United Kingdom) Abstract Chastek Benjamin (United States) FRI0550 REAL-WORLD TREATMENT PATTERNS AMONG RHEUMATOID ARTHRITIS PATIENTS WHO SWITCH FROM A TUMOR NECROSIS FACTOR INHIBITOR TO ANOTHER MEDICATION Abstract Alemao E (United States) FRI0551 EVALUATION OF CHANGE IN ANTI-CITRULLINATED PEPTIDE AUTOANTIBODY LEVELS IN CLINICAL PRACTICE AND ASSOCIATION WITH RESOURCE USE Abstract Albrecht Katinka (Germany) FRI0552 PATIENTS WITH RHEUMATOID ARTHRITIS ARE MORE OBESE THAN THE GENERAL POPULATION ALREADY AT DISEASE ONSET: A COLLABORATIVE ANALYSIS FROM THREE LARGE GERMAN RA DATABASES Abstract Tedeschi Sara (United States) FRI0553 OBESITY AND THE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS IN THE NURSES' HEALTH STUDIES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Goodman Susan (United States) FRI0554 POVERTY MODIFIES THE EFFECT OF RACE ON TOTAL KNEE ARTHROPLASTY OUTCOMES Abstract Curtis Jeffrey (United States) FRI0555 LONG TERM EFFECTIVENESS OF HERPES ZOSTER VACCINE AMONG PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASES Abstract Yelin Edward (United States) FRI0556 DOES LEAVING POVERTY REDUCE NEWLY ACCUMULATED DAMAGE IN SLE? Abstract Mangnus Lukas (Netherlands) FRI0557 THE ASSOCIATION BETWEEN BODY MASS INDEX AND MRI-DETECTED INFLAMMATION; PARADOXICAL EFFECTS IN RHEUMATOID ARTHRITIS, OTHER ARTHRITIDES AND SYMPTOM-FREE CONTROLS. Abstract Zlatkovic-Svenda Mirjana (Serbia) FRI0558 RHEUMATOID ARTHRITIS PREVALENCE IN EUROPE, A EULAR-ENDORSED SURVEY Abstract Ramos-Remus Cesar (Mexico) FRI0559 LATITUDE GRADIENTS INFLUENCE THE AGE OF ONSET OF RHEUMATOID ARTHRITIS: A WORLDWIDE SURVEY. Abstract Rantalaiho Vappu (Finland) FRI0560 THE INCREASE IN THE NATIONWIDE INCIDENCE OF INFLAMMATORY RHEUMATIC DISEASES IN FINLAND DURING THIS MILLENNIUM Poster Tour: From research to biomarkers and targeting SSc 67 of 111 Chair Riemekasten Gabriela (Germany) Chair Schniering Janine (Switzerland) Abstract Bosello Silvia (Italy) FRI0238 INCREASED SERUM FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN SYSTEMIC SCLEROSIS PATIENTS: CORRELATION WITH LUNG INVOLVEMENT AND INFLAMMATORY MILIEU. Abstract Abignano Giuseppina (United Kingdom) FRI0239 COMPLEMENTARY VALUE OF ELF TEST AND NT-PROBNP IN REFLECTING FIBROSIS AND VASCULOPATHY IN SYSTEMIC SCLEROSIS Abstract Jeong Wooseong (Korea, Republic Of) FRI0240 SIRT-1 REGULATES TGF-Β INDUCED DERMAL FIBROBLAST MIGRATION VIA MODULATION OF CYR61 EXPRESSION Abstract Lightfoot Adam (United Kingdom) FRI0241 HMGB1 INDUCES REACTIVE OXYGEN SPECIES (ROS)-DEPENDENT ACTIVATION OF THE ER STRESS PATHWAY IN C2C12 MYOTUBES Abstract Garbrielli Armando (Italy) ROLE OF MITOCHONDRIA- AND NADPH OXIDASE-DERIVED ROS IN FIBROBLASTS ISOLATED FROM PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS Abstract O'reilly Steven (United Kingdom) FRI0243 IS THE BMP ANTAGONIST GREMLIN-1 A TARGET IN SYSTEMIC SCLEROSIS? Abstract Rimar Doron (Israel) FRI0244 LYSYL OXIDASE AS A BIOMARKER IN SYSTEMIC SCLEROSIS– A MULTICENTER STUDY Abstract Zanatta Elisabetta (Italy) FRI0245 SCCA-IGM IS UP-REGULATED IN SCLERODERMA PATIENTS WITH REDUCED DLCO: A NEW BIOMARKER OF PULMONARY INVOLVEMENT? FRI0242 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Henrot Pauline (France) FRI0246 DYSREGULATION OF CCN PROTEINS IN SYSTEMIC SCLEROSIS PATIENTS WITH PIGMENTARY DISORDERS Poster Tour: Imaging in RMD - Adding value 68 of 111 Chair Naredo Esperanza (Spain) Chair Kosevoi Alexandra (Romania) Abstract Ahmad H A (United States) FRI0513 VALIDATING MRI-DETECTED INFLAMMATION THRESHOLDS PREDICTIVE OF STRUCTURAL DAMAGE PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL Abstract Ez-Zaitouni Zineb (Netherlands) FRI0514 ADDING MRI OF THE SPINE TO THE ASAS CLASSIFICATION CRITERIA FOR AXIAL SPONDYLOARTHRITIS, REDUNDANT OR BENEFICIAL? DATA FROM THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE)-COHORT. Abstract Figueiredo Camille (Germany) FRI0515 QUANTIFICATION AND IMPACT OF SECONDARY OSTEOARTHRITIS IN PATIENTS WITH ANTI-CITRULLINATED PROTEIN ANTIBODIES POSITIVE RHEUMATOID ARTHRITIS Abstract Suzuki Akitake (Japan) FRI0516 ULTRASONOGRAPHIC ASSESSMENT OF NEWLY DEVELOPED ELDERLY-ONSET RHEUMATOID ARTHRITIS: A COMPARISON WITH YOUNGER-ONSET RHEUMATOID ARTHRITIS Abstract Adinolfi Antonella (Italy) FRI0517 THE OMERACT ULTRASONOGRAPHIC CRITERIA FOR ELEMENTARY LESIONS IN CALCIUM PYROPHOSPHATE DEPOSITION DISEASE: RESULTS OF A DELPHI PROCESS BY ULTRASOUND WORKING GROUP Abstract Duftner Christina (Austria) FRI0518 ULTRASOUND DEFINITIONS FOR VASCULITIS IN CRANIAL AND LARGE VESSEL GIANT CELL ARTERITIS: RESULTS OF A DELPHI SURVEY OF THE OMERACT ULTRASOUND LARGE VESSEL VASCULITIS GROUP Abstract Mandl Peter (Austria) FRI0519 ULTRASOUND DEFINITION OF CARTILAGE CHANGE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RELIABILITY STUDY BY THE OMERACT ULTRASONOGRAPHY Abstract Lariviere Delphine (France) FRI0520 COMPARISON OF 18F-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS: A PROSPECTIVE, CASE-CONTROL STUDY Abstract Glinatsi Daniel (Denmark) FRI0521 RELIABILITY OF AN OMERACT RHEUMATOID ARTHRITIS TENOSYNOVITIS SCORING SYSTEM FOR WRIST AND HAND Abstract Möller Burkhard (Switzerland) FRI0522 ULTRASOUND-DETECTED SYNOVITIS MAY PREDICT RADIOGRAPHIC DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS OVER THE NEXT FIVE YEARS – A PROSPECTIVE COHORT STUDY NESTED IN THE SWISS QUALITY MANAGEMENT PROGRAM (SCQM) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Poster Tour: RA treatment: Predictors, tapering and biosimilars 69 of 111 Chair Buch Maya (United Kingdom) Chair Nikiphorou Elena (United Kingdom) Abstract Holroyd C. (United Kingdom) FRI0154 ARE THERE NEGATIVE EFFECTS ON DISEASE ACTIVITY AND FUNCTION ASSOCIATED WITH FAILED ANTI-TNF DOSE REDUCTION STRATEGIES FOR RA PATIENTS? Abstract Sigaux Johanna (France) FRI0155 FIFTY PERCENT OF PATIENTS WHO TAPERED TNF-BLOCKERS WHILE IN STABLE REMISSION ARE ABLE TO MAINTAIN A TAPERED REGIMEN AT 3 YEAR: LONG TERM FOLLOW-UP EXTENSION OF THE STRASS TRIAL. Abstract Nordström Dan (Finland) FRI0156 EFFECTIVENESS OF TUMOR NECROSIS FACTOR-INHIBITORS IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A COMPARISON BETWEEN RANDOMIZED CONTROLLED TRIALS AND ROUTINE CLINICAL PRACTICE Abstract Nerviani Alessandra (United Kingdom) FRI0157 A BASELINE PREDICTION MODEL FOR RESPONSE TO CERTOLIZUMAB-PEGOL: ROLE OF SYNOVIAL HISTOPATHOLOGY Abstract Bejerano Carmen (Spain) FRI0158 CLINICAL EVALUATION USEFULNESS OF STANDARDIZED PROTOCOL STRATEGIES OF DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION TREATED WITH BIOLOGIC THERAPIES. THE OPTIBIO STUDY Abstract Lau Arthur (Canada) FRI0159 PERSISTENCE WITH BIOLOGIC MONOTHERAPY IN COMPARISON WITH COMBINATION THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS; RESULTS FROM AN ONTARIO RHEUMATOID ARTHRITIS COHORT. Abstract Byng-Maddick Rachel (United Kingdom) FRI0160 ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TNF ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST. Abstract Weinblatt Michael (United States) FRI0161 SUSTAINED EFFICACY AND COMPARABLE SAFETY AND IMMUNOGENICITY AFTER TRANSITION TO SB5 (AN ADALIMUMAB BIOSIMILAR) VS CONTINUATION OF THE ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULT OF PHASE III STUDY Abstract Smolen Josef S (Austria) FRI0162 COMPARABLE SAFETY AND IMMUNOGENICITY AND SUSTAINED EFFICACY AFTER TRANSITION TO SB2 (AN INFLIXIMAB BIOSIMILAR) VS ONGOING INFLIXIMAB REFERENCE PRODUCT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF PHASE III TRANSITION STUDY Abstract Taylor Peter (United Kingdom) FRI0163 EFFICACY OF THE BIOSIMILAR BOW015, COMPARED TO ORIGINATOR INFLIXIMAB, INITIATED AT MODERATE AND SEVERE DISEASE ACTIVITY THRESHOLDS IN 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... RHEUMATOID ARTHRITIS Poster Tour: Safety and efficacy of non-TNFa blockers in the treatment of RA - I Chair Terslev Lene (Denmark) Chair Dreyer Lene (Denmark) Abstract Vital Edward (United Kingdom) FRI0198 WHICH SERONEGATIVE RA PATIENTS RESPOND TO RITUXIMAB? Abstract Behrens Frank (Germany) FRI0199 RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY) Abstract Cascino Matthew (United States) FRI0200 INCIDENT MALIGNANCIES FOLLOWING INITIATION OF RITUXIMAB FOR RHEUMATOID ARTHRITIS: ANALYSIS FROM THE SUNSTONE REGISTRY Abstract Skriner Karl (Germany) FRI0201 RITUXIMAB TREATED NON RESPONDER RHEUMATOID ARTHRITIS PATIENTS ARE GENERATING A NEW AUTOANTIBODY REPERTOIRE Abstract Specker Christof (Germany) FRI0202 SAFE AND EFFECTIVE TOCILIZUMAB THERAPY IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Teitsma Xavier (Netherlands) FRI0203 SUSTAINED DRUG FREE REMISSION IN EARLY RA PATIENTS TREATED TO TARGET WITH TOCILIZUMAB, METHOTREXATE OR THEIR COMBINATION Abstract Yokoe Isamu (Japan) FRI0204 EFFECT OF TOCILIZUMAB TREATMENT ON QTC INTERVAL IN PATIENTS WITH RHEUMATOID ARTHRITIS WITHOUT CARDIAC SYMPTOMS Abstract Harrold L R (United States) FRI0205 RELATIONSHIP BETWEEN ANTI-CITRULLINATED PROTEIN ANTIBODY STATUS AND RESPONSE TO ABATACEPT OR ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A US NATIONAL OBSERVATIONAL STUDY Abstract Takahashi Nobunori (Japan) FRI0206 SERO-POSITIVITY FOR RHEUMATOID FACTOR IS AN INDEPENDENT PREDICTOR FOR ACHIEVEMENT OF GOOD EULAR RESPONSE AT 24 WEEKS IN ACPA POSITIVE RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT: RESULTS FROM JAPANESE MULTICENTER REGISTRY Abstract Curtis Jeffrey (United States) FRI0207 REAL-WORLD COMPARATIVE RISKS OF HERPES VIRUS INFECTIONS IN TOFACITINIB AND BIOLOGIC-TREATED RHEUMATOID ARTHRITIS PATIENTS Poster Tour: Scleroderma, myositis and related syndromes I 70 of 111 Chair Cutolo Maurizio (Italy) Chair Sulli Alberto (Italy) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Jaeger Veronika (Switzerland) FRI0248 PREDICTORS OF DISABILITY IN SYSTEMIC SCLEROSIS: A STUDY FROM THE DESSCIPHER PROJECT Abstract Morrisroe Kathleen (Australia) FRI0249 RISK FACTORS FOR DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION IN AUSTRALIAN SCLERODERMA PATIENTS Abstract Garen Torhild (Norway) FRI0250 SELF REPORTED GASTROINTESTINAL TRACT SYMPTOMS IN SYSTEMIC SCLEROSIS: EXPERIENCE FROM A LARGE CONSECUTIVE COHORT T.GAREN, H.ANDERSSON, A.M. HOFFMANN VOLD, Ø.MIDTVEDT, Ø.PALM, K. FRESJAR, Ø.MOLBERG Abstract Aggarwal Rohit (United States) FRI0251 ANTI-MDA5 AUTO-ANTIBODY: EXPANDING THE CLINICAL SPECTRUM IN PATIENTS WITH DERMATOMYOSITIS IN NORTH AMERICA Abstract Khanna Dinesh (United States) FRI0252 EFFICACY OF MYCOPHENOLATE MOFETIL (MMF) VERSUS ORAL CYCLOPHOSPHAMIDE (CYC) ON SKIN THICKNESS IN THE SCLERODERMA LUNG STUDY II Abstract Rossi Daniela (Italy) FRI0253 A 18 MONTH OBSERVATION IN PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS TREATED WITH AN INTENSIFIED B-LYMPHOCYTE DEPLETION -CLINICAL AND IMMUNOLOGICAL RESPONSE Abstract Van Den Hombergh Wieneke (Netherlands) FRI0254 THE EFFECT OF CYCLOPHOSPHAMIDE ON LUNG FUNCTION IN DIFFERENT STAGES OF INTERSTITIAL LUNG DISEASE ASSOCIATED TO SYSTEMIC SCLEROSIS Abstract Fraticelli Paolo (Italy) FRI0255 COMBINATION THERAPY WITH RITUXIMAB AND MYCOPHENOLATE MOFETIL IN SYSTEMIC SCLEROSIS. SAFETY AND EFFICACY FROM 12 MONTHS Abstract Groseanu Laura (Romania) FRI0256 SIGNIFICANCE OF COGNITIVE IMPAIRMENT IN SYSTEMIC SCLEROSIS Abstract Hoffmann-Vold Anna-Maria (Norway) FRI0257 AUGMENTED CONCENTRATIONS OF CX3CL1 ARE ASSOCIATED WITH PROGRESSIV INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS Poster Tour: SLE and APS - Clinical aspects 71 of 111 Chair Vassilopoulos Dimitrios (Greece) Chair Koutsianas Christos (United Kingdom) Abstract Mok Chi Chiu (Hong Kong) FRI0305 FACTORS DETERMINING HYDROXYCHLOROQUINE SERUM LEVELS IN A COHORT OF CHINESE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Di Mario Clara (Italy) FRI0306 SERUM ANTI-MÜLLERIAN HORMONE LEVELS IN SLE PATIENTS: INFLUENCE OF DISEASE SEVERITY AND THERAPY ON THE OVARIAN RESERVE Abstract Wither Joan (Canada) FRI0307 CHANGES IN URINARY BIOMARKER LEVELS CAN PREDICT TREATMENT RESPONSES IN LUPUS NEPHRITIS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract El-Sherbiny Yasser (United Kingdom) FRI0308 SURFACE TETHERIN IS A NOVEL CELL-SPECIFIC BIOMARKER FOR INTERFERON RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Mohamed Alaa (United Kingdom) FRI0309 TYPE I INTERFERON ACTIVITY IS ASSOCIATED WITH MUCOCUTANEOUS BUT NOT MUSCULOSKELETAL DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Parodis Ioannis (Sweden) FRI0310 SERUM INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 (IGFBP2) AS A BIOMARKER OF CLINICAL AND HISTOPATHOLOGICAL TREATMENT RESPONSE IN LUPUS NEPHRITIS Abstract Sarbu Mihaela Ionela (Belgium) FRI0311 NEUROPSYCHIATRIC LUPUS: COMBINING ADVANCED MORPHOMETRIC METHODS, DIFFUSION TENSOR IMAGING AND CONVENTIONAL MRI LEADS TO THE PATHWAYS OF BRAIN ABNORMALITIES. CORRELATION WITH CLINICAL AND LABORATORY DATA Abstract Petri Michelle (United States) FRI0312 PREDICTORS OF INCIDENT EPISODES OF PROTEINURIA AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Riancho-Zarrabeitia Leyre (Spain) FRI0313 EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE Abstract Zuily Stéphane (France) FRI0314 ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) CLINICAL DATABASE AND REPOSITORY ANALYSIS: THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS ON THE CLINICAL PHENOTYPE OF ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PATIENTS Poster Tour: SPA - Clinical 72 of 111 Chair Landewé Robert B.M. (Netherlands) Chair Ramiro Sofia (Netherlands) Abstract López-Medina Clementina (Spain) FRI0394 ASSESSMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS AND THEIR ASSOCIATION WITH DISEASE FEATURES AND ITS ACTIVITY. A COMPARISON BETWEEN TWO POPULATION GROUPS FROM ASAS-COMOSPA. Abstract gao dai (China) FRI0395 LOW-DOSE SEMI-CORONAL CT OF THE SACROILIAC JOINTS IN THE EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS Abstract Baraliakos Xenofon (Germany) FRI0396 WHICH IS THE MOST RELIABLE IMAGING METHOD FOR DETECTION OF STRUCTURAL CHANGES IN THE SACROILIAC JOINTS OF PATIENTS WITH ANKYLOSING SPONDYLITIS? A CROSS-SECTIONAL STUDY COMPARING MRI, CT AND CONVENTIONAL RADIOGRAPHS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Poddubnyy Denis (Germany) FRI0397 THE DIAGNOSTIC VALUE OF THE SYMPTOM OF INFLAMMATORY BACK PAIN IN AXIAL SPONDYLOARTHRITIS IN THE RHEUMATOLOGY SETTING Abstract Gensler Lianne (United States) FRI0398 PHARMACOLOGIC THERAPY AND RADIOGRAPHIC PROGRESSION IN ANKYLOSING SPONDYLITIS: A GROWING CONTROVERSY Abstract Gu Jieruo (China) FRI0399 BACKFILL IS MORE IMPORTANT THAN EROSION AND FAT DEPOSITION IN DIAGNOSING AXIAL SPONDYLOARTHRITIS AS SEEN ON MRI Abstract Deminger Anna (Sweden) FRI0400 A FIVE YEAR PROSPECTIVE STUDY OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH ANKYLOSING SPONDYLITIS Abstract Kim Hye Won (Korea, Republic Of) FRI0401 SAFETY OF RESUMING TUMOR NECROSIS FACTOR INHIBITORS IN ANKYLOSING SPONDYLITIS PATIENTS CONCOMITANT WITH THE TREATMENT OF ACTIVE TUBERCULOSIS: A RETROSPECTIVE NATIONWIDE REGISTRY OF THE KOREAN SOCIETY OF SPONDYLOARTHRITIS RESEARCH Abstract Lee Seunghun (Korea, Republic Of) FRI0402 QUANTIFICATION OF FAT FRACTION OF VERTEBRAL BONE MARROW IN PATIENTS WITH ANKYLOSING SPONDYLITIS Abstract Sengupta Raj (United Kingdom) FRI0403 EXPLORING THE NATURAL HISTORY OF BONE MARROW OEDEMA LESIONS IN AXIAL SPONDYLOARTHRITIS: WHEN TO REPEAT AN MRI? Abstract Van Lunteren Miranda (Netherlands) FRI0404 ILLNESS PERCEPTIONS AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND OTHER FORMS OF CHRONIC BACK PAIN IN THE SPACE-COHORT Poster Tour: Time for some fun with molecules 73 of 111 Chair McInnes Iain (United Kingdom) Chair Goodyear Carl (United Kingdom) Abstract Cavalli Giulio (Italy) FRI0001 TREATING EXPERIMENTAL ARTHRITIS WITH THE INNATE IMMUNE INHIBITOR IL-37 REDUCES JOINT AND SYSTEMIC INFLAMMATION Abstract Malfait Anne-Marie (United States) FRI0002 SPINAL MICROGLIAL ACTIVATION IN A MURINE SURGICAL MODEL OF KNEE OSTEOARTHRITIS Abstract Watt Fiona (United Kingdom) FRI0003 SYNOVIAL FLUID BIOMARKERS OF THE ACUTE KNEE INJURY RESPONSE ARE ASSOCIATED WITH EARLY CLINICAL OUTCOMES Abstract Maier Christiane (Germany) FRI0004 INHIBITION OF PHOSPHODIESTERASE 4 (PDE4) REDUCES DERMAL FIBROSIS BY INTERFERING WITH THE RELEASE OF PRO-FIBROTIC CYTOKINES FROM M2-MACROPHAGES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Rodríguez-Carrio Javier (Spain) FRI0005 A DISTINCT PROFILE OF SERUM FREE FATTY ACIDS IS ASSOCIATED WITH CLINICAL FEATURES AND SKEWED TH1 RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS Abstract García Pérez Samuel (Netherlands) FRI0006 CLASS 3 SEMAPHORINS MODULATE THE INVASIVE CAPACITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES Abstract Irwin Sophie (United Kingdom) FRI0007 EFFECT OF TYPE 1 AND 2 INTERFERONS ON NEUTROPHIL APOPTOSIS IN NAЇVE AND TNF ALPHA PRIMED NEUTROPHILS Poster Tour: Vasculitis I Chair Salvarani Carlo (Italy) Chair Soriano Alessandra (Italy) Abstract Brennan David (United States) FRI0354 CARDIOPULMONARY INVOLVEMENT IN TAKAYASU ARTERITIS Abstract Venhoff Nils (Germany) FRI0355 COMPARISON OF RITUXIMAB WITH CYCLOPHOSPHAMIDE AS INDUCTION THERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS SYNDROME): A 24 MONTHS FOLLOW-UP ANALYSIS. Abstract Salvarani Carlo (Italy) FRI0356 PRIMARY CENTRAL NERVOUS SYSTEM VASCULITIS ASSOCIATED WITH LYMPHOMAS Abstract Koster Matthew (United States) FRI0357 INCIDENCE AND PREDICTORS OF THORACIC AORTIC DAMAGE IN BIOPSY-PROVEN GIANT CELL ARTERITIS: A SINGLE-INSTITUTION COHORT STUDY Abstract Ostrovršnik Jaka (Slovenia) FRI0358 SHORT TERM PROGNOSIS OF A PROSPECTIVELY FOLLOWED COHORT OF UNSELECTED ADULT IGA VASCULITIS CASES - A SINGLE RHEUMATOLOGY CENTRE EXPERIENCE Abstract Alibaz-Oner Fatma (United States) FRI0359 ASSESSMENT OF THE FREQUENCY OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TAKAYASU’S ARTERITIS Abstract Fernandez Berrizbeitia Olaia (Spain) FRI0360 AORTITIS DIAGNOSIS BY PET. A REPORT OF 33 PET FROM A UNIVERSITY HOSPITAL IN A 3 YEAR PERIOD. Abstract Murgia Giuseppe (Spain) FRI0361 THE EXTENSION OF INFLAMMATORY INFILTRATES OR INTIMAL HYPERPLASIA IN TEMPORAL ARTERIES DO NOT SIGNIFICANTLY PREDICT CTA-DETECTION OF AORTIC THICKENING IN NEWLY-DIAGNOSED PATIENTS WITH BIOPSY-PROVEN GIANT-CELL ARTERITIS Abstract Rodriguez-Carballeira Monica (Spain) FRI0362 PRONOSTIC FACTORS OF SURVIVAL IN ANCA-ASSOCIATED VASCULITIS (AAV). CHANGES IN THE NEW CENTURY Friday 10.06.2016 13:30 - 15:00 74 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... What is New (WIN) - ICC Auditorium WIN Session 6 Speaker Ferrari Serge (Switzerland) Speaker Doherty Michael (United Kingdom) Osteoporosis/bone diseases SP0127 Osteoarthritis Challenges in Clinical Practice Session - Hall B Difficult to treat rheumatoid arthritis Chair Sivera Francisca (Spain) Chair Breedveld Ferdinand C. (Netherlands) Presenter Schoneveld J. Leonard M. (Netherlands) Discussant van Laar Jacob M. (Netherlands) Case 1 discussion: "Nothing worked" Presenter Cooles Faye (United Kingdom) Case 2 presentation: A tale of too many side effects or All's well that ends well Discussant Isaacs John D. (United Kingdom) Case 2 discussion: "Adverse events make treatment impossible" SP0128 Case 1 presentation: A case of difficult to manage rheumatoid arthritis Clinical Science Session - Hall D Biomarkers: Powerful or powderpuff? 75 of 111 Chair Firestein Gary S (United States) Chair Nijjar Jagtar (United Kingdom) Speaker Yap Timothy (United Kingdom) Can biomarkers enhance medical care? Lessons from cancer Speaker Smolen Josef S. (Austria) New biomarkers are of little added value Speaker van Vollenhoven Ronald (Netherlands) SP0129 Biomarkers are critical for our future Abstract Mahto Arti (United Kingdom) OP0263 SYNOVIAL B-CELL GENE SIGNATURE PREDICTS RESPONSE TO RITUXIMAB THERAPY Abstract Macdonald Angus (United States) OP0264 RELATIVE FREQUENCIES OF CIRCULATING T FOLLICULAR HELPER AND T FOLLICULAR REGULATORY CELLS IN AUTOIMMUNE PATIENTS AND HEALTHY 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... CONTROL DONORS AND THE EFFECT OF DISEASE MODULATING THERAPY How to Treat / Manage (HOT) - Hall E HOT Session 8 Speaker Denton Christopher (United Kingdom) Speaker Solomon Dan (United States) Raynaud's Phenomenon / Systemic Sclerosis SP0130 Comorbidity within RA Clinical Science Session - Hall C The role of nuclear medicine in rheumatology Chair Uson Jacqueline (Spain) Chair Kampen Willm Uwe (Germany) Speaker Krishnarmurthy Mohan (United Kingdom) Speaker van der Laken Conny (Netherlands) SP0131 FDG-PET for imaging joint inflammation in chronic joint disease Speaker Kampen Willm Uwe (Germany) SP0132 60 years of radiosynoviorthesis: State of the art Abstract Schett Georg (Germany) OP0265 FEVER OF UNKNOWN ORIGIN (FUO) AND INFLAMMATION OF UNKNOWN ORIGIN (IUO): IS 18F-FDG-PET/CT A USEFUL FIRST LINE DIAGNOSTIC STRATEGY? Abstract Bruijnen Stefan (Netherlands) OP0266 BASELINE 89ZR-RITUXIMAB PET MAY PREDICT THERAPEUTIC RESPONSE 24 WEEKS AFTER INITIATION OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS. Role of bone scintigraphy in the management of rheumatoid arthritis/inflammatory joint disease Outcome Science Session - Hall A PROMs/PROs in rheumatological research - time for a critical appraisal? 76 of 111 Chair Petersson Ingemar (Sweden) Chair Verstappen Suzanne (United Kingdom) Speaker Hewlett Sarah (United Kingdom) SP0133 Do we need new PROMS or can we reuse? 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker van de Laar Mart (Netherlands) Psychometric properties of clinical relevance for commonly sused PRO:s in rheumatological care Speaker de Wit Maarten (Netherlands) SP0134 Abstract Homer Dawn (United Kingdom) OP0267-HPR A SURVEY OF PATIENT REPORTED EXPERIENCE, PATIENT REPORTED OUTCOME AND WORK IN PATIENTS WITH INFLAMMATORY ARTHRITIS SEEN IN NURSE LED RHEUMATOLOGY CLINICS IN THE UK Abstract Castrejon Isabel (United States) OP0268 Patient´s perceptions of remission and the art of conciliation THE EULAR OUTCOME MEASURE LIBRARY, AN EVOLUTIONAL DATABASE OF VALIDATED PATIENT-REPORTED OUTCOMES: USE AND DISSEMINATION IN THE FIRST TWO YEARS Health Professionals Session - Capital Suite 07 Collaboration for success. User-centred design for improvement of health services Chair Sverker Annette (Sweden) Chair Ndosi Mwidimi (United Kingdom) Speaker Goodrich Joanna (United Kingdom) Speaker Revenäs Asa (Sweden) SP0135 Co-designing a mobile internet service for self-management of physical activity in RA Speaker van der Weegen Sanne (Netherlands) SP0136 User involvement in the development of e-Health products Speaker Hakansson Karin (Sweden) SP0137 A user’s experience of co-design Abstract Kuijpers Els (Netherlands) OP0269-HPR PATIENT PARTICIPATION IN MULTIDISCIPLINARY TEAM CARE: VIEWS OF PATIENTS AND HEALTH CARE PROFESSIONALS Using experience-based co-design to improve the quality of healthcare services Basic and Translational Science Session - Capital Suite 11 ER stress & rheumatic disease 77 of 111 Chair Ciccia Francesco (Italy) Chair Jacques Peggy (Belgium) Speaker Lambrecht Bart (Belgium) Speaker Gaumer Sebastien (France) Overview of ER stress and immune system SP0138 The fruit fly, as a tool to study ER stress 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Kaser Arthur (United Kingdom) ER stress, autophagy and inflammatory bowel disease Abstract Jo Sungsin (Korea, Republic Of) OP0270 TARGETING IL-23 CAN ATTENUATE PROGRESSION OF SPINAL ANKYLOSIS IN ANKYLOSING SPONDYLITIS. Abstract Aguilera Sergio (Chile) PERK PATHWAY CHARACTERIZATION IN LABIAL SALIVARY GLANDS OF SJÖGREN SYNDROME´S PATIENTS: COULD IT BE AN ADAPTIVE RESPONSE? OP0271 Basic and Translational Science Session - Capital Suite 14 Joint EULAR - EFIS session: Do stromal cells house and cure immune cells? Chair Richez Christophe (France) Chair de Bari Cosimo (United Kingdom) Speaker Hauser Anja (Germany) Organisation of protective and pathogenic immunological memory by mesenchymal stromal cells Speaker Buckley Chris (United Kingdom) The role of fibroblast subsets in the persistence of inflammation Speaker Barone Francesca (United Kingdom) Stromal cells and lymphoid neogenesis Abstract Maracle Chrissta (Netherlands) OP0272 IDENTIFICATION OF NEW INHIBITORS OF ANGIOGENESIS IN A NOVEL 3D MODEL OF RHEUMATOID ARTHRITIS SYNOVIAL ANGIOGENESIS Abstract Veréb Zoltán (Hungary) OP0273 EFFECTS OF TUMOR NECROSIS FACTOR ALPHA ON CYTOKINE SECRETION OF SYNOVIAL FLUID-DERIVED MESENCHYMAL STEM CELL-LIKE CELLS PReS Session - Capital Suite 02 Role of imaging in childhood-onset rheumatic diseases 78 of 111 Chair Harjacek Miroslav (Croatia) Chair Collado Paz (Spain) Speaker Vojinovic Jelena (Serbia) Speaker Malattia Clara (Italy) Speaker Collado Paz (Spain) SP0140 Imaging techniques in pediatric connective tissue disease – which and when? Abstract Tzaribachev Nikolay (Germany) OP0274 QUANTIFICATION OF DYNAMIC MRI EXAMINATIONS IN JUVENILE IDIOPATHIC ARTHRITIS SP0139 The role of ultrasound in JIA The role of MRI in JIA 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Collado Paz (Spain) OP0275 PREVALENCE OF ULTRASOUND-DETECTED FINDINGS IN FOOT IN JUVENILE IDIOPATHIC ARTHRITIS VERSUS HEALTHY CHILDREN: ASSOCIATION TO PAEDIATRIC FOOT POSTURE The Young Rheumatologist - Capital Suite 01 Physician-patient relationship in the era of interactive media Chair Skingle Diana (United Kingdom) Chair Alunno Alessia (Italy) Speaker Nikiphorou Elena (United Kingdom) Speaker van Nieuwkoop Linda (Netherlands) The point of view of patients. Role of interactive media in accessing medical information and in building patient-physician relationship Speaker Faculty (-) Interactive open discussion Abstract Vliet Vlieland Theodora (Netherlands) OP0276 Abstract Clausen Jürgen (Germany) OP0277-PARE PATIENT RESEARCH PARTNERS INVOLVED IN A PROJECT TO ENHANCE DISEASEASSOCIATED COMMUNICATIONS SKILLS OF RHEUMATOID PATIENTS. SP0141 The point of view of physician. Social media: PROs and CONs of sharing patient and physician personal experience POSTGRADUATE RHEUMATOLOGY EDUCATION FOR HEALTH PROFESSIONALS IN RHEUMATOLOGY: AVAILABILITY, NEEDS AND BARRIERS Practical Skills Session - Capital Suite 06 Capillaroscopy II 79 of 111 Chair Sulli Alberto (Italy) Chair Smith Vanessa (Belgium) Speaker Smith Vanessa (Belgium) SP0028 How to differentiate normal from abnormal capillaroscopic patterns: role of in early diagnosis Speaker Sulli Alberto (Italy) SP0029 Counting and scoring the capillaries: manual versus (semi)automatic systems Speaker Herrick Ariane L. (United Kingdom) SP0030 Capillaroscopic versus laser doppler analysis of the microcirculation Speaker Cutolo Maurizio (Italy) Speaker Ingegnoli Francesca (Italy) Speaker Faculty (-) Why capillaroscopy can predict severity and prognosis SP0142 How to select the most appropriate capillaroscopic device: pros and cons Practical session with patients and case discussion 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Practical Skills Session - Capital Suite 13 Ultrasound Advanced I Chair Jousse-Joulin Sandrine (France) Chair Tamborrini Giorgio (Switzerland) Speaker Siddle Heidi (United Kingdom) SP0143 US for diagnosing inflammatory versus mechanical midfoot pain and relevant guided interventions + demo Speaker Janta Iustina (Romania) SP0144 Ultrasound of the nail; why use it in rheumatology? + demo Speaker Finzel Stephanie (Germany) SP0145 How to diferentiate erosions and vessel channels + demo Speaker Ammitzboll Mads (Denmark) SP0146 How to distinguish tenosynovitis from normal vessel artifacts in wrists and fingers + demo Tutor Oernbjerg Lykke (Denmark) PARE Session - Room S19 It`s in your hands Chair de la Torre-Aboki Jenny (Spain) Chair Boteva Boryana (Bulgaria) Speaker Mau Wilfried (Germany) SP0147 A self-determined life with a rheumatic disease – how can social participation be preserved or obtained and how can barriers be overcome Speaker Fonseca Santos Margarida (Portugal) SP0148 Learning to control – when knowledge becomes power over the day-to-day setbacks Speaker Tugwell Peter (Canada) Does enhancing health literacy improve equity and empowerment? Speaker Stones Simon (United Kingdom) Stene Prize Essay: Living with a rheumatic or musculoskeletal disease (RMD): How I take action to enjoy life to the full EULAR Projects in Education and Training - Room S20 The EULAR School of Rheumatology - A new era of education 80 of 111 Chair Iagnocco Annamaria (Italy) Chair Moltó Anna (France) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Bijlsma Johannes W.J. (Netherlands) EULAR Education in 2016. Where are we now? Speaker Burmester Gerd Rüdiger (Germany) EULAR Education: Where do we want to go? Speaker Iagnocco Annamaria (Italy) SP0149 EULAR Education: What is in it for you? Abstract Sabanathan Anetha (United Kingdom) OP0279 DEVELOPING AND RUNNING A RHEUMATOLOGY EMERGENCY SIMULATION COURSE Friday 10.06.2016 15:30 - 17:00 What is New (WIN) - ICC Auditorium WIN Session 7 Speaker Voll Reinhard E. (Germany) Systemic Lupus and APS Speaker Nestle Frank O. (United Kingdom) New developments in psoriasis: what rheumatologists should know Challenges in Clinical Practice Session - Hall B Vaccination in rheumatic patients: A two-edged sword Chair Amital Howard (Israel) Chair Wulffraat Nico (Netherlands) Presenter Perricone Carlo (Italy) Discussant Shoenfeld Yehuda (Israel) Presenter Toplak Natasa (Slovenia) Case 2 presentation: Vaccination in biologic-treated juvenile idiopathic arthritis Discussant Bijl Marc (Netherlands) Case 2 discussion: Vaccination management in rheumatic diseases, current recommendations Case 1 presentation: HPV vaccine and autoimmune rheumatological disease SP0150 Case 1 discussion: Adjuvants, vaccines and the role of immune stimulation in the genetically prone person for autoimmunity Clinical Science Session - Hall D Advances in large vessel vasculitis Chair 81 of 111 Matteson Eric (United States) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Chair Muratore Francesco (Italy) Speaker Cimmino Marco A. (Italy) SP0151 Clinical diagnosis of large vessel vasculitis Speaker Bley Torsten (Germany) SP0152 Role of imaging in the diagnosis and treatment of large vessel vasculitis Speaker Warrington Kenneth (United States) SP0153 Emerging therapies in large vessel vasculitis Abstract Belvedere Lindsay (Canada) OP0280 IMPROVED SURVIVAL IN GIANT CELL ARTERITIS: A POPULATION-BASED STUDY Abstract Macchioni Pierluigi (Italy) OP0281 SURVIVAL OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN ITALY DURING A 26-YEAR PERIOD : CORRELATION WITH HISTOLOGICAL PATTERN. SP0154 Comorbidities of PsA and other rheumatic conditions How to Treat / Manage (HOT) - Hall E HOT Session 9 Speaker Gladman Dafna D. (Canada) Speaker Winthrop Kevin (United States) Infection and rheumatic diseases Clinical Science Session - Hall C When and how to diagnose and treat Vitamin D deficiency? 82 of 111 Chair Damjanov Nemanja (Serbia) Chair Tincani Angela (Italy) Speaker Bischoff-Ferrari Heike (Switzerland) Speaker Andreoli Laura (Italy) Speaker Cutolo Maurizio (Italy) Abstract Oma Ingvild (Norway) Abstract Chaiamnuay Sumapa (Thailand) OP0283 Practical guidelines for the supplementation of vitamin D and the treatment of deficits SP0155 Viamin D and systemic lupus erythematosus: when and how to treat vitamin D insufficiency/deficiency The circannual rhythms of vitamin D serum levels follows the seasons: links with the immuneinflammatory response OP0282 EXPRESSION OF VITAMIN D RECEPTOR ASSOCIATED GENES IN THE AORTA OF CORONARY ARTERY DISEASE PATIENTS WITH AND WITHOUT RHEUMATOID ARTHRITIS A RANDOMIZED DOUBLE-BLIND COMPARATIVE CLINICAL TRIALS TO EVALUATE EFFICACY OF VITAMIN D IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Outcome Science Session - Hall A Data harmonization across (rheumatoid arthritis) clinical cohorts and registers Chair Radner Helga (Austria) Chair Dixon William G. (United Kingdom) Speaker Radner Helga (Austria) Speaker Nikiphorou Elena (United Kingdom) Speaker Askling Johan (Sweden) Abstract Norton Sam (United Kingdom) OP0284 COMPARABILITY OF THE HEALTH ASSESSMENT QUESTIONNAIRE BETWEEN COUNTRIES: PSYCHOMETRIC EXAMINATION OF CROSS-NATIONAL MEASUREMENT EQUIVALENCE Abstract Chatzidionysiou Katerina (Sweden) OP0285 THE EULAR TASK FORCE FOR STANDARDISING MINIMUM DATA COLLECTION IN RHEUMATOID ARTHRITIS OBSERVATIONAL RESEARCH: RESULTS OF A HIERARCHICAL LITERATURE REVIEW Heterogeneity of data collection in clinical RA cohorts and registers SP0156 How to collect comorbidities Towards a standardized data collection in RA? Joint Session HPR / Primary Care - Capital Suite 07 Telemedicine and e-health in community care Chair Swinnen Thijs (Belgium) Chair Bergman Stefan (Sweden) Speaker Russell Trevor (Australia) Internet-based multidisciplinary assessment Speaker Chambers Ruth (United Kingdom) SP0157 E-health in General Practice Speaker Dawson Tom (United Kingdom) SP0158 Technological challenges in implementing e-health Speaker Niezen Maartje (Netherlands) SP0159 Ethical implications of employing e-health solutions to promote healthy lifestyles Abstract Esbensen Bente Appel (Denmark) OP0286-HPR THE EFFICACY OF MOTIVATIONAL COUNSELLING AND SMS-REMINDERS ON DAILY SITTING TIME IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RANDOMISED CONTROLLED TRIAL Basic and Translational Science Session - Capital Suite 11 83 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... The inflammasome as a therapeutic target in inflammatory diseases Chair Taams Leonie (United Kingdom) Chair Mauro Claudio (United Kingdom) Speaker O'Neill Luke (Ireland) Speaker Lamkanfi Mohamed (Belgium) Abstract Campillo-Gimenez Laure (France) OP0287 Targeting the inflammasome in inflammatory disease SP0160 Protective and detrimental roles of inflammasomes CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTALS INDUCE IL-1Β PRODUCTION BY MONOCYTES THROUGH A POTASSIUM EFFLUX-DEPENDENT PATHWAY Basic and Translational Science Session - Capital Suite 14 Potential targets in inflammatory fibrotic conditions in SSc Chair Distler Jörg (Germany) Chair Becker Mike O. (Switzerland) Speaker Denton Christopher (United Kingdom) Cytokines as target in SSc Speaker Distler Oliver (Switzerland) Fibroblasts as target in SSc Speaker van Laar Jacob M. (Netherlands) Adaptive immune system as target in SSc Abstract Rudnik Michal (Switzerland) OP0289 MICRORNAS AS POTENTIAL REGULATORS OF MONOCYTE DIFFERENTIATION AND FUNCTION IN HEART FIBROSIS IN SYSTEMIC SCLEROSIS Abstract Elhai Muriel (France) OP0290 OX40L BLOCKADE PROTECTS AGAINST SKIN AND LUNG INFLAMMATION-DRIVEN FIBROSIS. The Young Rheumatologist - Capital Suite 01 How to get into the international world of rheumatology 84 of 111 Chair Sivera Francisca (Spain) Chair Ramiro Sofia (Netherlands) Speaker Moltó Anna (France) The role of EMEUNET Speaker Machado Pedro (Portugal) Opportunities abroad Speaker Dougados Maxime (France) Collaborative EU projects – how to get involved? 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Presenter Fragoulis George E. (Greece) Sicca symptoms in rheumatoid arthritis: real Sjogren's or not? Presenter Selickaja Sandra (Lithuania) Anti-TIF1-gamma antibodies – markers of paraneoplastic myositis but not of paraneoplastic rheumatic syndromes or solid tumors Practical Skills Session - Capital Suite 06 Data visualisation: tables and graphs for publication and presentation II Speaker Boers Maarten (Netherlands) SP0057 Data visualisation: tables and graphs for publication and presentation Practical Skills Session - Capital Suite 13 Ultrasound Basic II Chair Hanova Petra (Czech Republic) Chair Hammer Hilde Berner (Norway) Speaker d'Agostino Maria-Antonietta (France) Speaker Möller Ingrid (Spain) SP0058 Scoring OA + demo Speaker Diamantopoulos Andreas (Norway) SP0059 Scoring Large Vessel vasculitis Speaker Tamborrini Giorgio (Switzerland) SP0060 Tutor Oernbjerg Lykke (Denmark) Composite scoring system for RA synovitis + demo Impact on scoring - machine and experience PARE Session - Room S19 What`s new: Latest advances in treatment and management of Systemic Sclerosis and Fibromyalgia 85 of 111 Chair Fligelstone Kim (United Kingdom) Chair van Griensven Joop (Belgium) Speaker Müller-Ladner Ulf (Germany) Speaker da Silva José Antonio P. (Portugal) SP0161 Latest advances in the treatment and management of Systemic Sclerosis Fibromyalgia: body and mind pathways to disease control 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... EULAR Projects in Investigative Rheumatology - Room S20 EULAR Projects Investigative Rheumatology Chair Lories Rik (Belgium) Chair Mariette Xavier (France) Speaker Barone Francesca (United Kingdom) Essential - directions for Sjogren's disease research Speaker Jorgensen Christian (France) Gene and Cell therapy: towards a new generation of trials? Speaker van der Woude Diane (Netherlands) Speaker Faculty (-) SP0162 Becoming a bookmaker: the odds of rheumatoid arthritis Q&A Saturday 11.06.2016 08:30 - 10:00 What is New (WIN) - ICC Auditorium WIN Session 8 Speaker Mariette Xavier (France) Sjogren's Syndrome Speaker Vencovsky Jiri (Czech Republic) SP0163 Myositis Challenges in Clinical Practice Session - Hall B The elderly patient with osteoarthritis 86 of 111 Chair Singh Nijjar Jagtar (United Kingdom) Chair van Schaardenburg Dirkjan (Netherlands) Presenter Kwok Wing-Yee (Netherlands) Discussant Hawker Gillian (Canada) Case 2 discussion: Mutual influence of osteoarthritis and comorbitities on symptoms and outcome. Presenter Nagy Gyorgy (Hungary) Case 2 presentation: Thermal water and osteoarthritis, a case report SP0164 Case 1 presentation: Problems in conventional therapy in osteoarthritis 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Discussant Bender Tamas (Hungary) SP0165 Case 2 discussion: Balneotherapy: efficacy and safety in osteoarthritis Clinical Science Session - Hall D SLE: What will it be and how will it be treated 5 years from now Chair Alarcon-Riquelme Marta (Spain) Chair Fritsch-Stork Ruth (Netherlands) Speaker Rönnblom Lars (Sweden) Speaker Alarcon-Riquelme Marta (Spain) From immunogenetics to a new taxonomy for connective tissue diseases Speaker Fischer-Betz Rebecca (Germany) SP0167 Outcome assessment in SLE Speaker Voskuyl Alexandre E. (Netherlands) SP0168 How new treatments in lupus are changing the landscape Abstract Furie Richard (United States) OP0291 ANIFROLUMAB, AN ANTI-INTERFERON-ALPHA RECEPTOR MONOCLONAL ANTIBODY, IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) SP0169 Osteoporosis SP0166 The interferon pathway in SLE: from immunology to new insights and new treatment How to Treat / Manage (HOT) - Hall E HOT Session 10 Speaker Papapoulos Socrates (Netherlands) Speaker Berenbaum Francis (France) Osteoarthritis Clinical Science Session - Hall C “Time Is Joint”: Early recognition and treatment of arthritis 87 of 111 Chair Pisetsky David S. (United States) Chair Burmester Gerd Rüdiger (Germany) Speaker Bosworth Ailsa (United Kingdom) The patient perspective Speaker Mallen Christian D. (United Kingdom) The General Practitioner perspective 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Kirwan Paul (Ireland) Speaker van der Helm Annette (Netherlands) SP0170 The Health Professional perspective The doctor's perspective Outcome Science Session - Hall A Clinical outcomes for PMR / GCA Chair Mackie Sarah (United Kingdom) Chair Dasgupta Bhaskar (United Kingdom) Speaker Dejaco Christian (Austria) SP0171 EULAR/ACR guidelines for PMR – the updated evidence Speaker Buttgereit Frank (Germany) SP0172 Steroid complication in patients with PMR / GCA Speaker Helliwell Toby (United Kingdom) SP0173 Improving outcomes for patients in primary care Speaker Mackie Sarah (United Kingdom) Abstract Kume Kensuke (Japan) OP0292 INTERSPINOUS BURSITIS EVALUATION BY ULTRASOUND IS VERY USEFUL FOR DIAGNOSIS OF POLYMYALGIA RHEUMATICA EXTENSION STUDY Abstract Hider Samantha (United Kingdom) OP0293 PATIENT PRIORITIES FOR PMR RESEARCH: A PRIMARY CARE SURVEY. Patient relevant outcomes in PMR / GCA Health Professionals Session - Capital Suite 07 Getting active against rheumatoid arthritis fatigue 88 of 111 Chair van Eijk-Hustings Yvonne (Netherlands) Chair Prior Yeliz (United Kingdom) Speaker Cramp Fiona (United Kingdom) Speaker Knittle Keegan (Finland) SP0174 Health behaviour change techniques to effectively promote physical activity in people with rheumatoid arthritis Speaker Kennedy Norelee (Ireland) SP0175 Activity monitoring to support patient goals and assess progress Abstract McKenna Sean (Ireland) OP0294-HPR SLEEP QUALITY, SLEEP DISTURBANCES AND PHYSICAL ACTIVITY: A NATIONAL SURVEY OF IRISH PEOPLE WHO HAVE INFLAMMATORY ARTHRITIS Development of a physical activity programme for people with rheumatoid arthritis fatigue 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract O'Dwyer Tom (Ireland) OP0295-HPR INCREASING PHYSICAL ACTIVITY IN ANKYLOSING SPONDYLITIS (INPACT-AS): A RANDOMISED CONTROLLED TRIAL Basic and Translational Science Session - Capital Suite 11 Endothelial to mesenchymal transition and angiogenesis as driving mechanisms in systemic sclerosis. Chair Distler Oliver (Switzerland) Chair Denton Christopher (United Kingdom) Speaker Jimenez Sergio (United States) Speaker Distler Oliver (Switzerland) Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis Speaker Riemekasten Gabriela (Germany) Possible pathogenetic effects from the interaction between endothelial cells and specific antibodies in systemic sclerosis Abstract Soldano Stefano (Italy) OP0296 COMPARISON OF BOSENTAN AND MACITENTAN EFFECTS ON ENDOTHELIALTO-MESENCHYMAL TRANSITION PROCESS INDUCED BY ET-1 IN CULTURED HUMAN MICROVASCULAR ENDOTHELIAL CELLS Abstract Akashi Kengo (Japan) OP0297 KNOCKOUT OF ENDOTHELIN TYPE B RECEPTOR SIGNALING ATTENUATES BLEOMYCIN-INDUCED SKIN SCLEROSIS IN MICE SP0176 Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis Basic and Translational Science Session - Capital Suite 14 Cell-cell interaction in joint inflammation 89 of 111 Chair Buckley Chris (United Kingdom) Chair Tretter Theresa (Germany) Speaker Brahn Ernest (United States) Speaker Skapenko Alla (Germany) Cellular interactions of / with inflammatory cells Speaker Buckley Chris (United Kingdom) Cellular interactions with vascular cells and impact on angiogenesis Abstract Sun Meng (Sweden) SP0177 OP0298 Inhibitory pathways of synovial angiogenesis ANTI-CITRULLINATED PROTEIN ANTIBODIES PROMOTE SYNOVIAL FIBROBLASTS MIGRATION AND ADHESION THROUGH A PEPTIDYLARGININE DEIMINASES (PAD) DEPENDENT PATHWAY 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Vecellio Matteo (United Kingdom) OP0299 SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS IS INFLUENCED INDEPENDENTLY BY TWO CLOSELY ADJACENT RUNX3 SNPS, THAT SHOW STRONG FUNCTIONAL EFFECT IN DIFFERENT CELL TYPES PReS Session - Capital Suite 02 Transition of care Chair Pilkington Clarissa (United Kingdom) Chair Quartier Pierre (France) Speaker Minden Kirsten (Germany) SP0178 Transition care programmes: a European perspective Speaker Tucker Lori (Canada) SP0179 Transition care programmes: a North American perspective Speaker Foster Helen E. (United Kingdom) Abstract Hanns Laura (United Kingdom) OP0300 DO DEPRESSIVE SYMPTOMS AT DISEASE ONSET ASSOCIATE WITH FUTURE DISEASE ACTIVITY FOR ADOLESCENT PATIENTS WITH JIA? RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY (CAPS) Abstract Bruce Ellen (United Kingdom) OP0301 ADOLESCENT AND YOUNG ADULT CARE IN ADULT RHEUMATOLOGY: HOW WELL DO WE KNOW OUR HEEADDSS? EULAR-PReS recommendations for transitional care management for adolescents and young people The Young Rheumatologist - Capital Suite 01 Career paths in research - how to start and where to go? 90 of 111 Chair Buch Maya (United Kingdom) Chair Ramiro Sofia (Netherlands) Speaker Askling Johan (Sweden) Testimonies of clinical research Speaker Schett Georg (Germany) Testimonies of basic/translational research Speaker van der Heijde Désirée (Netherlands) The view and advice of an expert Presenter Fernandes Silvia (Portugal) Vitamin deficiency and disease activity/severity in spondyloarthritis: Results of the ASAS-Comospa intern. Study Presenter Tombetti Enrico (Italy) Takayasu arteritis: clinimetry, progression and coronary involvement 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Presenter Soare Alina (Romania) New fibrosis mechanism in systemic sclerosis and potential treatment targets Presenter Perniola Simone (Italy) SPECIALIZED PRO-RESOLVING MEDIATOR RECEPTORS IN OSTEOARTHRITIC SYNOVIUM AND CARTILAGE Practical Skills Session - Capital Suite 06 Laboratory II Chair Dörner Thomas (Germany) Chair Miossec Pierre (France) Speaker Dörner Thomas (Germany) APS Speaker Miossec Pierre (France) Vasculitis, systemic autoimmunity Speaker Feist Eugen (Germany) Inflammatory joint diseases Practical Skills Session - Capital Suite 13 Ultrasound Advanced II Chair Ammitzboll Mads (Denmark) Chair Jousse-Joulin Sandrine (France) Speaker Siddle Heidi (United Kingdom) SP0143 US for diagnosing inflammatory versus mechanical midfoot pain and relevant guided interventions + demo Speaker Janta Iustina (Romania) SP0144 Ultrasound of the nail; why use it in rheumatology? + demo Speaker Finzel Stephanie (Germany) SP0145 How to diferentiate erosions and vessel channels + demo Speaker Ammitzboll Mads (Denmark) Tutor Oernbjerg Lykke (Denmark) How to distinguish tenosynovitis from normal vessel artifacts in wrists and fingers + demo EULAR Projects in Epidemiology and Health Services - Room S20 Benchmarking of Healthcare Quality Indicators and Standard of Care for RA and OA 91 of 111 Chair Petersson Ingemar (Sweden) Chair Woolf Anthony (United Kingdom) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Woolf Anthony (United Kingdom) The EUMUSC.NET project in the national and international perspective of WHO burden of disease perspective Speaker Petersson Ingemar (Sweden) The importance of structured bench marking for the development of health care services and research Speaker Carmona Loreto (Spain) he use of Health Care Quality Indicators and Standard of Care in rheumatological practice Speaker Faculty (-) Q&A Saturday 11.06.2016 10:15 - 11:45 PARE Session - Room S19 New approaches to understanding and managing chronic musculoskeletal pain Chair Mateus Elsa (Portugal) Chair Betteridge Neil (United Kingdom) Speaker Williams Frances (United Kingdom) Speaker Moore Pete (United Kingdom) Speaker Marques Catarina (Portugal) SP0181 Abstract O Leary Grainne (Ireland) OP0302-PARE SUPPORTING PEOPLE WORKING WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS) Abstract Svanberg Beryl (Sweden) OP0303-PARE RAISING PUBLIC AWARENESS ON OSTEOARTHRITIS THROUGH AN EDUCATIONAL CAMPAIN SP0180 Advances in the genetics of chronic pain syndromes: how twin studies help Self-management of pain: The Pain Toolkit and its use in everyday life Chronic pain control: A Portuguese patient group initiative Poster Tour - Poster Area HPR - Poster Tour: Getting around rheumatic disease 92 of 111 Chair Redmond Anthony (United Kingdom) Chair Fongen Camilla (Norway) Abstract Grech Louise (Malta) SAT0637-HPR BIOSIMILARS: THE PERCEPTION AMONGST MALTESE CLINICIANS Abstract Grygielska Jolanta (Poland) SAT0638-HPR DELAYS IN DIAGNOSING OF PATIENTS WITH RHEUMATIC DISEASES IN POLAND 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Pavic Nikolic Milena (Slovenia) SAT0639-HPR THE MOST FREQUENT INQUIRIES OF PATIENTS ON SUBCUTANEOUS ANTI -TNF ALPHA THERAPIES Abstract Dikranian Ara (United States) SAT0640-HPR UNDERSTANDING THE IMPORTANCE OF A PATIENT’S ROLE IN THE MANAGEMENT OF RA: PHYSICIAN- AND PATIENT-BASED SURVEY RESULTS DEVELOPED BY THE RA NARRATIVE ADVISORY PANEL Abstract Andersson Maria (Sweden) SAT0641-HPR REASONS TO STOP DRINKING ALCOHOL AMONG PATIENTS WITH RHEUMATOID ARTHRITIS – A MIXED METHOD STUDY Abstract De Boer-Nijhof Nienke (Netherlands) SAT0642-HPR COLLABORATION OF PATIENTS AND HEALTH PROFESSIONALS IN DEVELOPMENT AND RESEARCH OF CARE-INTERVENTION: CASE EXAMPLE PRESENTED BY A PATIENT RESEARCH PARTNER Abstract Siddle Heidi (United Kingdom) SAT0643-HPR POINTS TO CONSIDER FOR HEALTH PROFESSIONALS UNDERTAKING MUSCULOSKELETAL ULTRASOUND FOR RHEUMATIC AND MUSCULOSKELETAL DISEASES: PROGRESS OF A EULAR TASK FORCE. Abstract Sarran Constance (France) SAT0644-HPR BELIEFS, KNOWLEDGES AND REPRESENTATIONS OF PATIENTS WITH GOUT DISEASE FOLLOWED BY GENERAL HEALTHCARE AND HOSPITAL RHEUMATOLOGY : FROM DIONYSUS TO THE SWORD OF DAMOCLES Poster Tour: Basic research in systemic sclerosis 93 of 111 Chair Riemekasten Gabriela (Germany) Chair Maurer Britta (Switzerland) Abstract Chakraborty Debomita (Germany) SAT0184 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) INTEGRATES SEVERAL PROFIBROTIC PATHWAYS IN SYSTEMIC SCLEROSIS Abstract Chen Chih-Wei (Germany) SAT0185 WNT5A PROMOTES FIBROBLAST ACTIVATION AND TISSUE FIBROSIS BY ROR2/ RYK DEPENDENT ACTIVATION OF PCP-SIGNALING. Abstract Mallano Tatjana (Germany) SAT0186 THE HOMEOPROTEIN ENGRAILED-1 REGULATES CANONICAL TGF-Β SIGNALING VIA FIBROBLAST DIFFERENTIATION AND TISSUE FIBROSIS Abstract Lu Xin (China) SAT0187 THE ANTIMICROBIAL PEPTIDE LL-37 AND TYPE I INTERFERON IN IDIOPATHIC INFLAMMATORY MYOPATHIES Abstract Bhattarai Salyan (Germany) SAT0188 SKELETAL MUSCLE FIBERS IN MYOSITIS ACTIVELY UPREGULATE IMMUNOPROTEASOME SUBUNITS Abstract Jakobsson Per-Johan (Sweden) SAT0189 CHARACTERIZATION OF EXTRACELLULAR HISTIDYL-TRNA SYNTHETASE IN MYOSITIS Abstract Kim Young (Korea, Republic Of) SAT0190 HISTOLOGICAL STUDY ON THE EXPRESSION OF TRANSCRIPTIONAL INTERMEDIARY FACTOR 1(TIF 1) IN THE PATIENTS WITH INFLAMMATORY MYOPATHIES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Contin-Bordes Cecile (France) SAT0191 PLATELETS INDUCE THYMIC STROMAL LYMPHOPOIETIN PRODUCTION BY ENDOTHELIAL CELLS: CONTRIBUTION TO HUMAN SYSTEMIC SCLEROSIS FIBROSIS Abstract Aringer Martin (Germany) SAT0192 DECREASED INTERLEUKIN-6/STAT3, BUT INCREASED INTERFERON/STAT1 SIGNALLING IN LYMPHOCYTES OF PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) Abstract Tam Angela (United Kingdom) SAT0193 MACROPHAGES RESPONDING TO MECHANICAL STRESS IN SCLERODERMA Abstract Pigatto Erika (Italy) SAT0194 IL-6 SERUM LEVELS AND CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS. Poster Tour: Biology of RA II 94 of 111 Chair Szekanecz Zoltán (Hungary) Chair Balogh Emese (Ireland) Abstract Gaber Timo (Germany) SAT0042 DISENTANGLING THE ROLE OF HYPOXIA-INDUCIBLE FACTOR 1 AND 2 IN THE ADAPTION PROCESS OF HUMAN MICROVASCULAR ENDOTHELIAL CELLS TO PATHOPHYSIOLOGICAL HYPOXIA Abstract Skriner Karl (Germany) SAT0043 INHIBITORY POTENTIAL OF SPECIFIC MONOCLONAL ACPAS IN TWO MOUSE SUBSPECIES GENETICALLY SEPARATED ABOUT ONE MILLION YEARS AGO Abstract Nam Eon Jeong (Korea, Republic SAT0044 Of) ROBUST THERAPEUTIC EFFICACY OF MATRIX METALLOPROTEINASE-2 CLEAVABLE FAS-1-RGD PEPTIDE COMPLEX ON CHRONIC INFLAMMATORY ARTHRITIS Abstract Rantapää-Dahlqvist Solbritt (Sweden) ANTIBODIES DIRECTED AGAINST ENDOGENOUS AND EXOGENOUS CITRULLINATED ANTIGENS PRE-DATE THE ONSET OF RHEUMATOID ARTHRITIS Abstract Lee Sang, Yeob (Korea, Republic SAT0046 Of) REGULATION OF SIRT1 MAYBE A PIONEERING STRATEGY IN TREATMENT OF RHEUMATOID ARTHRITIS Abstract Guillot Xavier (France) SAT0047 LOCAL CRYOTHERAPY DOWN-REGULATES LOCAL AND SYSTEMIC IL-6 AND IL-17 PATHWAYS IN ADJUVANT-INDUCED ARTHRITIS Abstract Mo Ying-Qian (China) SAT0048 OVEREXPRESSION OF CCL18 PROMOTES MIGRATION AND ACTIVATION OF FIBROBLAST-LIKE SYNOVIOCYTES IN RHEUMATOID ARTHRITIS Abstract Just Søren (Denmark) SAT0049 CIRCULATING CD45+ CD34+ CD11B+ CELLS ARE IMMATURE FIBROCYTES AND THE LEVEL CORRELATES WITH THE NUMBER OF MONONUCLEAR CELLS THAT IN VITRO DIFFERENTIATE TO MATURE FIBROCYTES: A POTENTIAL NEW MARKER FOR INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS. Abstract Puchner Antonia (Austria) SAT0050 RESIDENT NON-CLASSICAL MONOCYTES ARE CRITICALLY IMPORTANT FOR TISSUE DESTRUCTION IN ARTHRITIS SAT0045 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Tan Wenfeng (China) SAT0051 TRANSCRIPTION FACTOR SOX5 PROMOTES RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST MIGRATION AND INVASION BY REGULATING MMP9 EXPRESSION VIA DOWNREGULATED MIR-15A/MIR-16 Poster Tour: Genetic basis and genomics of disease Chair Neumann Elena (Germany) Chair Ospelt Caroline (Switzerland) Abstract Lessard Christopher (United States) SAT0001 IDENTIFICATION OF SJÖGREN’S SYNDROME RISK LOCI NEAR TNFAIP3 AND PRDM1 Abstract Gonzalez A (Spain) SAT0002 SPECIFIC PREMATURE EPIGENETIC AGING OF CARTILAGE IN OSTEOARTHRITIS Abstract Kowal-Bielecka Otylia (Poland) SAT0003 THE ROLE OF 12/15-LIPOXYGENASE IN THE PATHOGENESIS OF OSTEOPOROSIS IN MICE. Abstract Stuhlmüller Bruno (Germany) SAT0004 GENOMIC STRATIFICATION BY HLA-DRB4 EXPRESSION IDENTIFIES INNATE AND ADAPTIVE IMMUNE PATTERNS AS DIFFERENTIAL PREDICTORS OF RESPONSE TO METHOTREXATE IN RHEUMATOID ARTHRITIS Abstract Rego-Pérez Ignacio (Spain) SAT0005 A META-ANALYSIS AND A FUNCTIONAL STUDY WITH TRANSMITOCHONDRIAL CYBRIDS CONFIRM THE ROLE OF THE MTDNA HAPLOGROUPS IN THE DEVELOPMENT OF INCIDENT KNEE OSTEOARTHRITIS. DATA FROM CHECK AND OAI Abstract Conigliaro Paola (Italy) SAT0006 POLYMORPHISMS IN STAT4, IL10, PSORS1C1, PTPN2 AND MIR146A GENES ARE DIFFERENTLY ASSOCIATED WITH NEGATIVE PROGNOSTIC FACTORS IN ITALIAN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS Abstract Chen Zhiyong (China) SAT0007 GENETIC POLYMORPHISMS OF HLA-DRB1 ARE ASSOCIATED WITH DERMATOMYOSITIS AND ANTI-MDA5 ANTIBODIES IN CHINESE Abstract Genre Fernanda (Spain) SAT0008 IL-17A GENE IMPLICATION IN SPANISH PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Nair Nisha (United Kingdom) SAT0009 INVESTIGATION OF DIFFERENTIAL METHYLATION AS A POTENTIAL BIOMARKER OF METHOTREXATE RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract Omoyinmi Ebun (United Kingdom) SAT0010 A TARGETED NEXT-GENERATION SEQUENCING GENE PANEL FOR AUTOINFLAMMATION. Poster Tour: Imaging RMD - What else? 95 of 111 Chair Naredo Esperanza (Spain) Chair Moeller-Bisgaard Signe (Denmark) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Aga Anna-Birgitte (Norway) SAT0528 DEVELOPMENT AND VALIDATION OF A RESPONSIVE ULTRASOUND JOINT INFLAMMATION SCORE FOR RHEUMATOID ARTHRITIS THROUGH A DATA-DRIVEN APPROACH Abstract Shah Syed Mahmood (United States) SAT0529 HYDROXYCHLOROQUINE RETINOPATHY: UPDATE ON APPLICATION OF THE 2011 SCREENING GUIDELINES IN AN ACADEMIC PRACTICE. Abstract Geng Yan (China) SAT0530 DEEP CLINICAL REMISSION - AN OPTIMIZED TARGET IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS? EXPERIENCE FROM AN ULTRASONOGRAPHY STUDY Abstract Scharmga Andrea (Netherlands) SAT0531 CAN HISTOLOGICALLY DEFINED PERI-ARTICULAR VASCULAR CHANNELS BE IDENTIFIED ON HIGH-RESOLUTION COMPUTED TOMOGRAPHY? – A STUDY IN CADAVERIC FINGER JOINTS Abstract Shen Jiayun (Hong Kong) SAT0532 TIBIAL CORTICAL THICKNESS MEASURED BY HIGH–RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY DISCRIMINATES VERTEBRAL FRACTURES IN PATIENTS ON LONG-TERM GLUCOCORTICOIDS INDEPENDENT OF AREAL BONE MINERAL DENSITY Abstract Najm Aurelie (France) SAT0533 KNEE SYNOVITIS: ULTRASONOGRAPHIC FINDINGS STRONGLY CORRELATE WITH SYNOVIAL MEMBRANE HISTOLOGY. Abstract Milchert Marcin (Poland) SAT0534 HOW TO DEFINE SONOGRAPHIC SIGNS OF AXILLARY VASCULITIS IN GIANT CELL ARTERITIS? Abstract Rueda-Gotor Javier (Spain) SAT0535 CAROTID ULTRASOUND IN THE CARDIOVASCULAR RISK STRATIFICATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF A POPULATION-BASED STUDY Abstract Wendling Daniel (France) SAT0536 UTILITY OF 18F-FLUORO-DEXOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR THE DIAGNOSIS OF POLYMYALGIA RHEUMATICA: A CONTROLLED STUDY. Abstract Basaric Milica (Serbia) SAT0537 SENSITIVITY AND SPECIFICITY OF ULTRASOUND SCORE FOR THE DIAGNOSIS OF GOUT Poster Tour: Infection related rheumatic diseases 96 of 111 Chair Vassilopoulos Dimitrios (Greece) Chair Thomas Konstantinos (Greece) Abstract Premkumar Arthi (Singapore) SAT0481 CLINICAL FEATURES ASSOCIATED WITH HIGHER MORTALITY IN ADULTS WITH SEPTIC ARTHRITIS - A 10-YEAR RETROSPECTIVE STUDY Abstract Md Yusof Md Yuzaiful (United Kingdom) SAT0482 RISK FACTORS FOR SEVERE INFECTION AND OUTCOME OF SECONDARY HYPOGAMMAGLOBULINAEMIA IN PATIENTS WITH AUTOIMMUNE RHEUMATIC 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... DISEASES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS FROM 400 PATIENTS AT A SINGLE CENTRE Abstract GAIGNEUX EMELINE (France) SAT0483 ULTRASONOGRAPHY CHANGES DURING THE COURSE OF SEPTIC ARTHRITIS ARE ASSOCIATED WITH FUNCTIONAL OUTCOME Abstract Koutsianas Christos (Greece) SAT0484 LONG-TERM SAFETY OF NON-TNF INHIBITOR BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS WITH CHRONIC OR PAST HEPATITIS B VIRUS INFECTION Abstract Martín Nares Eduardo (Mexico) SAT0485 PREVALENCE OF AUTOIMMUNE DISEASES IN HIV-INFECTED PATIENTS IN MEXICO. Abstract Fukui Shoichi (Japan) SAT0486 TNF INHIBITORS HAVE NO EFFECTS TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)-INFECTED CELL LINE Abstract Cates Matthew (United Kingdom) SAT0487 SCREENING FOR PAST INFECTION WITH HEPATITIS B IN PATIENTS RECEIVING RITUXIMAB: AN AUDIT Abstract Ceballos Flavia (Argentina) SAT0488 TUBERCULOSIS IN A REGISTRY OF RHEUMATIC PATIENTS TREATED WITH BIOLOGICAL DRUGS Abstract Cipriani Paola (Italy) SAT0489 BIOLOGIC THERAPIES AND INFECTIONS IN THE DAILY PRACTICE: A STUDY ON HISTORICAL COHORT FROM 3 ITALIAN RHEUMATOLOGIC UNITS. Abstract Amarilyo Gil (Israel) SAT0490 POOR LONG-TERM ADHERENCE TO SECONDARY PENICILLIN PROPHYLAXIS AMONG PEDIATRIC PATIENTS WITH RHEUMATIC FEVER Poster Tour: Innate immune cells coming to play 97 of 111 Chair Voll Reinhard E. (Germany) Chair Herrmann Martin (Germany) Abstract Wohlfahrt Thomas (Germany) SAT0021 TYPE 2 INNATE LYMPHOID CELLS ARE RAPIDLY AND PERSISTENTLY RECRUITED IN EXPERIMENTAL FIBROSIS AND THEIR COUNTS CORRELATE WITH THE SEVERITY OF SKIN AND LUNG FIBROSIS IN SYSTEMIC SCLEROSIS Abstract Geven Edwin (Netherlands) SAT0022 S100A8/A9 IS A POTENT SERUM AND IMAGING BIOMARKER TOOL FOR ASSESSING JOINT INFLAMMATION AND DESTRUCTION IN SERONEGATIVE EXPERIMENTAL ARTHRITIS Abstract Ciccia Francesco (Italy) SAT0023 ARTERY TERTIARY LYMPHOID ORGANS OCCUR IN GIANT CELL ARTERITIS Abstract Klein . Kerstin (Switzerland) SAT0024 EPIGENETIC ANALYSIS OF LPS-INDUCED TOLERANCE IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS AND MACROPHAGES Abstract Kraaij Tineke (Netherlands) SAT0025 ENHANCED CAPACITY OF MPO-ANCA COMPARED TO PR3-ANCA FOR INDUCING NEUTROPHIL EXTRACELLULAR TRAPS 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Norling Lucy (United Kingdom) SAT0026 PRO-RESOLVING AND CARTILAGE-PROTECTIVE ACTIONS OF RESOLVIN D1 IN INFLAMMATORY ARTHRITIS Abstract Young Nicholas (United States) SAT0027 INHIBITION OF TLR7 AND TLR8 SIGNALING BY ANTAGONIZING MICRO-RNA DERIVED FROM EXTRACELLULAR VESICLES SUPPRESSES INFLAMMATION IN A NOVEL HUMAN-MOUSE CHIMERIC MODEL OF LUPUS Abstract Munk Heidi (Denmark) SAT0028 CIRCULATING SURFACTANT PROTEIN-D (SP-D) MOLECULAR SIZE PROFILE DIFFERS BETWEEN PATIENTS WITH UNTREATED AXIAL SPONDYLOARTHRITIS AND HEALTHY CONTROL SUBJECTS. Abstract Mok Mo Yin (Hong Kong) SAT0029 DECTIN-1 MEDIATES ABERRANT INNATE AND ADAPTIVE IMMUNE RESPONSE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Wang Qi (Netherlands) SAT0030 ACTIVE PMR AND GCA IS ASSOCIATED WITH CHANGES IN MONOCYTE SUBSET COMPOSITION Poster Tour: New approaches to back pain - soft tissue problems 98 of 111 Chair Mallen Christian D. (United Kingdom) Chair Hider Sam (United Kingdom) Abstract Colombey Antoine (France) SAT0502 TOLERANCE AND ACCEPTABILITY OF US GUIDED EPIDURAL INJECTIONS VIA THE SACRAL HIATUS Abstract Brady Sharmayne (Australia) SAT0503 RELATIONSHIPS BETWEEN WEIGHT, PHYSICAL ACTIVITY AND BACK PAIN IN YOUNG ADULT WOMEN Abstract Ranasinghe Priyanga (Sri Lanka) SAT0504 PREVALENCE AND CORRELATES OF HOUSEHOLD WORK RELATED MUSCULOSKELETAL DISORDERS IN LOW BACK REGION AMONG SRI LANKAN HOUSEWIVES Abstract Singh Gurkirpal (United States) SAT0505 SEVERELY-DISABLING CHRONIC LOW BACK PAIN: COMBINATION TREATMENT WITH GLUCOSAMINE–CHONDROITIN SULFATE REDUCES DISABILITY, PAIN AND NSAID CONSUMPTION – RESULTS FROM A LARGE, COMMUNITY-BASED, PILOT, OPEN PROSPECTIVE INTERVENTIONAL STUDY Abstract Hussain Sultana Monira (Australia) SAT0506 TELEVISION VIEWING TIME, PHYSICAL ACTIVITY AND LOW BACK PAIN IN COMMUNITY-BASED ADULTS: RESULTS FROM A PROSPECTIVE COHORT STUDY Abstract Baklaci Korhan (Turkey) SAT0507 COMPARISON OF ORAL SPLINTING AND KINESIOTAPING IN TEMPOROMANDIBULAR JOINT PAIN 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Buchbinder Rachelle (Australia) SAT0508 MANUAL THERAPY AND EXERCISE FOR ROTATOR CUFF DISEASE: A COCHRANE REVIEW Abstract Darrieutort-Laffite Christelle (France) SAT0509 FEASIBILITY OF ULTRASOUND-GUIDED FACET JOINT INJECTIONS THROUGH A LONGITUDINAL APPROACH. Abstract Cerqueira Marcos (Portugal) SAT0510 PAINFUL SHOULDER: RELEVANCE OF CLINICAL AND SONOGRAPHIC DATA ON CORTICOSTEROID INJECTION OUTCOME Abstract Baltsezak Stan (United Kingdom) SAT0511 MANAGEMENT OF ADHESIVE CAPSULITIS WITH LANDMARK GUIDED HIGH VOLUME STEROID INJECTIONS IN THE COMMUNITY BASED MUSCULOSKELETAL CLINIC Poster Tour: New insights in osteoarthritis 99 of 111 Chair Kloppenburg Margreet (Netherlands) Chair Courties Alice (France) Abstract Kopec Jacek (Canada) SAT0424 TRENDS IN OSTEOARTHRITIS INCIDENCE IN BRITISH COLUMBIA, CANADA, 2001-2012 Abstract Pan Feng (Australia) SAT0425 DOES WEIGHT IN THE OFFSPRING OF PEOPLE WITH A TOTAL KNEE REPLACEMENT FOR SEVERE PRIMARY KNEE OSTEOARTHRITIS HAVE A MORE DETRIMENTAL EFFECT ON KNEE CARTILAGE AND PAIN? A 10-YEAR PROSPECTIVE STUDY Abstract MARQUES-GIL DAVID (Spain) SAT0426 FUNCTIONAL CONNECTIVITY ALTERATIONS IN KNEE OA PATIENTS: AN FMRI STUDY Abstract Son Kyeong Min (Korea, Republic SAT0427 Of) THE ABSENCE OF SYMPTOM IN SUBJECTS WITH ADVANCED KNEE OA Abstract Yazici Yusuf (United States) SAT0428 SAFETY, CLINICAL AND IMAGING OUTCOMES OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: EXPLORATORY ANALYSIS OF RESULTS FROM A 24 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY Abstract Wang Xia (Australia) SAT0429 EFFECT OF VITAMIN D SUPPLEMENTATION ON EFFUSION-SYNOVITIS IN KNEE OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL Abstract Magnusson Karin (Norway) SAT0430 NEITHER OBESITY, SMOKING AND ALCOHOL ARE ASSOCIATED WITH HAND OSTEOARTHRITIS (OA) - LONGITUDINAL DATA FROM OSTEOARTHRITIS INITIATIVE (OAI) Abstract Muraki Shigeyuki (Japan) SAT0431 THRESHOLD OF JOINT SPACE WIDTH FOR KNEE PAIN: THE ROAD STUDY Abstract Kloek Corelien J.J. (Netherlands) SAT0432 BLENDED PHYSICAL ACTIVITY INTERVENTION WITH REDUCED FACE-TO-FACE CONTACT AND USUAL PHYSICAL THERAPY SHOW SIMILAR EFFECTIVENESS IN PATIENTS WITH KNEE AND HIP OSTEOARTHRITIS: A RANDOMIZED CONTROLLED 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... TRIAL Abstract Host Lauren (Australia) SAT0433 ZOLEDRONIC ACID DOES NOT SLOW SPINAL RADIOGRAPHIC PROGRESSION IN THOSE WITH RADIOGRAPHIC OSTEOARTHRITIS Poster Tour: Optimising treatment of axial SpA 100 of 111 Chair Dougados Maxime (France) Chair Poddubnyy Denis (Germany) Abstract Glintborg Bente (Denmark) SAT0371 HLA-B27 STATUS IS ASSOCIATED WITH TNFΑ INHIBITOR TREATMENT OUTCOMES IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS OBSERVATIONAL COHORT STUDY FROM THE NATIONWIDE DANBIO REGISTRY Abstract Park Jun Won (Korea, Republic Of) SAT0372 IMPACT OF DOSE TAPERING OF TUMOUR NECROSIS FACTOR-BLOCKERS ON RADIOGRAPHIC PROGRESSION IN THE ANKYLOSING SPONDYLITIS – A 4 YEAR PROSPECTIVE FOLLOW UP FROM SINGLE-CENTRE COHORT Abstract Carron Philippe (Belgium) SAT0373 EFFICACY AND SAFETY OF GOLIMUMAB IN PATIENTS WITH ACTIVE, VERY EARLY PERIPHERAL SPONDYLOARTHRITIS: FIRST RESULTS FROM THE CRESPA STUDY, A MONOCENTRIC, PLACEBO-CONTROLLED RANDOMIZED TRIAL. Abstract Micu Mihaela (Romania) SAT0374 PREGNANCY OUTCOME IN COUPLES WITH MALES EXPOSED TO LONG TERM ANTI –TNF ALPHA BLOCKER THERAPIES Abstract van der Heijde Désirée (Netherlands) SAT0375 CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA TRIAL Abstract Braun Juergen (Germany) SAT0376 SERUM CRP LEVELS DEMONSTRATE PREDICTIVE VALUE FOR RADIOGRAPHIC AND MRI OUTCOMES IN PATIENTS WITH ACTIVE AS TREATED WITH THE TNF-INHIBITOR GOLIMUMAB Abstract Jeong Hyemin (Korea, Republic Of) SAT0377 Abstract Maksymowych Walter (Canada) SAT0378 MODIFICATION OF STRUCTURAL LESIONS ON MAGNETIC RESONANCE IMAGING BY ETANERCEPT: A 12-WEEK RANDOMIZED PLACEBO-CONTROLLED TRIAL Abstract Maas Fiona (Netherlands) SAT0379 REDUCTION IN SPINAL RADIOGRAPHIC PROGRESSION IN ANKYLOSING SPONDYLITIS PATIENTS RECEIVING PROLONGED TREATMENT WITH TNF INHIBITORS: RESULTS FROM THE GLAS COHORT Abstract Gensler Lianne (United States) SAT0380 NSAIDS MODIFY THE EFFECT OF TUMOR NECROSIS FACTOR INHIBITORS ON NEW BONE FORMATION IN ANKYLOSING SPONDYLITIS DRUG SURVIVAL OF TUMOR NECROSIS FACTOR Α INHIBITORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN KOREA 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Poster Tour: Safety and efficacy of non TNFa blockers in the treatment of RA - II 101 of 111 Chair Terslev Lene (Denmark) Chair Krabbe Simon (Denmark) Abstract Yoshizaki Kazuyuki (Japan) SAT0144 SOLUBLE FORM OF GP130 MOLECULE, AN IL-6 INHIBITOR, CONTRIBUTES THE EFFICACY ON RA TO TOCILIZUMAB (AN ANTI-IL-6 RECEPTOR ANTIBODY) THERAPY. Abstract Takeuchi Tsutomu (Japan) SAT0145 EFFICACY AND SAFETY OF SIRUKUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TREATMENT: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY Abstract Weinblatt Michael (United States) SAT0146 EARTH EXPLORER 2, A PHASE IIB EXPLORATORY STUDY EVALUATING EFFICACY AND SAFETY OF MAVRILIMUMAB, A FULLY HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR-ALPHA MONOCLONAL ANTIBODY, AND THE TUMOR NECROSIS FACTOR ANTAGONIST GOLIMUMAB IN RHEUMATOID ARTHRITIS Abstract Steffgen J (Germany) SAT0147 SAFETY AND EFFICACY OF BI 655064, AN ANTAGONISTIC ANTI-CD40 ANTIBODY IN RHEUMATOID ARTHRITIS (RA) PATIENTS Abstract Durez P. (Belgium) SAT0148 IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH OLOKIZUMAB TREATMENT IN PATIENTS WITH ACTIVE, MODERATE TO SEVERE RHEUMATOID ARTHRITIS WHO HAD FAILED PREVIOUS ANTI-TNF THERAPY: RESULTS FROM THE RA0056 DOUBLEBLIND, RANDOMIZED CONTROLLED STUDY, AND RA0057, ITS OPEN-LABEL EXTENSION Abstract van der Heijde Désirée (Netherlands) SAT0149 RADIOGRAPHIC OUTCOMES IN PATIENTS ACHIEVING CLINICAL REMISSION OR LOW DISEASE ACTIVITY IN A PHASE 3 STUDY OF SARILUMAB PLUS METHOTREXATE IN PATIENTS WITH ACTIVE, MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS Abstract Suissa S (Canada) SAT0150 COMPARATIVE RISK OF MALIGNANCY WITH INITIATON OF ABATACEPT AND OTHER BIOLOGICS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COHORT ANALYSIS OF A UNITED STATES CLAIMS DATABASE Abstract Zayat Ahmed (United Kingdom) SAT0151 IMAGING AND HISTOPATHOLOGICAL CHANGES TO TOCILIZUMAB IN PATIENTS WITH MODERATE TO SEVERE RA: A SINGLE CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY Abstract Locci Marie (France) SAT0152 SAFETY OF SURGERY IN PATIENTS TREATED WITH TOCILIZUMAB FOR RHEUMATOID ARTHRITIS: DATA FROM THE REGATE REGISTRY. Abstract Emery P (United Kingdom) SAT0153 ABATACEPT PLUS METHOTREXATE CAN EFFECTIVELY AND SAFELY REGAIN THE TARGET OF REMISSION FOLLOWING RE-TREATMENT FOR FLARES AFTER 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... DRUG-FREE WITHDRAWAL IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS Poster Tour: Scleroderma, myositis and related syndromes II Chair Cutolo Maurizio (Italy) Chair Smith Vanessa (Belgium) Abstract Felis-Giemza Anna (Poland) SAT0195 EARLY NAILFOLD CAPILLAROSCOPIC PATTERN PREDOMINATES IN PATIENTS WITH MIXED CONNECTIVE TISSUE DISEASE Abstract Betelli Mauro (Italy) SAT0196 IMPRESS 2 (INTERNATIONAL MULTICENTRIC PROSPECTIVE STUDY ON PREGNANCY IN SYSTEMIC SCLEROSIS). PROSPECTIVE, CASE-CONTROL STUDY OF PREGNANCY IN SYSTEMIC SCLEROSIS Abstract Alegre Sancho Juan José (Spain) SAT0197 CAPILLAROSCOPY AND MACROVASCULAR DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS. Abstract Blagojevic Jelena (United Kingdom) THE DESSCIPHER PROJECT IN SYSTEMIC SCLEROSIS (SSC): OBSERVATIONAL DATA ON DIGITAL ULCERS (DU) PREVENTION FROM THE EUSTAR GROUP Abstract Jung Kyong Hee (Korea, Republic SAT0199 Of) NMR-BASED METABOLOMIC ANALYSIS FOR THE DIAGNOSIS OF SYSTEMIC SCLEROSIS Abstract Juhl Pernille (Denmark) SAT0200 SERUM BIOMARKERS OF COLLAGEN TURNOVER IN EARLY AND LATE DIFFUSE SYSTEMIC SCLEROSIS Abstract Miller Gopika (United States) SAT0201 DERMATOMYOSITIS AND PREGNANCY: ASSESSMENT OF DISEASE ACTIVITY AND PREGNANCY OUTCOMES COMPLICATED BY MATERNAL DERMATOMYOSITIS Abstract Bernero Elena (Italy) SAT0202 NAILFOLD MICROANGIOPATHY EXTENT AND CHOROIDAL VASCULAR THICKNESS EVALUATED BY NAILFOLD VIDEOCAPILLAROSCOPY AND OPTICAL COHERENCE TOMOGRAPHY IN SYSTEMIC SCLEROSIS PATIENTS Abstract Khelkovskaya-Sergeeva Anna (Russian Federation) SAT0203 RITUXIMAB IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES ASSOCIATED WITH INTERSTITIAL LUNG DISEASE Abstract Dobrota Rucsandra (Switzerland) SAT0204 SAT0198 THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) SCORE – A NEW PATIENT-REPORTED OUTCOME MEASURE FOR PATIENTS WITH SYSTEMIC SCLEROSIS UNDER DEVELOPMENT Poster Tour: SLE and Sjögren's - Clinical aspects 102 of 111 Chair van Vollenhoven Ronald (Netherlands) Chair Tsalapaki Christina (Greece) 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Bruce Ian N (United Kingdom) SAT0281 COMPENSATORY BRAIN MECHANISMS TO MAINTAIN COGNITIVE FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Golder Vera (Australia) SAT0282 FREQUENCY AND PREDICTORS OF ATTAINMENT OF THE LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) IN A CROSS SECTIONAL STUDY OF SLE PATIENTS IN THE ASIA PACIFIC. Abstract Monova Daniela (Bulgaria) SAT0283 RELAPSES OF LUPUS NEPHRITIS - RISK FACTORS, INCIDENCE AND IMPACT ON OUTCOME Abstract Heslinga Maaike (Netherlands) SAT0284 BOTH PROLONGED REMISSION AND LUPUS LOW DISEASE ACTIVITY STATE ARE ASSOCIATED WITH REDUCED DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Chehab Gamal (Germany) SAT0285 VACCINATIONS IN SLE: COVERAGE AND REASONS FOR NON-VACCINATION RESULTS FROM THE LULA-STUDY Abstract Li Tzu-Hao (Taiwan, Province of China) SAT0286 RISK OF SEVERE HERPES SIMPLEX VIRUS INFECTION IN PATIENTS SLE: A NATIONWIDE POPULATION COHORT STUDY Abstract Ramos-Casals Manuel (Spain) SAT0287 ETHNIC DIFFERENCES STRONGLY INFLUENCE THE PHENOTYPIC EXPRESSION OF PRIMARY SJÖGREN: STUDY OF 7887 PATIENTS FROM 20 COUNTRIES ON 5 CONTINENTS (EULAR-SS TASK FORCE BIG DATA SJÖGREN PROJECT) Abstract Howard Tripp Nadia (United Kingdom) SAT0288 CLINICAL PHENOTYPING IN 608 PATIENTS FROM THE UNITED KINGDOM PRIMARY SJÖGREN’S SYNDROME REGISTRY Abstract Hofauer Benedikt (Germany) SAT0289 SONOGRAPHIC ALTERATIONS DURING THE COURSE OF SJÖGREN´S SYNDROME – A FIVE-YEAR FOLLOW UP Abstract Quartuccio Luca (Italy) SAT0290 A HIGHER DISEASE ACTIVITY IN ANTI-SSA/SSB POSITIVE SJÖGREN’S SYNDROME IS EXPLAINED BY A HIGHER CLINICAL AND BIOLOGICAL B-CELL ACTIVATION. Poster Tour: Vasculitis II 103 of 111 Chair Salvarani Carlo (Italy) Chair Muratore Francesco (Italy) Abstract Xenitidis Theodoros (Germany) SAT0330 EFFECTIVE AND RAPID TREATMENT OF FLARES IN PATIENTS WITH BEHÇET’S DISEASE BY THE SINGLE CHAIN ANTI-TNF ANTIBODY DLX105 Abstract Fernández-Díaz Carlos (Spain) SAT0331 ITNFΑ AGENTS IN REFRACTORY NON-INFECTIOUS AORTITIS: STUDY ON 19 PATIENTS Abstract Zimba Olena (Ukraine) SAT0332 TAKAYASU ARTERITIS (TA): THE PATHOLOGICAL CHANGES IN THE CORONARY ARTERIES 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Korkmaz Cengiz (Turkey) SAT0333 HEMOSTATIC MECHANISMS MAY PLAY A ROLE IN THE DEVELOPMENT OF THROMBOSIS IN MALE PATIENTS WITH BEHCET’S DISEASE: A THROMBOELASTOGRAPHIC ANALYSIS Abstract Wallace Zachary (United States) SAT0334 NATIONWIDE TRENDS IN HOSPITALIZATION AND IN-HOSPITAL MORTALITY ASSOCIATED WITH ANCA-ASSOCIATED VASCULITIS (AAV) Abstract Tombetti Enrico (Italy) SAT0335 DIFFERENTIAL MODULATION OF THE CHROMOGRANIN-A SYSTEM IN TAKAYASU ARTERITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS Abstract Lamprecht Peter (Germany) SAT0336 DAMAGE-ASSOCIATED MOLECULAR PATTERNS IL-33 AND HIGH-MOBILITY GROUP BOX 1 AMPLIFY INFLAMMATORY PROCESSES IN GRANULOMATOSIS WITH POLYANGIITIS Abstract Sakairi Toru (Japan) SAT0337 HYPERTROPHIC PACHYMENINGITIS ASSOCIATED WITH ANCA VASCULITIS; A CASE SERIES OF 16 PATIENTS Abstract Jeong Hyemin (Korea, Republic Of) SAT0338 CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF PATIENTS WITH CHRONIC PERIAORTITIS PReS - Poster Tour: Juvenile-onset connective tissue diseases 104 of 111 Chair Kasapcopur Özgür (Turkey) Chair Belot Alexandre (France) Abstract Campos Lucia (Brazil) SAT0253 EVANS SYNDROME AT CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS DIAGNOSIS: A LARGE MULTICENTER STUDY Abstract Sahin Sezgin (Turkey) SAT0254 THE ICEBERG IN JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: SUBCLINICAL DETERIORATION OF CARDIAC FUNCTIONS ASSESSED WITH TWO-DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY AND CONTRIBUTING FACTORS OF SYSTOLIC DYSFUNCTION Abstract Costa Reis Patrícia (United States) SAT0255 PROSPECTIVE STUDY: THE ROLE OF URINARY HER2 AS A LUPUS NEPHRITIS BIOMARKER Abstract Stevens Brandi (United States) SAT0256 JUVENILE SYSTEMIC SCLEROSIS COHORT WITHIN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) LEGACY REGISTRY: BASELINE AND FOLLOW UP CHARACTERISTICS Abstract Foeldvari Ivan (Germany) SAT0257 UPDATE ON THE JUVENILE SYSTEMIC SCLEROSIS INCEPTION COHORT PROJECT. CHARACTERISTICS OF THE FIRST 74 PATIENTS AT FIRST ASSESSMENT. WWW.JUVENILESCLERODERMA.COM 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Sahin Sezgin (Turkey) SAT0258 ASSESSING MYOCARDIAL DEFORMATION OF KAWASAKI PATIENTS WITH SPECKLETRACKING ECHOCARDIOGRAPHY ON LONG TERM FOLLOW UP Abstract Specht Clémentine (France) SAT0259 DERMATOLOGICAL FEATURES OF KAWASAKI DISEASE: DATA EXTRACTED FROM THE FRENCH KAWASAKI DISEASE COHORT (KAWANET) Abstract Hinton Mark (United Kingdom) SAT0260 A NOVEL MRI-BASED ANALYSIS WORKFLOW FOR CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS (CRMO) Abstract Kostik Mikhail (Russian Federation) SAT0261 DIFFERENT TREATMENT STRATEGIES FOR CHRONIC NON-BACTERIAL OSTEOMYELITIS: THE EXPERINCE OF 52 PATIENTS. Abstract Lin Dong Fang (China) SAT0262 7 CASES OF CHINESE JUVENILE RELAPSING POLYCHONDRITIS AND SYSTEMIC REVIEW Saturday 11.06.2016 12:00 - 13:30 What is New (WIN) - ICC Auditorium WIN Session 9 Speaker Sarzi-Puttini Piercarlo (Italy) Pain and Fibromyalgia Speaker d'Agostino Maria-Antonietta (France) New developments in imaging for rheumatic diseases Challenges in Clinical Practice Session - Hall B Seronegative inflammatory arthritis: diagnostic and management challenges 105 of 111 Chair Isaacs John D. (United Kingdom) Chair Nikiphorou Elena (United Kingdom) Presenter Gaudé Marine (France) Discussant Puéchal Xavier (France) Case 1 discussion: Non-rheumatic inflammatory arthritis Presenter Nikiphorou Elena (United Kingdom) Case 2 presentation: Challenging 'seronegative' arthritis Discussant Huizinga Tom (Netherlands) Case 2 discussion: Beyond rheumatoid factor and anti-CCP SP0182 Case 1 presentation: Is this really rheumatoid arthritis? 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Clinical Science Session - Hall D Picking knowledge from other medical disciplines for SSc Chair Riemekasten Gabriela (Germany) Chair Allanore Yannick (France) Speaker Dragun Duska (Germany) Advances from nephrologists Speaker Coghlan Gerry (United Kingdom) Advances from PAH specialists Speaker Tschöpe Carsten (Germany) Advances from angeoloists and cardiologists Abstract Avouac Jérôme (France) OP0304 ESTROGENS INHIBIT THE PROFIBROTIC EFFECTS OF TGF-BETA AND PROTECT FROM THE DEVELOPMENT OF EXPERIMENTAL DERMAL FIBROSIS Abstract Smržová Andrea (Czech Republic) OP0305 PSYCHOLOGICAL PROFILE OF SCLERODERMA PATIENTS DESCRIBED BY MULTIDIMENSIONAL MINNESOTA MULTIPHASIC PERSONALITY INVENTORY (MMPI II) AND BECK DEPRESSION INVENTORY TESTS (BDI II) How to Treat / Manage (HOT) - Hall E HOT Session 11 Chair Landewé Robert B.M. (Netherlands) Chair van Vollenhoven Ronald (Netherlands) Speaker van der Heijde Désirée (Netherlands) Update of the ASAS/EULAR recommendations for the management of axial SpA Speaker van der Helm Annette (Netherlands) EULAR classification criteria for clinically suspect arthralgia Speaker Combe Bernard (France) Speaker Smolen Josef S. (Austria) SP0183 Update of the EULAR recommendations for the management of early arthritis Update on EULAR recommendations for the treatment of RA with DMARDs Clinical Science Session - Hall C Paget’s and other rare bone diseases 106 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Chair Kuchuk Natalia (Netherlands) Speaker Buttgereit Frank (Germany) SP0186 Glucocorticoid induced osteoporosis Speaker Giusti Andrea (Italy) SP0185 Reflex dystrophy: diagnosis and treatment Speaker Ralston Stuart H. (United Kingdom) SP0184 Paget's disease: new developments Abstract Papapoulos S (Netherlands) OP0306 TEN YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM EXTENSION TRIAL Outcome Science Session - Hall A Analytical Issues of Complex Databases Chair Finckh Axel (Switzerland) Chair Verstappen Suzanne (United Kingdom) Speaker Frisell Thomas (Sweden) SP0187 Why Missing Data is a Problem, and what you shouldn’t do to solve it Speaker Sergeant Jamie (United Kingdom) SP0188 Multiple imputation: a possible solution to the problem of missing data Speaker Twisk Jos (Netherlands) Why choosing marginal models for longitudinal datasets? Speaker Norton Sam (United Kingdom) SP0189 Why choose random effects models for longitudinal datasets? Abstract Sandberg Maria (Sweden) OP0307 NO LONG-TERM EFFECT ON DISEASE ACTIVITY AND PAIN OF PHYSICAL ACTIVITY FOUND IN PROSPECTIVE OBSERVATIONAL STUDY OF EARLY RHEUMATOID ARTHRITIS. Health Professionals Session - Capital Suite 07 Intimate life and sexual relations in RA 107 of 111 Chair Domjan Andrea (Hungary) Chair Smucrová Hana (Czech Republic) Speaker Sverker Annette (Sweden) SP0190 Lived experiences of intimate life in men and women with early RA Speaker Areskoug Kristina (Sweden) SP0191 Sexual health in rheumatoid arthritis – the role of the physiotherapist Speaker Ryan Sarah (United Kingdom) SP0192 Disease impact on sexuality and its management in rheumatology care Speaker Zabalan Codruta (Romania) SP0193 Nine years of marriage and three in bed - myself, my husband and my RA 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Abstract Santos-Moreno Pedro (Colombia) OP0308-HPR PRECIPITATING, PREDISPOSING AND MAINTENANCE FACTORS ASSOCIATED WITH SEXUAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS Basic and Translational Science Session - Capital Suite 11 Bone and heart: common molecular mechanisms in osteoporosis and atherosclerosis Chair Shoenfeld Yehuda (Israel) Chair Lakatos Peter (Hungary) Speaker Schett Georg (Germany) Speaker Geusens Piet (Netherlands) SP0194 Do bone erosions result from local synovitis or bone marrow edema? Speaker Lems Willem F. (Netherlands) SP0195 Osteoporosis and cardiovascular disease Abstract Vasilkova Volha (Belarus) OP0309 ASSOCIATION OF BONE MINERAL DENSITY AND CAROTID ATHEROSCLEROSIS IN PATIENTS WITH DIABETES TYPE 2 Abstract Lopez-Pedrera Chary (Spain) OP0310 ASSOCIATION OF NEUTROPHIL EXTRACELLULAR TRAPS WITH ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS Basic molecular mechanisms of bone turnover and atherosclerosis Basic and Translational Science Session - Capital Suite 14 Adiposity as a driver of arthritis through inflammatory mechanisms Chair Block Joel A. (United States) Chair Wittoek Ruth (Belgium) Speaker Senolt Ladislav (Czech Republic) Speaker Griffin Tim (United States) Speaker Messier Stephen (United States) Abstract Largo Raquel (Spain) OP0311 SYNOVIAL LIPODYSTROPHY INDUCED BY HYPERCHOLESTEROLEMIA AGGRAVATES SYNOVITIS IN AN EXPERIMENTAL MODEL OF OSTEOARTHRITIS IN RABBITS Abstract Carames Beatriz (Spain) OP0312 DIABETES-ACCELERATED EXPERIMENTAL OSTEOARTHRITIS IS PREVENTED BY AUTOPHAGY ACTIVATION Adipokines: Role in local and systemic inflammation of rheumatic diseases SP0196 Obesity and diet in experimental models of OA Exercise and diet to treat OA The Young Rheumatologist - Capital Suite 01 108 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... EULAR educational offer Chair Mandl Peter (Austria) Chair Sepriano Alexandre (Portugal) Speaker Hachulla Eric (France) SP0197 EULAR educational offer: where are we now? Speaker Haines Catherine (United Kingdom) SP0198 A masterclass on assessment questions in online courses Speaker Naredo Esperanza (Spain) SP0199 Developments in EULAR educational projects in ultrasound Speaker Iagnocco Annamaria (Italy) SP0200 Competency assessment in US: an example of qualification offered by EULAR Speaker Faculty (-) Q&A and active discussion Practical Skills Session - Capital Suite 06 Local procedures including aspirations, injections and biopsies II Chair Damjanov Nemanja (Serbia) Chair Machado Pedro (Portugal) Speaker Damjanov Nemanja (Serbia) SP0111 Sonographic-guided joint and periarticular aspirations and injections Speaker Scirè Carlo Alberto (Italy) SP0112 Minimally invasive ultrasound-guided synovial biopsy Speaker Bouffard Antonio (United States) Speaker Ungari Claudio (Italy) Speaker Faculty (-) Interventional radiology: minimally invasive image-guided procedures to diagnose and treat musculoskeletal diseases SP0113 Minimally invasive biopsy of salivary glands Q&A and discussion Practical Skills Session - Capital Suite 13 MRI II 109 of 111 Chair Juhl Pedersen Susanne (Denmark) Chair Ostergaard Mikkel (Denmark) Speaker Ostergaard Mikkel (Denmark) SP0114 How to define and assess inflammatory and destructive changes in RA and PsA – including quiz cases 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... Speaker Eshed Iris (Israel) SP0115 MRI of inflammatory diseases of vessels and muscles – How to apply, including case stories Speaker Diekhoff Torsten (Germany) SP0116 How to use MRI to differentiate SpA from its differential diagnoses – including quiz cases Speaker Juhl Pedersen Susanne (Denmark) When and how to use MRI in clinical practice – including quiz cases Joint Session PARE / HPR - Room S19 There is more than drugs Chair Clausen Jürgen (Germany) Chair Moe Rikke Helene (Norway) Speaker Pfeifer Klaus (Germany) SP0201 Sports and exercise for arthritis patients Speaker Schubert Christian (Austria) SP0202 Psychoneuroimmunology: From psyche to immune activity and back Speaker Dager Turid (Norway) Abstract Löfberg Elin (Sweden) OP0313-PARE THE SWEDISH RHEUMATISM ASSOCIATION’S BLOG ABOUT TRAINING – A NEW WAY OF LEARNING Abstract Van Der Giesen Florus (Netherlands) OP0314-PARE GROUP EXERCISE THERAPY IN ANKYLOSING SPONDYLITIS (AS): THE PATIENTS’ PERSPECTIVE. Indiviualised multidisciplinary rehabilitation - criterias of success in a rehabilitation perspective Saturday 11.06.2016 13:45 - 14:45 Highlight Session - Hall B Clinical Basic Translational Highlight Session Chair Elewaut Dirk (Belgium) Chair Fonseca Joao Eurico (Portugal) Speaker Pitzalis Costantino (United Kingdom) Basic and Translational Highlights Speaker Landewé Robert B.M. (Netherlands) Clinical Highlights Highlight Session - Capital Suite 07 110 of 111 3.6.16 11:32 http://81.63.133.217/EULAR Production/2016_London.nsf/fmWebPGMbyDayPublic_prn?openfor... HPR Highlight session Chair van den Ende Els (Netherlands) Chair Munuera Pedro (Spain) Speaker Aletaha Daniel (Austria) Highlights from Scientific Programme Speaker Prior Yeliz (United Kingdom) Highlights from Health Professionals' Programme Speaker Welling Joep (Netherlands) Highlights from PARE Programme Highlight Session - Room S19 PARE Highlight Session 111 of 111 Chair Kouloumas Marios (Cyprus) Chair Wiek Dieter (Germany) Speaker Moltó Anna (France) Highlights from the Scientific Programme Speaker Swinnen Thijs (Belgium) Highlights from the Health Professionals Programme 3.6.16 11:32
